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ABSTRACT OF DISSERTATION
COPLANAR PCB-INDUCED INFLAMMATION AND DIETARY INTERVENTIONS
Diseases, such as cardiovascular disease (CVD), are linked to chronic low levels of
inflammation. This inflamed state is the product of risk factors including exposure to
environmental pollutants, such as polychlorinated biphenyls (PCBs), which are
correlated with increased risk for CVD and diabetes. In response to this health risk, our
research addresses the mechanisms by which coplanar PCBs elicit an inflammatory
response and the mitigation of PCB-induced inflammation through dietary intervention
using docosahexaenoic acid (DHA), an omega-3 lipid.
Investigators from the University of Kentucky Engineering Department are developing
remediation technologies that detoxify PCBs through dechlorination. We studied the
cellular toxicity of coplanar PCB 77 remediation products in primary vascular endothelial
cells. The dechlorination products elicited different toxicological responses, which were
less than the parent compound and contributed to the overall inflammatory response.
The presence of PCB 77 at any concentration was sufficient to promote an inflammatory
response, which was attenuated with complete dechlorination.
PCB 77 is a good model for coplanar PCB-induced toxicity, but in environmental and
human samples, coplanar PCB 126 is detected more frequently. Using different doses of
PCB 126, we determined that acute exposure to 5 µmol PCB 126/kg mouse was
sufficient to produce an inflammatory response without inducing a toxic wasting
phenotype. PCB-induced inflammation was attenuated in vitro by DHA-derived
neuroprostanes. Applying this information, we fed mice a DHA-enriched diet and
exposed them to PCB 126. Liver and adipose lipid profiles confirm an increase in
omega-3 fatty acid composition and DHA metabolites, and changes in gene expression
indicate a heightened anti-oxidant response in the presence of PCB-induced
inflammation. These data provide an overview of the in vivo response to a PCB-induced
inflammation after DHA dietary feeding.
We have demonstrated that PCB-induced endothelial dysfunction is propagated through
lipid domains called caveolae. Caveolae are also signaling domains for toll-like receptor
4 (TLR4), and receptor for lipopolysaccharide (LPS). Similar to PCBs, TLR4 signaling is
inhibited by DHA. We compared the caveolae-associated signaling response after
exposure to coplanar PCB 126 or LPS. The domain localization of caveolae was altered
by both PCB 126 and LPS. Our study determined that PCB 126-induced inflammation
was not inhibited by a TLR4-specific inhibitor, but caveolae-based signaling was critical
to both PCB 126- and LPS-induced inflammation.
Environmental pollutants, such as coplanar PCBs, are risk factors in the development of
chronic diseases. Here we investigate possible signaling pathways associated with
environmental toxicity and apply potential dietary interventions with omega-3 lipids.
KEYWORDS: Polychlorinated biphenyls (PCBs); endothelial cells; inflammation;
docosahexaenoic acid (DHA); caveolae
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Chapter One: Introduction
1.1 Environmental pollution – PCB
The unprecedented boom in chemical manufacturing had produced a legacy of chemical
wastes and byproducts that flowed into streams and piled up in landfills. Scientists and
the public began to awaken to the horror of a polluted world. Rachel Carson, a leader in
the environmental movement, raised public awareness through her book Silent Spring;
she writes,
“The most alarming of all man’s assaults upon the environment is the
contamination of air, earth, rivers, and sea with dangerous and even lethal
materials. This pollution is for the most part irrecoverable; the chain of evil it
initiates not only in the world that must support life but in living tissues is for the
most part irreversible1.”
In response to the public outcry and mounting scientific evidence about environmental
and human health effects, Congress passed a series of environmental legislation, and
the President established the Environmental Protection Agency (EPA)2. Within this
legislation, certain environmental pollutants were banned from manufacturing including
polychlorinated biphenyls (PCBs). PCBs like many other contaminants from that era are
distinguished by their stable chemical structure which includes a biphenyl and many
configurations of chlorine substitutions that account for up to 209 possible congeners3
(Figure 1.1). Produced in mixtures, called Aroclors, PCBs were widely marketed and
used in applications in which their stability and low electrical conductivity were prized;
these applications included dielectric fluid in capacitors and light ballasts and building
materials such as paint and sealants4.
The two major classes of PCBs are defined by the stereochemistry of the biphenyl bond
(Figure 1.1)3, 5. The coplanar PCBs do not contain ortho-substitutions and exhibit dioxinlike properties. The presence of coplanar PCBs in human and animal tissues are orders
of magnitude lower than other congeners, but as a class of compounds they exhibit
greater potential for toxicity, especially PCB 1266, 7. They are dioxin-like and bind the aryl
hydrocarbon receptor (AhR) which activates cytochrome P450 (CYP) metabolizing
enzymes, the expression of which are associated with increased cellular oxidative stress
and inflammation8. Chlorine substitutions in the ortho- position cause steric hindrance for
noncoplanar PCBs, which have different biological activity than the coplanar PCBs.
Noncoplanar PCBs have an affinity for the constitutive androstane receptor (CAR)9,
which activates CYP metabolizing enzymes, and are known to disrupt Ca2+ signaling in
1

the brain through the ryanodine receptors3, 10. In addition, noncoplanar PCBs have been
associated with certain metabolic disorders. For example, PCB 153 is a noncoplanar
PCB that is present in high levels in human serum; it is associated with increased risk for
nonalcoholic fatty liver disease and Type 2 diabetes11, 12. Congeners which are monoortho-substituted, such as PCB 118, have reduced AhR activity and have molecular
similarities to noncoplanar PCBs3, 5, 13. Our research has demonstrated that in
comparison to noncoplanar PCBs, coplanar PCBs and mixed inducers promote oxidative
stress and decrease endothelial barrier function, which is critical to inflammatory process
that causes endothelial dysfunction and promotes the vascular inflammation that leads
to atherosclerosis14. We have also demonstrated that certain nutrients either promote or
inhibit coplanar PCB-induced endothelial cell dysfunction. For example, the omega-6
fatty acid linoleic acid promotes coplanar PCB-induced inflammation, but when the ratio
of omega-3 to omega-6 fatty acids is increased, the omega-3 fatty acids protect against
PCB-induced oxidative stress and nuclear factor kappa B (NFкB) activation15, 16. As a
result, the work in our laboratory has focused on the dioxin-like, coplanar PCBs.
Pollutant toxicity is compared using toxic equivalency factors (TEFs) which designate a
toxicity value based on a comparison to the toxicity of 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD, dioxin). For PCBs, only coplanar PCBs (non-ortho substituted) exhibit
dioxin-like qualities and are ligands had arylhydrocarbon receptor (AhR). The major
congeners in this class are PCB 77, PCB 126, and PCB 169 with TEFs in humans of
0.0001, 0.1 and 0.01, respectively17. In addition, PCB 170 and PCB 180 have
ethoxyresorufin-O-deethylase (EROD) activity that is sufficient for a TEF equivalency to
be assigned. Based on the median TEF values of PCB 105, PCB 118, and PCB 156, the
TEF for mono-ortho PCBs, containing one ortho substitution or a mixed congener, is
0.0000318. Together, TEFs can be combined to develop toxic equivalents (TEQ) that
may be applied when assessing limits in food sources, sediments, waterways, etc.
However, the TEFs are based primarily on studies of oral exposure, which is often the
source of exposure for both animals and humans18. As such, human exposure risk and
risk attenuation continue to be primary concerns in environmental health research.
PCB distribution in the body
The concept of persistence and biomagnification in humans and animals is based on the
ability of adipose tissue to act as a storage facility for persistent organic pollutants
(POPs)19, 20. The degree of lipophilicity for a particular toxicant is determined by a log10
2

value of >6.0 for the solubility ratio of octanol to water21. POPs that exceed the 6.0
lipophilicity threshold are soluble in dietary fat sources and are absorbed in the intestinal
lumen with triacylglycerols into the lymphatic circulation22. After entry into the lymphatic
system, they are incorporated into chylomicrons which transport the toxicants to other
tissues including the primary storage depot, the adipose. PCBs display a range of
affinities and distribute among LDL, HDL, and albumin fractions23, 24. Fortunately, the
body has a mechanism for reducing its burden of PCBs and other POPs by utilizing
enterohepatic circulation21. Through this cycle, POPs may be returned to circulation in
the blood, be acquired by the liver which packages them with bile for excretion into the
intestine. Once in the intestine, the pollutants will either be reabsorbed with the bile salts
or be excreted in the feces. Through a similar pattern of circulation, POPs are also
incorporated into mother’s breast milk, which serves as one of the first and most
concentrated exposures for humans25, 26. The circulation of these compounds is not an
innocuous process, and PCBs or other compounds are able to interact with the tissues
that are exposed during circulation including the vascular endothelium and the liver.
PCBs and other dioxin-like compounds are associated with a wide range of human
health outcomes, the mechanisms of which are still being explored. The immune,
hepatic, neural, endocrine, vascular and reproductive systems are all affected in by PCB
exposure27-29.
Molecular interactions of coplanar PCBs with target receptors
As dioxin-like compounds, coplanar PCBs are ligands for the AhR. The transcription
factor, AhR, is a member of the PER-ARNT-SIM (PAS) superfamily that has a helix-loophelix structure. This highly conserved protein requires ligand binding for activity and is a
cellular sensor that has a critical function in development, especially of the liver and
vascular systems, circadian rhythms, hypoxia, hormonal signaling, inflammation and
other biological processes30. The AhR and its chaperone proteins including two HSP90
units reside in the cytosol until ligand binding which causes the release of one HSP90
and translocation into the nucleus where AhR dimerizes with ARNT (AhR nuclear
translocator), releases the second HSP90, binds to a xenobiotic response element
(XRE, also called the dioxin response element, DRE) and facilitates transcription29. The
transcriptional changes directed by XRE binding facilitate cellular responses to
environmental stimuli; however, when these signals are prolonged by strong ligand
affinity, such as is the case of AhR binding with TCDD, disease processes are activated.
AhR activity promotes expression of Phase I and Phase II metabolism and anti-oxidant
3

response enzymes, such as the Phase I enzyme cytochrome P450 1A1 (CYP1A1)31, 32.
Ligands of the AhR require a degree of hydrophobicity, e.g. be lipophilic in nature, and
exhibit certain electronegative and hydrogen bonding properties, and as follows, this
includes a varied set of xenobiotic, endogenous and dietary compounds33. The
xenobiotic ligands that meet the physical requirements of the AhR binding pocket
represent a large number of environmental pollutants examples of which include the
following: PCBs, dioxins, naphthalenes and PAHs (polycyclic aromatic hydrocarbons),
such as benzo[a]pyrene. An equally extensive list of possible endogenous ligands have
also been identified for the AhR; these include the following: indigoids (indigo and
indirubin), 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE),
equilenin (equine estrogen), metabolites of arachidonic acid, of heme and of tryptophan.
From food sources, derivatives of indole-3-carbinol, found in cruciferous vegetables, and
flavonoids, such as quercetin are potential ligands. The diversity of AhR ligands has led
scientists to appreciate a number of functional roles for this transcription factor. Through
endogenous ligand activation, the AhR is responsible for a number of developmental
and cellular processes including cardiovascular, immune and neuronal systems34; for
example, AhR deficient mice have incomplete liver vascularization33. Dietary
polyphenols, like flavonoids, have been linked to the protective anti-oxidant response
and initiate binding to alternative XRE binding sites. In contrast, xenobiotics, such as
PCBs, hijack the endogenous functions of the AhR to produce an inflammatory
response34. The AhR-induced inflammatory response is linked to the upregulation of
detoxifying enzymes, such as CYP1A1, and cross-talk with the nuclear nuclear factor
(erythroid-derived 2)-like 2 (Nrf2) mediated anti-oxidant response35.
The AhR induces CYP1A1 expression in response to coplanar PCBs and other ligands36,
37

. CYP1A1 activity includes the hydroxylation or epoxidation of the offending xenobiotic.

When the reaction is unsuccessful and the enzyme “slips” or becomes uncoupled, a
superoxide ion is released into the cell rather than being added to the compound38.
Xenobiotics, such as PCBs, are not well metabolized, and their interaction with Phase I
enzymes, like CYP1A1, leads to a greater release of reactive oxygen species (ROS),
which significantly shift the redox balance of the cell39. Nrf2 regulated anti-oxidant
enzymes, such as glutathione-S-transferase (GST) and NAD(P)H:quinine
oxidoreductase (NQO1), serve to mitigate the increase in ROS, but when the oxidant
capacity has been exceeded the cell initiates NFĸB and other redox sensitive

4

transcription factors to produce a heightened inflammatory cascade40, 41. NFĸB promotes
the transcription of the chemokine monocyte chemoattractant protein 1 (MCP-1)42, 43,
also called CCL2, and vascular cell adhesion molecule 1 (VCAM1)44, 45, which are key
markers of endothelial cell dysfunction and the initiation of macrophage recruitment. The
cytochrome P450 enzymes are part of Phase I metabolism during which the substrates
are attacked at the site of a good leaving group which is replaced by hydroxyl, epoxide
or carboxyl functional groups 46, 47. This conversion is the first step in the transformation
of the liphophilic molecule into a water soluble substrate that can be excreted through
the kidneys. Phase II metabolizing enzymes that are upregulated through AhR activation
include glutathione transferases, UDP-glucuronyltransferases and sulfotransferases48,
which utilize the nucleophilic functional group to add a water soluble moiety such as a
glucuronic acid, amino acid (glutathione, GSH) or sulfuric acid47. CYP metabolism of
PCBs results in epoxide and hydroxylated products that are processed by the Phase II
enzymes to generate all these metabolites3.
1.2 PCBs and predisposition to inflammatory response
Endothelial dysfunction
As sensitive modulators of vascular homeostasis, endothelial cells both respond to the
changing climate within the blood and regulate the vascular environment49. For the
average American, this “climate” includes the following: dietary factors such as high
levels of fatty acids, sodium, and glucose; lifestyle factors such as minimal physical
activity; and exposure environmental pollutants from food, air, and built environments50,
51

. The endothelium responds to each of these factors by modulating the physiological

environment including vasorelaxation through endothelial nitric oxide synthase (eNOS)
signaling or inflammation through cytokine and adhesion molecule expression52, 53. The
endothelial inflammatory response culminates in a change in function termed endothelial
dysfunction in which cytokines like the chemokine monocyte chemoattractant protein-1
(MCP-1) are secreted to recruit macrophages that are captured via adhesion molecules
like VCAM1, and decreases in cell:cell junction integrity allow the macrophages to
penetrate the endothelial cell barrier42, 54, 55. Once in the intimal space, macrophages
promote the inflammatory state by producing cytokines and through phagocytosis of oxLDL, which together promote formation of foam cells that accumulate to form plaques.

5

Inflammation and disease risk
Inflammation is a characteristic held in common by a variety of diseases including lupus,
rheumatoid arthritis, Crohn disease, ulcerative colitis, dermatomyositis and
polymyositis56. The majority of these disorders can increase a patient’s risk for
myocardial infarction or coronary artery disease related events when compared to
control or the general population; for this analysis, only disorders associated with
inflammatory bowel disease did not increase vascular disease risk56. The heightened
inflammatory state increased lipoprotein oxidation and unresolved inflammation
promoting the observed effect on cardiovascular outcomes. The pro-inflammatory
cytokines, tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6) are risk factors for
cardiovascular diseases and are increased in rheumatoid arthritis (RA) patients; further,
coronary calcification is greater in RA patients with longer disease histories, which is
associated with increased cardiovascular disease prevalence in this patient population57.
Interestingly, many chronic inflammatory disease states are characterized by a
dysregulated immune response in the epithelial and mesenchymal cell structures of the
affected organ; in the case of atherosclerosis, the endothelium is activated by bacterial
components, lipoproteins or other stimuli which induce vascular cell adhesion molecule 1
(VCAM1) expression and the recruitment of immune cells that perpetuate the interstitial
inflammatory response58. Coplanar PCBs and other environmental pollutants are
potential activators of vascular inflammation.
PCBs as a risk factor in diseases of inflammation
Low grade inflammation is associated with many of chronic disorders including
cardiovascular diseases, diabetes, metabolic syndrome and obesity. Tissue
inflammation in the vascular system, adipose, and liver are all indicators and risk factors
for the development of disease. PCBs have been associated with the development of
multiple inflammation-associated medical conditions. For example, diabetes and
metabolic syndrome are increased relative to PCB levels in both the general population
and in communities with increased PCB exposure59-61. In particular, a survey of the
Japanese population indicated that PCB 126 was a key toxicant associated with the
increased prevalence of metabolic syndrome61. In a study of the 2003-2004 NHANES
data, elevated serum alanine aminotransferase (ALT), a biomarker associated with nonalcoholic fatty liver disease (NAFLD) and other liver diseases, was increased in
association with heavy metal and PCB exposure62, and NAFLD was increased in mice
exposed to PCBs11. Toxicant induced liver diseases, which include toxicant-associated
6

fatty liver disease and toxicant-associated steatohepatitis, are associated with exposure
to industrial chemicals including vinyl chloride and PCBs63. Further, cardiovascular
disease risk was increased in an elderly population independent of lipid levels and other
cardiovascular disease risk factors64, and in rats, PCB 126 was associated with
heightened cardiovascular disease risk resulting from changes in cholesterol, blood
pressure and heart weight65. Industrial workers with high levels of PCB exposure have
significantly increased levels of cardiovascular disease-related death66. These data
support of the role of PCBs in the propagation of inflammatory diseases.
PCBs, as lipophilic compounds, accumulate in the adipose and are recirculated through
the body by enterohepatic circulation, a process which exposes both the vascular
system and the liver to these toxicants. Given this environment, PCBs induce a stress
response that promotes chronic, low grade inflammation and thus predispose the
vasculature, specifically the endothelium, to heightened response to lifestyle and
pathogenic stressors, like bacterial lipopolysaccharide (LPS)67. A recent study of the
Framingham heart study cohort has concluded that the traditional risk factors are
insufficient to explain the level of inflammation observed in the study68; this would
suggest that genetic factors and environmental factors like PCBs could be the
“unobserved” risk factors. Vascular biomarkers like soluble VCAM1 provide a critical
observational link between metabolic syndrome and insulin resistance and the
development of CVD and diabetes69. Studies have suggested that certain PCBs
contribute to the development of metabolic syndromes like Type II Diabetes and
atherosclerosis64, 70-72. Coplanar PCBs initiate an inflammatory signaling cascade that
increases oxidative stress and promotes endothelial dysfunction in vascular endothelial
cells73. To better understand the inflammatory potential of PCBs, chapter two assesses
endothelial cell response to PCB 77 and PCB 77 remediation products which are the
byproducts of PCB 77 dechlorination. To establish a dosing model and further our
understanding of environmentally persistent coplanar PCBs, chapter three determines
which of five increasing concentration of PCB 126 are effective in producing a moderate
inflammatory response without causing toxic wasting syndrome. Using the dosing model
developed in chapter three, we were able to test nutritional interventions of PCB 126induced inflammation in chapter four.
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1.3 Nutrition and inflammation
Fatty acids and inflammation
A fatty acid is a long carbon chain with four to twenty-four carbons that is capped by a
methyl group containing the omega carbon and a carboxyl group74. There are multiple
structural classes of fatty acids that are defined by the number and location of double
bonds within the carbon chain and include saturated, monounsaturated,
polyunsaturated, and trans fatty acids. Diets high in saturated fat have been associated
with cardiovascular disease and are known to promote inflammation75, 76. Saturated fatty
acids, which are not essential for a complete human diet, are long carbon chains that are
fully substituted with hydrogen atoms and do not contain double bonds; examples
include palmitate, laurate, myristate and stearate, which are found in red meat and
dairy74. The amount of saturated fat consumed determines the inflammatory effects. In a
study in mice, mice consuming 12% saturated fat, which is equivalent to the average
American diet, had greater adipose inflammation and macrophage activity than mice fed
diets with 6% and 24% saturated fat77. One of the mechanism by which saturated fatty
acids cause inflammation is through the toll-like receptors (TLRs)76, including TLR4
which has increased expression in atherosclerotic lesions78. Saturated fatty acids
modulate gene expression and increase TLR expression which increases sensitivity to
inflammatory stimuli, such as lipopolysaccharide (LPS)79. In the Nurses’ Health Study,
women who consumed 5% more saturated fat compared to those who consumed 5%
more carbohydrate were 17% more likely to have a cardiac event80. Replacing dietary
saturated fatty acids with polyunsaturated fatty acids reduces the number of coronary
events81. Unlike saturated fatty acids, polyunsaturated fats (PUFA), e.g. omega-3 and
omega-6 fatty acids, have two or more double bonds with the first double bond at the
third or sixth carbon, respectively. PUFA are essential to the human diet74, yet
differences exist between the omega-3 and omega-6 inflammatory potential.
Omega-3 and omega-6 fatty acids and inflammation
The ratio of omega-3/omega-6 fatty acids influences metabolism of fatty acid substrates
and the generation of inflammatory mediators. For example, the elongation of the parent
omega-3 fatty acid α-linolenic acid to the longer chain docosahexaenoic acid (DHA)
molecules can be inhibited by competition with high levels of the omega-6 linoleic acid
for the same desaturase enzymes82. Linoleic acid is elongated to form arachidonic acid,
which is the primary substrate for prostaglandin, leukotriene and thromboxane formation;
higher substrate availability increases the baseline levels of these inflammatory
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eicosanoids82. Long-chain omega-3 fatty acids, eicosapentanoic acid (EPA) and DHA
are also metabolized by cyclooxygenases (COX) and lipoxygenases.(LOX) to form
eicosanoid and docosanoid metabolites, which are either less inflammatory than their
omega-6 derived counterparts or have anti-inflammatory properties83, 84 (Figure 1.285-88).
Arachidonic acid is a major component of the plasma membrane and is the precursor of
prostaglandin E2 (PGE2) and leukotriene B4 (LTB4); diets containing omega-3 fatty acid
rich-flaxseed oil or fish oil competitively reduced the production of arachidonic acidderived eicosanoids and other inflammatory cytokines89. F2-isoprostanes (F2-IsoPs),
which are similar in structure to the COX-derived prostaglandins, are formed by nonenzymatic peroxidation of arachidonate and are an indication of oxidative stress90.
Elevated levels of F2-IsoPs are associated with chronic disease states including
atherosclerosis, hypercholesterolemia, diabetes, obesity, Alzheimer’s, pulmonary
disorders, and allergen-aggravated asthma90. All of these disorders are associated with
elevated levels of inflammation and oxidative stress.
Different fatty acids modulate PCB-induced inflammation. In a feeding study using LDLR-/- (low-density lipoprotein receptor deficient) mice, we observed VCAM1 tissue
expression in the endothelium of mice fed omega-6-rich corn oil, and PCB treatment
promoted more extensive VCAM1 expression extending to the smooth muscle portions
of the vessel wall91. In contrast, dietary feeding of monounsaturated-rich olive oil did not
promote vascular inflammation, and though PCBs induced inflammation in olive oil fed
mice, the high oleic acid diet supported compensatory metabolic changes in the livers of
PCB-treated mice. In vitro work using primary vascular endothelial cells enabled us to
modulate PCB-induced inflammation by changing the omega-3/omega-6 fatty acid ratio.
Increasing levels of α-linolenic acid (omega-3) to linoleic acid (omega-6) reduced
VCAM1 and COX-2 mRNA and protein expression and attenuated PGE2 production.
With the same model, we demonstrated that oxidized DHA-derived A4/J4-neuroprostanes
reduced coplanar PCB-induced oxidative stress, NFкB activation, and MCP-1 protein
and mRNA expression92. When compared, DHA-derived neuroprostanes were more
effective at attenuating PCB-induced inflammation than those derived from EPA. From
these data, we concluded that future in vivo nutritional intervention studies, as presented
in chapter four, would use a DHA-enriched diet.
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Omega-3 fatty acids and implications in inflammation resolution
Fish oil presents the richest source of DHA and EPA, and the precursor fatty acid, αlinolenic acid, is available from multiple plant sources including walnuts, flax seed, and
canola oil74. A human trial comparing the effect of DHA-EPA, α-linolenic acid (ALA),
DHA-EPA/ALA combination or placebo treatment on major cardiovascular events found
that ALA was most beneficial to women and that the DHA-EPA treatment was most
beneficial to patients with a diabetic comorbidity93. A meta-analysis of eleven studies that
provided DHA/EPA supplementation for one year or longer determined that
supplementation significantly reduced the risk of sudden cardiac death and all-cause
mortality for high risk patients and reduced the risk of nonfatal cardiovascular events in
patients with moderate risk94. In culture, omega-6 fatty acid-exposed endothelial cells
had more monocyte adhesion, a pre-cursor to atherosclerotic plaque formation, than
those treated with omega-3 fatty acids; these changes were attributed to an alteration in
the function of COX-295. Omega-3 fatty acids alter inflammatory response through many
potential mechanisms including (a) modification of the membrane through disruption of
lipid rafts, (b) propagation of bioactive metabolites, and/or (c) alteration of nuclear
transcription factor signaling96. Omega-3 enriched diet disrupts the microenvironment of
caveolae lipid domains in colonocytes initiating changes in signaling by displacing
caveolin-1 (Cav-1) and other raft specific signaling molecules97. Endothelial cells treated
with DHA have similar disruption in lipid raft composition that displaces the Cav-1 protein
and releases endothelial nitric oxide (eNOS), which is critical to vascular homeostasis98.
In a model of allergic lung inflammation, omega-3 fatty acid supplementation reduced
arachidonic acid-derived F2-isoprostane production presumably through displacement of
arachidonic acid and competition for COX and LOX enzymes99. E-series and D-series
resolvins are derived from EPA and DHA, respectively. Research into the functional
roles of resolvins and other EPA- and DHA-derived metabolites demonstrate changes to
leukocyte response including the inhibition of dendritic cell and T-cell maturation and
activation, reduction of leukocyte chemotaxis, and changes in the cytokine response by
immune cells100-102. Understanding the molecular signaling pathways by which omega-3
fatty acid-derived metabolites promote these actions is an area of active research.
Peroxisome proliferator-activated receptors (PPARs) are of particular interest. An
increase in PPARγ activity is associated improved outcomes in many inflammatory
disease states; unfortunately, rosiglitazone, pioglitazone and other PPARγ agonists have
undesirable side effects103. Oxidized-DHA metabolites are possible ligands of PPARγ
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Chapter One: Introduction
1.1 Environmental pollution – PCB
The unprecedented boom in chemical manufacturing had produced a legacy of chemical
wastes and byproducts that flowed into streams and piled up in landfills. Scientists and
the public began to awaken to the horror of a polluted world. Rachel Carson, a leader in
the environmental movement, raised public awareness through her book Silent Spring;
she writes,
“The most alarming of all man’s assaults upon the environment is the
contamination of air, earth, rivers, and sea with dangerous and even lethal
materials. This pollution is for the most part irrecoverable; the chain of evil it
initiates not only in the world that must support life but in living tissues is for the
most part irreversible1.”
In response to the public outcry and mounting scientific evidence about environmental
and human health effects, Congress passed a series of environmental legislation, and
the President established the Environmental Protection Agency (EPA)2. Within this
legislation, certain environmental pollutants were banned from manufacturing including
polychlorinated biphenyls (PCBs). PCBs like many other contaminants from that era are
distinguished by their stable chemical structure which includes a biphenyl and many
configurations of chlorine substitutions that account for up to 209 possible congeners3
(Figure 1.1). Produced in mixtures, called Aroclors, PCBs were widely marketed and
used in applications in which their stability and low electrical conductivity were prized;
these applications included dielectric fluid in capacitors and light ballasts and building
materials such as paint and sealants4.
The two major classes of PCBs are defined by the stereochemistry of the biphenyl bond
(Figure 1.1)3, 5. The coplanar PCBs do not contain ortho-substitutions and exhibit dioxinlike properties. The presence of coplanar PCBs in human and animal tissues are orders
of magnitude lower than other congeners, but as a class of compounds they exhibit
greater potential for toxicity, especially PCB 1266, 7. They are dioxin-like and bind the aryl
hydrocarbon receptor (AhR) which activates cytochrome P450 (CYP) metabolizing
enzymes, the expression of which are associated with increased cellular oxidative stress
and inflammation8. Chlorine substitutions in the ortho- position cause steric hindrance for
noncoplanar PCBs, which have different biological activity than the coplanar PCBs.
Noncoplanar PCBs have an affinity for the constitutive androstane receptor (CAR)9,
which activates CYP metabolizing enzymes, and are known to disrupt Ca2+ signaling in
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the brain through the ryanodine receptors3, 10. In addition, noncoplanar PCBs have been
associated with certain metabolic disorders. For example, PCB 153 is a noncoplanar
PCB that is present in high levels in human serum; it is associated with increased risk for
nonalcoholic fatty liver disease and Type 2 diabetes11, 12. Congeners which are monoortho-substituted, such as PCB 118, have reduced AhR activity and have molecular
similarities to noncoplanar PCBs3, 5, 13. Our research has demonstrated that in
comparison to noncoplanar PCBs, coplanar PCBs and mixed inducers promote oxidative
stress and decrease endothelial barrier function, which is critical to inflammatory process
that causes endothelial dysfunction and promotes the vascular inflammation that leads
to atherosclerosis14. We have also demonstrated that certain nutrients either promote or
inhibit coplanar PCB-induced endothelial cell dysfunction. For example, the omega-6
fatty acid linoleic acid promotes coplanar PCB-induced inflammation, but when the ratio
of omega-3 to omega-6 fatty acids is increased, the omega-3 fatty acids protect against
PCB-induced oxidative stress and nuclear factor kappa B (NFкB) activation15, 16. As a
result, the work in our laboratory has focused on the dioxin-like, coplanar PCBs.
Pollutant toxicity is compared using toxic equivalency factors (TEFs) which designate a
toxicity value based on a comparison to the toxicity of 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD, dioxin). For PCBs, only coplanar PCBs (non-ortho substituted) exhibit
dioxin-like qualities and are ligands had arylhydrocarbon receptor (AhR). The major
congeners in this class are PCB 77, PCB 126, and PCB 169 with TEFs in humans of
0.0001, 0.1 and 0.01, respectively17. In addition, PCB 170 and PCB 180 have
ethoxyresorufin-O-deethylase (EROD) activity that is sufficient for a TEF equivalency to
be assigned. Based on the median TEF values of PCB 105, PCB 118, and PCB 156, the
TEF for mono-ortho PCBs, containing one ortho substitution or a mixed congener, is
0.0000318. Together, TEFs can be combined to develop toxic equivalents (TEQ) that
may be applied when assessing limits in food sources, sediments, waterways, etc.
However, the TEFs are based primarily on studies of oral exposure, which is often the
source of exposure for both animals and humans18. As such, human exposure risk and
risk attenuation continue to be primary concerns in environmental health research.
PCB distribution in the body
The concept of persistence and biomagnification in humans and animals is based on the
ability of adipose tissue to act as a storage facility for persistent organic pollutants
(POPs)19, 20. The degree of lipophilicity for a particular toxicant is determined by a log10
2

value of >6.0 for the solubility ratio of octanol to water21. POPs that exceed the 6.0
lipophilicity threshold are soluble in dietary fat sources and are absorbed in the intestinal
lumen with triacylglycerols into the lymphatic circulation22. After entry into the lymphatic
system, they are incorporated into chylomicrons which transport the toxicants to other
tissues including the primary storage depot, the adipose. PCBs display a range of
affinities and distribute among LDL, HDL, and albumin fractions23, 24. Fortunately, the
body has a mechanism for reducing its burden of PCBs and other POPs by utilizing
enterohepatic circulation21. Through this cycle, POPs may be returned to circulation in
the blood, be acquired by the liver which packages them with bile for excretion into the
intestine. Once in the intestine, the pollutants will either be reabsorbed with the bile salts
or be excreted in the feces. Through a similar pattern of circulation, POPs are also
incorporated into mother’s breast milk, which serves as one of the first and most
concentrated exposures for humans25, 26. The circulation of these compounds is not an
innocuous process, and PCBs or other compounds are able to interact with the tissues
that are exposed during circulation including the vascular endothelium and the liver.
PCBs and other dioxin-like compounds are associated with a wide range of human
health outcomes, the mechanisms of which are still being explored. The immune,
hepatic, neural, endocrine, vascular and reproductive systems are all affected in by PCB
exposure27-29.
Molecular interactions of coplanar PCBs with target receptors
As dioxin-like compounds, coplanar PCBs are ligands for the AhR. The transcription
factor, AhR, is a member of the PER-ARNT-SIM (PAS) superfamily that has a helix-loophelix structure. This highly conserved protein requires ligand binding for activity and is a
cellular sensor that has a critical function in development, especially of the liver and
vascular systems, circadian rhythms, hypoxia, hormonal signaling, inflammation and
other biological processes30. The AhR and its chaperone proteins including two HSP90
units reside in the cytosol until ligand binding which causes the release of one HSP90
and translocation into the nucleus where AhR dimerizes with ARNT (AhR nuclear
translocator), releases the second HSP90, binds to a xenobiotic response element
(XRE, also called the dioxin response element, DRE) and facilitates transcription29. The
transcriptional changes directed by XRE binding facilitate cellular responses to
environmental stimuli; however, when these signals are prolonged by strong ligand
affinity, such as is the case of AhR binding with TCDD, disease processes are activated.
AhR activity promotes expression of Phase I and Phase II metabolism and anti-oxidant
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response enzymes, such as the Phase I enzyme cytochrome P450 1A1 (CYP1A1)31, 32.
Ligands of the AhR require a degree of hydrophobicity, e.g. be lipophilic in nature, and
exhibit certain electronegative and hydrogen bonding properties, and as follows, this
includes a varied set of xenobiotic, endogenous and dietary compounds33. The
xenobiotic ligands that meet the physical requirements of the AhR binding pocket
represent a large number of environmental pollutants examples of which include the
following: PCBs, dioxins, naphthalenes and PAHs (polycyclic aromatic hydrocarbons),
such as benzo[a]pyrene. An equally extensive list of possible endogenous ligands have
also been identified for the AhR; these include the following: indigoids (indigo and
indirubin), 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE),
equilenin (equine estrogen), metabolites of arachidonic acid, of heme and of tryptophan.
From food sources, derivatives of indole-3-carbinol, found in cruciferous vegetables, and
flavonoids, such as quercetin are potential ligands. The diversity of AhR ligands has led
scientists to appreciate a number of functional roles for this transcription factor. Through
endogenous ligand activation, the AhR is responsible for a number of developmental
and cellular processes including cardiovascular, immune and neuronal systems34; for
example, AhR deficient mice have incomplete liver vascularization33. Dietary
polyphenols, like flavonoids, have been linked to the protective anti-oxidant response
and initiate binding to alternative XRE binding sites. In contrast, xenobiotics, such as
PCBs, hijack the endogenous functions of the AhR to produce an inflammatory
response34. The AhR-induced inflammatory response is linked to the upregulation of
detoxifying enzymes, such as CYP1A1, and cross-talk with the nuclear nuclear factor
(erythroid-derived 2)-like 2 (Nrf2) mediated anti-oxidant response35.
The AhR induces CYP1A1 expression in response to coplanar PCBs and other ligands36,
37

. CYP1A1 activity includes the hydroxylation or epoxidation of the offending xenobiotic.

When the reaction is unsuccessful and the enzyme “slips” or becomes uncoupled, a
superoxide ion is released into the cell rather than being added to the compound38.
Xenobiotics, such as PCBs, are not well metabolized, and their interaction with Phase I
enzymes, like CYP1A1, leads to a greater release of reactive oxygen species (ROS),
which significantly shift the redox balance of the cell39. Nrf2 regulated anti-oxidant
enzymes, such as glutathione-S-transferase (GST) and NAD(P)H:quinine
oxidoreductase (NQO1), serve to mitigate the increase in ROS, but when the oxidant
capacity has been exceeded the cell initiates NFĸB and other redox sensitive
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transcription factors to produce a heightened inflammatory cascade40, 41. NFĸB promotes
the transcription of the chemokine monocyte chemoattractant protein 1 (MCP-1)42, 43,
also called CCL2, and vascular cell adhesion molecule 1 (VCAM1)44, 45, which are key
markers of endothelial cell dysfunction and the initiation of macrophage recruitment. The
cytochrome P450 enzymes are part of Phase I metabolism during which the substrates
are attacked at the site of a good leaving group which is replaced by hydroxyl, epoxide
or carboxyl functional groups 46, 47. This conversion is the first step in the transformation
of the liphophilic molecule into a water soluble substrate that can be excreted through
the kidneys. Phase II metabolizing enzymes that are upregulated through AhR activation
include glutathione transferases, UDP-glucuronyltransferases and sulfotransferases48,
which utilize the nucleophilic functional group to add a water soluble moiety such as a
glucuronic acid, amino acid (glutathione, GSH) or sulfuric acid47. CYP metabolism of
PCBs results in epoxide and hydroxylated products that are processed by the Phase II
enzymes to generate all these metabolites3.
1.2 PCBs and predisposition to inflammatory response
Endothelial dysfunction
As sensitive modulators of vascular homeostasis, endothelial cells both respond to the
changing climate within the blood and regulate the vascular environment49. For the
average American, this “climate” includes the following: dietary factors such as high
levels of fatty acids, sodium, and glucose; lifestyle factors such as minimal physical
activity; and exposure environmental pollutants from food, air, and built environments50,
51

. The endothelium responds to each of these factors by modulating the physiological

environment including vasorelaxation through endothelial nitric oxide synthase (eNOS)
signaling or inflammation through cytokine and adhesion molecule expression52, 53. The
endothelial inflammatory response culminates in a change in function termed endothelial
dysfunction in which cytokines like the chemokine monocyte chemoattractant protein-1
(MCP-1) are secreted to recruit macrophages that are captured via adhesion molecules
like VCAM1, and decreases in cell:cell junction integrity allow the macrophages to
penetrate the endothelial cell barrier42, 54, 55. Once in the intimal space, macrophages
promote the inflammatory state by producing cytokines and through phagocytosis of oxLDL, which together promote formation of foam cells that accumulate to form plaques.
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Inflammation and disease risk
Inflammation is a characteristic held in common by a variety of diseases including lupus,
rheumatoid arthritis, Crohn disease, ulcerative colitis, dermatomyositis and
polymyositis56. The majority of these disorders can increase a patient’s risk for
myocardial infarction or coronary artery disease related events when compared to
control or the general population; for this analysis, only disorders associated with
inflammatory bowel disease did not increase vascular disease risk56. The heightened
inflammatory state increased lipoprotein oxidation and unresolved inflammation
promoting the observed effect on cardiovascular outcomes. The pro-inflammatory
cytokines, tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6) are risk factors for
cardiovascular diseases and are increased in rheumatoid arthritis (RA) patients; further,
coronary calcification is greater in RA patients with longer disease histories, which is
associated with increased cardiovascular disease prevalence in this patient population57.
Interestingly, many chronic inflammatory disease states are characterized by a
dysregulated immune response in the epithelial and mesenchymal cell structures of the
affected organ; in the case of atherosclerosis, the endothelium is activated by bacterial
components, lipoproteins or other stimuli which induce vascular cell adhesion molecule 1
(VCAM1) expression and the recruitment of immune cells that perpetuate the interstitial
inflammatory response58. Coplanar PCBs and other environmental pollutants are
potential activators of vascular inflammation.
PCBs as a risk factor in diseases of inflammation
Low grade inflammation is associated with many of chronic disorders including
cardiovascular diseases, diabetes, metabolic syndrome and obesity. Tissue
inflammation in the vascular system, adipose, and liver are all indicators and risk factors
for the development of disease. PCBs have been associated with the development of
multiple inflammation-associated medical conditions. For example, diabetes and
metabolic syndrome are increased relative to PCB levels in both the general population
and in communities with increased PCB exposure59-61. In particular, a survey of the
Japanese population indicated that PCB 126 was a key toxicant associated with the
increased prevalence of metabolic syndrome61. In a study of the 2003-2004 NHANES
data, elevated serum alanine aminotransferase (ALT), a biomarker associated with nonalcoholic fatty liver disease (NAFLD) and other liver diseases, was increased in
association with heavy metal and PCB exposure62, and NAFLD was increased in mice
exposed to PCBs11. Toxicant induced liver diseases, which include toxicant-associated
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fatty liver disease and toxicant-associated steatohepatitis, are associated with exposure
to industrial chemicals including vinyl chloride and PCBs63. Further, cardiovascular
disease risk was increased in an elderly population independent of lipid levels and other
cardiovascular disease risk factors64, and in rats, PCB 126 was associated with
heightened cardiovascular disease risk resulting from changes in cholesterol, blood
pressure and heart weight65. Industrial workers with high levels of PCB exposure have
significantly increased levels of cardiovascular disease-related death66. These data
support of the role of PCBs in the propagation of inflammatory diseases.
PCBs, as lipophilic compounds, accumulate in the adipose and are recirculated through
the body by enterohepatic circulation, a process which exposes both the vascular
system and the liver to these toxicants. Given this environment, PCBs induce a stress
response that promotes chronic, low grade inflammation and thus predispose the
vasculature, specifically the endothelium, to heightened response to lifestyle and
pathogenic stressors, like bacterial lipopolysaccharide (LPS)67. A recent study of the
Framingham heart study cohort has concluded that the traditional risk factors are
insufficient to explain the level of inflammation observed in the study68; this would
suggest that genetic factors and environmental factors like PCBs could be the
“unobserved” risk factors. Vascular biomarkers like soluble VCAM1 provide a critical
observational link between metabolic syndrome and insulin resistance and the
development of CVD and diabetes69. Studies have suggested that certain PCBs
contribute to the development of metabolic syndromes like Type II Diabetes and
atherosclerosis64, 70-72. Coplanar PCBs initiate an inflammatory signaling cascade that
increases oxidative stress and promotes endothelial dysfunction in vascular endothelial
cells73. To better understand the inflammatory potential of PCBs, chapter two assesses
endothelial cell response to PCB 77 and PCB 77 remediation products which are the
byproducts of PCB 77 dechlorination. To establish a dosing model and further our
understanding of environmentally persistent coplanar PCBs, chapter three determines
which of five increasing concentration of PCB 126 are effective in producing a moderate
inflammatory response without causing toxic wasting syndrome. Using the dosing model
developed in chapter three, we were able to test nutritional interventions of PCB 126induced inflammation in chapter four.
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1.3 Nutrition and inflammation
Fatty acids and inflammation
A fatty acid is a long carbon chain with four to twenty-four carbons that is capped by a
methyl group containing the omega carbon and a carboxyl group74. There are multiple
structural classes of fatty acids that are defined by the number and location of double
bonds within the carbon chain and include saturated, monounsaturated,
polyunsaturated, and trans fatty acids. Diets high in saturated fat have been associated
with cardiovascular disease and are known to promote inflammation75, 76. Saturated fatty
acids, which are not essential for a complete human diet, are long carbon chains that are
fully substituted with hydrogen atoms and do not contain double bonds; examples
include palmitate, laurate, myristate and stearate, which are found in red meat and
dairy74. The amount of saturated fat consumed determines the inflammatory effects. In a
study in mice, mice consuming 12% saturated fat, which is equivalent to the average
American diet, had greater adipose inflammation and macrophage activity than mice fed
diets with 6% and 24% saturated fat77. One of the mechanism by which saturated fatty
acids cause inflammation is through the toll-like receptors (TLRs)76, including TLR4
which has increased expression in atherosclerotic lesions78. Saturated fatty acids
modulate gene expression and increase TLR expression which increases sensitivity to
inflammatory stimuli, such as lipopolysaccharide (LPS)79. In the Nurses’ Health Study,
women who consumed 5% more saturated fat compared to those who consumed 5%
more carbohydrate were 17% more likely to have a cardiac event80. Replacing dietary
saturated fatty acids with polyunsaturated fatty acids reduces the number of coronary
events81. Unlike saturated fatty acids, polyunsaturated fats (PUFA), e.g. omega-3 and
omega-6 fatty acids, have two or more double bonds with the first double bond at the
third or sixth carbon, respectively. PUFA are essential to the human diet74, yet
differences exist between the omega-3 and omega-6 inflammatory potential.
Omega-3 and omega-6 fatty acids and inflammation
The ratio of omega-3/omega-6 fatty acids influences metabolism of fatty acid substrates
and the generation of inflammatory mediators. For example, the elongation of the parent
omega-3 fatty acid α-linolenic acid to the longer chain docosahexaenoic acid (DHA)
molecules can be inhibited by competition with high levels of the omega-6 linoleic acid
for the same desaturase enzymes82. Linoleic acid is elongated to form arachidonic acid,
which is the primary substrate for prostaglandin, leukotriene and thromboxane formation;
higher substrate availability increases the baseline levels of these inflammatory
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eicosanoids82. Long-chain omega-3 fatty acids, eicosapentanoic acid (EPA) and DHA
are also metabolized by cyclooxygenases (COX) and lipoxygenases.(LOX) to form
eicosanoid and docosanoid metabolites, which are either less inflammatory than their
omega-6 derived counterparts or have anti-inflammatory properties83, 84 (Figure 1.285-88).
Arachidonic acid is a major component of the plasma membrane and is the precursor of
prostaglandin E2 (PGE2) and leukotriene B4 (LTB4); diets containing omega-3 fatty acid
rich-flaxseed oil or fish oil competitively reduced the production of arachidonic acidderived eicosanoids and other inflammatory cytokines89. F2-isoprostanes (F2-IsoPs),
which are similar in structure to the COX-derived prostaglandins, are formed by nonenzymatic peroxidation of arachidonate and are an indication of oxidative stress90.
Elevated levels of F2-IsoPs are associated with chronic disease states including
atherosclerosis, hypercholesterolemia, diabetes, obesity, Alzheimer’s, pulmonary
disorders, and allergen-aggravated asthma90. All of these disorders are associated with
elevated levels of inflammation and oxidative stress.
Different fatty acids modulate PCB-induced inflammation. In a feeding study using LDLR-/- (low-density lipoprotein receptor deficient) mice, we observed VCAM1 tissue
expression in the endothelium of mice fed omega-6-rich corn oil, and PCB treatment
promoted more extensive VCAM1 expression extending to the smooth muscle portions
of the vessel wall91. In contrast, dietary feeding of monounsaturated-rich olive oil did not
promote vascular inflammation, and though PCBs induced inflammation in olive oil fed
mice, the high oleic acid diet supported compensatory metabolic changes in the livers of
PCB-treated mice. In vitro work using primary vascular endothelial cells enabled us to
modulate PCB-induced inflammation by changing the omega-3/omega-6 fatty acid ratio.
Increasing levels of α-linolenic acid (omega-3) to linoleic acid (omega-6) reduced
VCAM1 and COX-2 mRNA and protein expression and attenuated PGE2 production.
With the same model, we demonstrated that oxidized DHA-derived A4/J4-neuroprostanes
reduced coplanar PCB-induced oxidative stress, NFкB activation, and MCP-1 protein
and mRNA expression92. When compared, DHA-derived neuroprostanes were more
effective at attenuating PCB-induced inflammation than those derived from EPA. From
these data, we concluded that future in vivo nutritional intervention studies, as presented
in chapter four, would use a DHA-enriched diet.
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Omega-3 fatty acids and implications in inflammation resolution
Fish oil presents the richest source of DHA and EPA, and the precursor fatty acid, αlinolenic acid, is available from multiple plant sources including walnuts, flax seed, and
canola oil74. A human trial comparing the effect of DHA-EPA, α-linolenic acid (ALA),
DHA-EPA/ALA combination or placebo treatment on major cardiovascular events found
that ALA was most beneficial to women and that the DHA-EPA treatment was most
beneficial to patients with a diabetic comorbidity93. A meta-analysis of eleven studies that
provided DHA/EPA supplementation for one year or longer determined that
supplementation significantly reduced the risk of sudden cardiac death and all-cause
mortality for high risk patients and reduced the risk of nonfatal cardiovascular events in
patients with moderate risk94. In culture, omega-6 fatty acid-exposed endothelial cells
had more monocyte adhesion, a pre-cursor to atherosclerotic plaque formation, than
those treated with omega-3 fatty acids; these changes were attributed to an alteration in
the function of COX-295. Omega-3 fatty acids alter inflammatory response through many
potential mechanisms including (a) modification of the membrane through disruption of
lipid rafts, (b) propagation of bioactive metabolites, and/or (c) alteration of nuclear
transcription factor signaling96. Omega-3 enriched diet disrupts the microenvironment of
caveolae lipid domains in colonocytes initiating changes in signaling by displacing
caveolin-1 (Cav-1) and other raft specific signaling molecules97. Endothelial cells treated
with DHA have similar disruption in lipid raft composition that displaces the Cav-1 protein
and releases endothelial nitric oxide (eNOS), which is critical to vascular homeostasis98.
In a model of allergic lung inflammation, omega-3 fatty acid supplementation reduced
arachidonic acid-derived F2-isoprostane production presumably through displacement of
arachidonic acid and competition for COX and LOX enzymes99. E-series and D-series
resolvins are derived from EPA and DHA, respectively. Research into the functional
roles of resolvins and other EPA- and DHA-derived metabolites demonstrate changes to
leukocyte response including the inhibition of dendritic cell and T-cell maturation and
activation, reduction of leukocyte chemotaxis, and changes in the cytokine response by
immune cells100-102. Understanding the molecular signaling pathways by which omega-3
fatty acid-derived metabolites promote these actions is an area of active research.
Peroxisome proliferator-activated receptors (PPARs) are of particular interest. An
increase in PPARγ activity is associated improved outcomes in many inflammatory
disease states; unfortunately, rosiglitazone, pioglitazone and other PPARγ agonists have
undesirable side effects103. Oxidized-DHA metabolites are possible ligands of PPARγ
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Chapter One: Introduction
1.1 Environmental pollution – PCB
The unprecedented boom in chemical manufacturing had produced a legacy of chemical
wastes and byproducts that flowed into streams and piled up in landfills. Scientists and
the public began to awaken to the horror of a polluted world. Rachel Carson, a leader in
the environmental movement, raised public awareness through her book Silent Spring;
she writes,
“The most alarming of all man’s assaults upon the environment is the
contamination of air, earth, rivers, and sea with dangerous and even lethal
materials. This pollution is for the most part irrecoverable; the chain of evil it
initiates not only in the world that must support life but in living tissues is for the
most part irreversible1.”
In response to the public outcry and mounting scientific evidence about environmental
and human health effects, Congress passed a series of environmental legislation, and
the President established the Environmental Protection Agency (EPA)2. Within this
legislation, certain environmental pollutants were banned from manufacturing including
polychlorinated biphenyls (PCBs). PCBs like many other contaminants from that era are
distinguished by their stable chemical structure which includes a biphenyl and many
configurations of chlorine substitutions that account for up to 209 possible congeners3
(Figure 1.1). Produced in mixtures, called Aroclors, PCBs were widely marketed and
used in applications in which their stability and low electrical conductivity were prized;
these applications included dielectric fluid in capacitors and light ballasts and building
materials such as paint and sealants4.
The two major classes of PCBs are defined by the stereochemistry of the biphenyl bond
(Figure 1.1)3, 5. The coplanar PCBs do not contain ortho-substitutions and exhibit dioxinlike properties. The presence of coplanar PCBs in human and animal tissues are orders
of magnitude lower than other congeners, but as a class of compounds they exhibit
greater potential for toxicity, especially PCB 1266, 7. They are dioxin-like and bind the aryl
hydrocarbon receptor (AhR) which activates cytochrome P450 (CYP) metabolizing
enzymes, the expression of which are associated with increased cellular oxidative stress
and inflammation8. Chlorine substitutions in the ortho- position cause steric hindrance for
noncoplanar PCBs, which have different biological activity than the coplanar PCBs.
Noncoplanar PCBs have an affinity for the constitutive androstane receptor (CAR)9,
which activates CYP metabolizing enzymes, and are known to disrupt Ca2+ signaling in
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the brain through the ryanodine receptors3, 10. In addition, noncoplanar PCBs have been
associated with certain metabolic disorders. For example, PCB 153 is a noncoplanar
PCB that is present in high levels in human serum; it is associated with increased risk for
nonalcoholic fatty liver disease and Type 2 diabetes11, 12. Congeners which are monoortho-substituted, such as PCB 118, have reduced AhR activity and have molecular
similarities to noncoplanar PCBs3, 5, 13. Our research has demonstrated that in
comparison to noncoplanar PCBs, coplanar PCBs and mixed inducers promote oxidative
stress and decrease endothelial barrier function, which is critical to inflammatory process
that causes endothelial dysfunction and promotes the vascular inflammation that leads
to atherosclerosis14. We have also demonstrated that certain nutrients either promote or
inhibit coplanar PCB-induced endothelial cell dysfunction. For example, the omega-6
fatty acid linoleic acid promotes coplanar PCB-induced inflammation, but when the ratio
of omega-3 to omega-6 fatty acids is increased, the omega-3 fatty acids protect against
PCB-induced oxidative stress and nuclear factor kappa B (NFкB) activation15, 16. As a
result, the work in our laboratory has focused on the dioxin-like, coplanar PCBs.
Pollutant toxicity is compared using toxic equivalency factors (TEFs) which designate a
toxicity value based on a comparison to the toxicity of 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD, dioxin). For PCBs, only coplanar PCBs (non-ortho substituted) exhibit
dioxin-like qualities and are ligands had arylhydrocarbon receptor (AhR). The major
congeners in this class are PCB 77, PCB 126, and PCB 169 with TEFs in humans of
0.0001, 0.1 and 0.01, respectively17. In addition, PCB 170 and PCB 180 have
ethoxyresorufin-O-deethylase (EROD) activity that is sufficient for a TEF equivalency to
be assigned. Based on the median TEF values of PCB 105, PCB 118, and PCB 156, the
TEF for mono-ortho PCBs, containing one ortho substitution or a mixed congener, is
0.0000318. Together, TEFs can be combined to develop toxic equivalents (TEQ) that
may be applied when assessing limits in food sources, sediments, waterways, etc.
However, the TEFs are based primarily on studies of oral exposure, which is often the
source of exposure for both animals and humans18. As such, human exposure risk and
risk attenuation continue to be primary concerns in environmental health research.
PCB distribution in the body
The concept of persistence and biomagnification in humans and animals is based on the
ability of adipose tissue to act as a storage facility for persistent organic pollutants
(POPs)19, 20. The degree of lipophilicity for a particular toxicant is determined by a log10
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value of >6.0 for the solubility ratio of octanol to water21. POPs that exceed the 6.0
lipophilicity threshold are soluble in dietary fat sources and are absorbed in the intestinal
lumen with triacylglycerols into the lymphatic circulation22. After entry into the lymphatic
system, they are incorporated into chylomicrons which transport the toxicants to other
tissues including the primary storage depot, the adipose. PCBs display a range of
affinities and distribute among LDL, HDL, and albumin fractions23, 24. Fortunately, the
body has a mechanism for reducing its burden of PCBs and other POPs by utilizing
enterohepatic circulation21. Through this cycle, POPs may be returned to circulation in
the blood, be acquired by the liver which packages them with bile for excretion into the
intestine. Once in the intestine, the pollutants will either be reabsorbed with the bile salts
or be excreted in the feces. Through a similar pattern of circulation, POPs are also
incorporated into mother’s breast milk, which serves as one of the first and most
concentrated exposures for humans25, 26. The circulation of these compounds is not an
innocuous process, and PCBs or other compounds are able to interact with the tissues
that are exposed during circulation including the vascular endothelium and the liver.
PCBs and other dioxin-like compounds are associated with a wide range of human
health outcomes, the mechanisms of which are still being explored. The immune,
hepatic, neural, endocrine, vascular and reproductive systems are all affected in by PCB
exposure27-29.
Molecular interactions of coplanar PCBs with target receptors
As dioxin-like compounds, coplanar PCBs are ligands for the AhR. The transcription
factor, AhR, is a member of the PER-ARNT-SIM (PAS) superfamily that has a helix-loophelix structure. This highly conserved protein requires ligand binding for activity and is a
cellular sensor that has a critical function in development, especially of the liver and
vascular systems, circadian rhythms, hypoxia, hormonal signaling, inflammation and
other biological processes30. The AhR and its chaperone proteins including two HSP90
units reside in the cytosol until ligand binding which causes the release of one HSP90
and translocation into the nucleus where AhR dimerizes with ARNT (AhR nuclear
translocator), releases the second HSP90, binds to a xenobiotic response element
(XRE, also called the dioxin response element, DRE) and facilitates transcription29. The
transcriptional changes directed by XRE binding facilitate cellular responses to
environmental stimuli; however, when these signals are prolonged by strong ligand
affinity, such as is the case of AhR binding with TCDD, disease processes are activated.
AhR activity promotes expression of Phase I and Phase II metabolism and anti-oxidant
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response enzymes, such as the Phase I enzyme cytochrome P450 1A1 (CYP1A1)31, 32.
Ligands of the AhR require a degree of hydrophobicity, e.g. be lipophilic in nature, and
exhibit certain electronegative and hydrogen bonding properties, and as follows, this
includes a varied set of xenobiotic, endogenous and dietary compounds33. The
xenobiotic ligands that meet the physical requirements of the AhR binding pocket
represent a large number of environmental pollutants examples of which include the
following: PCBs, dioxins, naphthalenes and PAHs (polycyclic aromatic hydrocarbons),
such as benzo[a]pyrene. An equally extensive list of possible endogenous ligands have
also been identified for the AhR; these include the following: indigoids (indigo and
indirubin), 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE),
equilenin (equine estrogen), metabolites of arachidonic acid, of heme and of tryptophan.
From food sources, derivatives of indole-3-carbinol, found in cruciferous vegetables, and
flavonoids, such as quercetin are potential ligands. The diversity of AhR ligands has led
scientists to appreciate a number of functional roles for this transcription factor. Through
endogenous ligand activation, the AhR is responsible for a number of developmental
and cellular processes including cardiovascular, immune and neuronal systems34; for
example, AhR deficient mice have incomplete liver vascularization33. Dietary
polyphenols, like flavonoids, have been linked to the protective anti-oxidant response
and initiate binding to alternative XRE binding sites. In contrast, xenobiotics, such as
PCBs, hijack the endogenous functions of the AhR to produce an inflammatory
response34. The AhR-induced inflammatory response is linked to the upregulation of
detoxifying enzymes, such as CYP1A1, and cross-talk with the nuclear nuclear factor
(erythroid-derived 2)-like 2 (Nrf2) mediated anti-oxidant response35.
The AhR induces CYP1A1 expression in response to coplanar PCBs and other ligands36,
37

. CYP1A1 activity includes the hydroxylation or epoxidation of the offending xenobiotic.

When the reaction is unsuccessful and the enzyme “slips” or becomes uncoupled, a
superoxide ion is released into the cell rather than being added to the compound38.
Xenobiotics, such as PCBs, are not well metabolized, and their interaction with Phase I
enzymes, like CYP1A1, leads to a greater release of reactive oxygen species (ROS),
which significantly shift the redox balance of the cell39. Nrf2 regulated anti-oxidant
enzymes, such as glutathione-S-transferase (GST) and NAD(P)H:quinine
oxidoreductase (NQO1), serve to mitigate the increase in ROS, but when the oxidant
capacity has been exceeded the cell initiates NFĸB and other redox sensitive
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transcription factors to produce a heightened inflammatory cascade40, 41. NFĸB promotes
the transcription of the chemokine monocyte chemoattractant protein 1 (MCP-1)42, 43,
also called CCL2, and vascular cell adhesion molecule 1 (VCAM1)44, 45, which are key
markers of endothelial cell dysfunction and the initiation of macrophage recruitment. The
cytochrome P450 enzymes are part of Phase I metabolism during which the substrates
are attacked at the site of a good leaving group which is replaced by hydroxyl, epoxide
or carboxyl functional groups 46, 47. This conversion is the first step in the transformation
of the liphophilic molecule into a water soluble substrate that can be excreted through
the kidneys. Phase II metabolizing enzymes that are upregulated through AhR activation
include glutathione transferases, UDP-glucuronyltransferases and sulfotransferases48,
which utilize the nucleophilic functional group to add a water soluble moiety such as a
glucuronic acid, amino acid (glutathione, GSH) or sulfuric acid47. CYP metabolism of
PCBs results in epoxide and hydroxylated products that are processed by the Phase II
enzymes to generate all these metabolites3.
1.2 PCBs and predisposition to inflammatory response
Endothelial dysfunction
As sensitive modulators of vascular homeostasis, endothelial cells both respond to the
changing climate within the blood and regulate the vascular environment49. For the
average American, this “climate” includes the following: dietary factors such as high
levels of fatty acids, sodium, and glucose; lifestyle factors such as minimal physical
activity; and exposure environmental pollutants from food, air, and built environments50,
51

. The endothelium responds to each of these factors by modulating the physiological

environment including vasorelaxation through endothelial nitric oxide synthase (eNOS)
signaling or inflammation through cytokine and adhesion molecule expression52, 53. The
endothelial inflammatory response culminates in a change in function termed endothelial
dysfunction in which cytokines like the chemokine monocyte chemoattractant protein-1
(MCP-1) are secreted to recruit macrophages that are captured via adhesion molecules
like VCAM1, and decreases in cell:cell junction integrity allow the macrophages to
penetrate the endothelial cell barrier42, 54, 55. Once in the intimal space, macrophages
promote the inflammatory state by producing cytokines and through phagocytosis of oxLDL, which together promote formation of foam cells that accumulate to form plaques.
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Inflammation and disease risk
Inflammation is a characteristic held in common by a variety of diseases including lupus,
rheumatoid arthritis, Crohn disease, ulcerative colitis, dermatomyositis and
polymyositis56. The majority of these disorders can increase a patient’s risk for
myocardial infarction or coronary artery disease related events when compared to
control or the general population; for this analysis, only disorders associated with
inflammatory bowel disease did not increase vascular disease risk56. The heightened
inflammatory state increased lipoprotein oxidation and unresolved inflammation
promoting the observed effect on cardiovascular outcomes. The pro-inflammatory
cytokines, tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6) are risk factors for
cardiovascular diseases and are increased in rheumatoid arthritis (RA) patients; further,
coronary calcification is greater in RA patients with longer disease histories, which is
associated with increased cardiovascular disease prevalence in this patient population57.
Interestingly, many chronic inflammatory disease states are characterized by a
dysregulated immune response in the epithelial and mesenchymal cell structures of the
affected organ; in the case of atherosclerosis, the endothelium is activated by bacterial
components, lipoproteins or other stimuli which induce vascular cell adhesion molecule 1
(VCAM1) expression and the recruitment of immune cells that perpetuate the interstitial
inflammatory response58. Coplanar PCBs and other environmental pollutants are
potential activators of vascular inflammation.
PCBs as a risk factor in diseases of inflammation
Low grade inflammation is associated with many of chronic disorders including
cardiovascular diseases, diabetes, metabolic syndrome and obesity. Tissue
inflammation in the vascular system, adipose, and liver are all indicators and risk factors
for the development of disease. PCBs have been associated with the development of
multiple inflammation-associated medical conditions. For example, diabetes and
metabolic syndrome are increased relative to PCB levels in both the general population
and in communities with increased PCB exposure59-61. In particular, a survey of the
Japanese population indicated that PCB 126 was a key toxicant associated with the
increased prevalence of metabolic syndrome61. In a study of the 2003-2004 NHANES
data, elevated serum alanine aminotransferase (ALT), a biomarker associated with nonalcoholic fatty liver disease (NAFLD) and other liver diseases, was increased in
association with heavy metal and PCB exposure62, and NAFLD was increased in mice
exposed to PCBs11. Toxicant induced liver diseases, which include toxicant-associated
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fatty liver disease and toxicant-associated steatohepatitis, are associated with exposure
to industrial chemicals including vinyl chloride and PCBs63. Further, cardiovascular
disease risk was increased in an elderly population independent of lipid levels and other
cardiovascular disease risk factors64, and in rats, PCB 126 was associated with
heightened cardiovascular disease risk resulting from changes in cholesterol, blood
pressure and heart weight65. Industrial workers with high levels of PCB exposure have
significantly increased levels of cardiovascular disease-related death66. These data
support of the role of PCBs in the propagation of inflammatory diseases.
PCBs, as lipophilic compounds, accumulate in the adipose and are recirculated through
the body by enterohepatic circulation, a process which exposes both the vascular
system and the liver to these toxicants. Given this environment, PCBs induce a stress
response that promotes chronic, low grade inflammation and thus predispose the
vasculature, specifically the endothelium, to heightened response to lifestyle and
pathogenic stressors, like bacterial lipopolysaccharide (LPS)67. A recent study of the
Framingham heart study cohort has concluded that the traditional risk factors are
insufficient to explain the level of inflammation observed in the study68; this would
suggest that genetic factors and environmental factors like PCBs could be the
“unobserved” risk factors. Vascular biomarkers like soluble VCAM1 provide a critical
observational link between metabolic syndrome and insulin resistance and the
development of CVD and diabetes69. Studies have suggested that certain PCBs
contribute to the development of metabolic syndromes like Type II Diabetes and
atherosclerosis64, 70-72. Coplanar PCBs initiate an inflammatory signaling cascade that
increases oxidative stress and promotes endothelial dysfunction in vascular endothelial
cells73. To better understand the inflammatory potential of PCBs, chapter two assesses
endothelial cell response to PCB 77 and PCB 77 remediation products which are the
byproducts of PCB 77 dechlorination. To establish a dosing model and further our
understanding of environmentally persistent coplanar PCBs, chapter three determines
which of five increasing concentration of PCB 126 are effective in producing a moderate
inflammatory response without causing toxic wasting syndrome. Using the dosing model
developed in chapter three, we were able to test nutritional interventions of PCB 126induced inflammation in chapter four.
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1.3 Nutrition and inflammation
Fatty acids and inflammation
A fatty acid is a long carbon chain with four to twenty-four carbons that is capped by a
methyl group containing the omega carbon and a carboxyl group74. There are multiple
structural classes of fatty acids that are defined by the number and location of double
bonds within the carbon chain and include saturated, monounsaturated,
polyunsaturated, and trans fatty acids. Diets high in saturated fat have been associated
with cardiovascular disease and are known to promote inflammation75, 76. Saturated fatty
acids, which are not essential for a complete human diet, are long carbon chains that are
fully substituted with hydrogen atoms and do not contain double bonds; examples
include palmitate, laurate, myristate and stearate, which are found in red meat and
dairy74. The amount of saturated fat consumed determines the inflammatory effects. In a
study in mice, mice consuming 12% saturated fat, which is equivalent to the average
American diet, had greater adipose inflammation and macrophage activity than mice fed
diets with 6% and 24% saturated fat77. One of the mechanism by which saturated fatty
acids cause inflammation is through the toll-like receptors (TLRs)76, including TLR4
which has increased expression in atherosclerotic lesions78. Saturated fatty acids
modulate gene expression and increase TLR expression which increases sensitivity to
inflammatory stimuli, such as lipopolysaccharide (LPS)79. In the Nurses’ Health Study,
women who consumed 5% more saturated fat compared to those who consumed 5%
more carbohydrate were 17% more likely to have a cardiac event80. Replacing dietary
saturated fatty acids with polyunsaturated fatty acids reduces the number of coronary
events81. Unlike saturated fatty acids, polyunsaturated fats (PUFA), e.g. omega-3 and
omega-6 fatty acids, have two or more double bonds with the first double bond at the
third or sixth carbon, respectively. PUFA are essential to the human diet74, yet
differences exist between the omega-3 and omega-6 inflammatory potential.
Omega-3 and omega-6 fatty acids and inflammation
The ratio of omega-3/omega-6 fatty acids influences metabolism of fatty acid substrates
and the generation of inflammatory mediators. For example, the elongation of the parent
omega-3 fatty acid α-linolenic acid to the longer chain docosahexaenoic acid (DHA)
molecules can be inhibited by competition with high levels of the omega-6 linoleic acid
for the same desaturase enzymes82. Linoleic acid is elongated to form arachidonic acid,
which is the primary substrate for prostaglandin, leukotriene and thromboxane formation;
higher substrate availability increases the baseline levels of these inflammatory
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eicosanoids82. Long-chain omega-3 fatty acids, eicosapentanoic acid (EPA) and DHA
are also metabolized by cyclooxygenases (COX) and lipoxygenases.(LOX) to form
eicosanoid and docosanoid metabolites, which are either less inflammatory than their
omega-6 derived counterparts or have anti-inflammatory properties83, 84 (Figure 1.285-88).
Arachidonic acid is a major component of the plasma membrane and is the precursor of
prostaglandin E2 (PGE2) and leukotriene B4 (LTB4); diets containing omega-3 fatty acid
rich-flaxseed oil or fish oil competitively reduced the production of arachidonic acidderived eicosanoids and other inflammatory cytokines89. F2-isoprostanes (F2-IsoPs),
which are similar in structure to the COX-derived prostaglandins, are formed by nonenzymatic peroxidation of arachidonate and are an indication of oxidative stress90.
Elevated levels of F2-IsoPs are associated with chronic disease states including
atherosclerosis, hypercholesterolemia, diabetes, obesity, Alzheimer’s, pulmonary
disorders, and allergen-aggravated asthma90. All of these disorders are associated with
elevated levels of inflammation and oxidative stress.
Different fatty acids modulate PCB-induced inflammation. In a feeding study using LDLR-/- (low-density lipoprotein receptor deficient) mice, we observed VCAM1 tissue
expression in the endothelium of mice fed omega-6-rich corn oil, and PCB treatment
promoted more extensive VCAM1 expression extending to the smooth muscle portions
of the vessel wall91. In contrast, dietary feeding of monounsaturated-rich olive oil did not
promote vascular inflammation, and though PCBs induced inflammation in olive oil fed
mice, the high oleic acid diet supported compensatory metabolic changes in the livers of
PCB-treated mice. In vitro work using primary vascular endothelial cells enabled us to
modulate PCB-induced inflammation by changing the omega-3/omega-6 fatty acid ratio.
Increasing levels of α-linolenic acid (omega-3) to linoleic acid (omega-6) reduced
VCAM1 and COX-2 mRNA and protein expression and attenuated PGE2 production.
With the same model, we demonstrated that oxidized DHA-derived A4/J4-neuroprostanes
reduced coplanar PCB-induced oxidative stress, NFкB activation, and MCP-1 protein
and mRNA expression92. When compared, DHA-derived neuroprostanes were more
effective at attenuating PCB-induced inflammation than those derived from EPA. From
these data, we concluded that future in vivo nutritional intervention studies, as presented
in chapter four, would use a DHA-enriched diet.
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Omega-3 fatty acids and implications in inflammation resolution
Fish oil presents the richest source of DHA and EPA, and the precursor fatty acid, αlinolenic acid, is available from multiple plant sources including walnuts, flax seed, and
canola oil74. A human trial comparing the effect of DHA-EPA, α-linolenic acid (ALA),
DHA-EPA/ALA combination or placebo treatment on major cardiovascular events found
that ALA was most beneficial to women and that the DHA-EPA treatment was most
beneficial to patients with a diabetic comorbidity93. A meta-analysis of eleven studies that
provided DHA/EPA supplementation for one year or longer determined that
supplementation significantly reduced the risk of sudden cardiac death and all-cause
mortality for high risk patients and reduced the risk of nonfatal cardiovascular events in
patients with moderate risk94. In culture, omega-6 fatty acid-exposed endothelial cells
had more monocyte adhesion, a pre-cursor to atherosclerotic plaque formation, than
those treated with omega-3 fatty acids; these changes were attributed to an alteration in
the function of COX-295. Omega-3 fatty acids alter inflammatory response through many
potential mechanisms including (a) modification of the membrane through disruption of
lipid rafts, (b) propagation of bioactive metabolites, and/or (c) alteration of nuclear
transcription factor signaling96. Omega-3 enriched diet disrupts the microenvironment of
caveolae lipid domains in colonocytes initiating changes in signaling by displacing
caveolin-1 (Cav-1) and other raft specific signaling molecules97. Endothelial cells treated
with DHA have similar disruption in lipid raft composition that displaces the Cav-1 protein
and releases endothelial nitric oxide (eNOS), which is critical to vascular homeostasis98.
In a model of allergic lung inflammation, omega-3 fatty acid supplementation reduced
arachidonic acid-derived F2-isoprostane production presumably through displacement of
arachidonic acid and competition for COX and LOX enzymes99. E-series and D-series
resolvins are derived from EPA and DHA, respectively. Research into the functional
roles of resolvins and other EPA- and DHA-derived metabolites demonstrate changes to
leukocyte response including the inhibition of dendritic cell and T-cell maturation and
activation, reduction of leukocyte chemotaxis, and changes in the cytokine response by
immune cells100-102. Understanding the molecular signaling pathways by which omega-3
fatty acid-derived metabolites promote these actions is an area of active research.
Peroxisome proliferator-activated receptors (PPARs) are of particular interest. An
increase in PPARγ activity is associated improved outcomes in many inflammatory
disease states; unfortunately, rosiglitazone, pioglitazone and other PPARγ agonists have
undesirable side effects103. Oxidized-DHA metabolites are possible ligands of PPARγ
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with natural metabolism pathways that would limit potential side effects103. Others have
demonstrated an Nrf2-dependent anti-oxidant effect in adipocytes following EPA and
DHA treatment104. Our work suggests that caveolae are critical to PCB-induced
inflammation making lipid rafts a target for omega-3 fatty acid nutritional intervention105,
and our study of oxidized DHA neuroprostane metabolites indicates molecular
modulation of Nrf2 signaling92. Thus, omega-3 fatty acid-derived protection is most likely
an integration of multiple mechanisms. We recognize that the inflammatory signaling of
TLR4 is sensitive to DHA modulation of caveolae-based signaling molecules106, 107. In
chapter five, we propose TLR4 as a model caveolae-based signaling pathway that could
be developed for future study of omega-3 nutritional intervention of PCB-induced
inflammation.
1.4 Targets for nutritional modulation of inflammation
Caveolae – the interface of innate immunity and nutritional intervention
Lipid or membrane rafts are 10-200 nm structures that are typified by sphingolipid and
cholesterol enrichment and are characterized dynamic protein interactions as these
domains play a critical though often transient role in protein scaffolding and signaling108.
Caveolae are some of the larger raft structures included in this classification. The major
structural proteins are the caveolins. Caveolin-1 (Cav-1) and caveolin-2 (Cav-2) are
ubiquitously expressed and are particularly enriched in endothelial cells and
adipocytes109. Muscle specific caveolin-3 (Cav-3) is structurally similar to Cav-1, and
both Cav-1 and Cav-3 are critical to caveolae formation in their respective tissues
whereas Cav-2 is not essential for the formation of the raft structure110. Caveolae play a
crucial role in cellular and tissue nutrition having the ability to capture and endocytose
albumin and fatty acids111, 112. Fatty acid binding by Cav-1 facilitates fatty acid distribution
within cellular membranes as Cav-1 migrates between the plasma membrane and the
Golgi apparatus24, which makes Cav-1 a likely modulator of lipophilic environmental
pollutant trafficking. Further, caveolae provide a signaling hub, in which endogenous
molecules, like fatty acids, and xenobiotics, such as PCBs, may modulate the cellular
response, which make them of particular interest in the study of lipophilic environmental
pollutants and nutrients105.
The development of Cav-1/ApoE double knockout (KO) mice substantiated the role of
caveolae in vascular disease in part by altering protein expression of CD36 and VCAM1
in the plasma membrane113. In addition, Cav-1 deficient mice are more resistant to LPS
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challenge with reduced mortality from 90% to 30%114. LPS is the primary ligand of TLR4,
which initiates an inflammatory signaling cascade115. TLR4 signaling requires
dimerization of the TLR4 monomer and membrane translocation to lipid rich domains,
such as caveolae, in the plasma membrane116, 117. Cholesterol and saturated fat
enrichment promote TLR4 trafficking to Cav-1-rich membrane fractions76, 118. TLR
activity is inhibited by omega-3 fatty acids including the inflammatory response
modulated by TLR4, TLR2/1 and TLR2/6106, 119, and this inhibition has been attributed to
disruption of TLR4 activated COX-2 expression and mitigation of ROS107, 120, 121. Nrf2
regulates anti-oxidant enzyme expression that is critical to cell survival; this includes
hemeoxygenase 1 (HO-1), an anti-oxidant enzyme that interacts with caveolae122.
Interestingly, in LPS stimulated cells, carbon monoxide CO production by HO-1 inhibits
NADPH oxidase generated ROS and alters the Cav-1/TLR4 interaction to prevent
myeloid differentiation primary response 88 (MyD88) scaffolding with TLR4121, 123.
Similarly, DHA inhibits TLR4 dimerization and trafficking into lipid rafts by altering the raft
microdomain composition and inhibiting NADPH oxidase ROS production107. It is clear
that caveolae provide a critical structural interface for membrane signaling and protein
scaffolding108, and Cav-1 is also integral to both PCB-induced inflammation and
modulation of inflammation.
Coplanar PCB induction of the AhR-mediated inflammatory response including upregulation of CYP1A1, MCP1, and VCAM1 expression require the presence of Cav-1124126

. Further Cav-1 is a key regulator of nutritional interventions including both fatty acids

and flavonoids. For example, we have demonstrated that α-linolenic acid, an omega-3
fatty acid, reduces Cav-1 expression and overall inflammatory response to TNFα
stimulation127. Similarily, quercetin, a flavanol found in fruit and vegetables, decreases
PCB-mediated CYP1A1 expression by reducing the levels of phosphorylated Cav-1128.
Epigallocatechin gallate (EGCG), a green tea catechin, accumulates in the caveolae rich
cellular fractions, displaces Cav-1, promotes Nrf2-dependent anti-oxidant gene
expression, and reduces the NFкB-mediated inflammatory response129, 130. EGCG and αlinolenic acid both attenuate the linoleic acid and PCB-induced inflammatory response16,
130, 131

. Caveolae are critical mediators of both pro- and anti-inflammatory stimuli and

present an ideal platform in which to study the interface of innate immune and toxicantinduced inflammatory signaling as a potential target for nutritional modulation.
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1.5 Summary
The major aim of this dissertation is to better understand the molecular
consequences of coplanar PCB-induced inflammation and examine omega-3 fatty
acids as potential nutritional modulators of environmental toxicant-induced
inflammation. From the environmental to the molecular level, the human body is a
staging ground for the many environmental factors that we encounter. Whether the
stimuli are PCBs or remediation mixtures, the nuances of the physiological response
include oxidative stress and the induction of inflammatory cytokines. We propose that
omega-3 fatty acids are protective dietary components against inflammation. Thus, the
activation of anti-oxidant enzymes and the fine tuning of the immunological response by
fatty acid metabolites are fields ready for continued investigation.
The following dissertation provides a discussion which begins with an
environmental problem, tests a nutritional intervention using omega-3 fatty acids,
and explores a mechanistic target for studies of nutritional interventions (Figure
1.3):
In chapter two, endothelial cell culture provides an in vitro model for the study of the
inflammatory response to coplanar PCBs, such as PCB 77. Remediation products of
PCB 77 were used to demonstrate the sensitivity of the biological response to low levels
of the parent compound and its dechlorination products. As long as remediation
technologies such as the dechlorination process that was assessed in chapter two are
not a hundred percent efficient, there will be a continued risk of human exposures and
disease outcomes associated with PCBs and other environmental pollutants.
In response, we need to develop means of attenuating health risks using lifestyle
changes such as diet/nutrition and exercise. The subsequent chapters develop a
toxicant exposure model and test a nutritional intervention. In chapter three, we
characterize the use of PCB 126 as a model toxicant and define the toxicological
response to acute exposure in C57BL/6 mice. After defining the PCB 126 exposure level
in chapter three, we assess in vivo the role of the omega-3 fatty acid, DHA, in the
modulation of the PCB 126-induced inflammatory response in chapter four.
In chapter five, we complement the in vivo work by investigating in vitro mechanisms of
the toxicant inflammatory responses. Others have shown that omega-3 fatty acids
attenuate LPS stimulated inflammation; thus, LPS was used as a positive control. The
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research in this chapter was focused on caveolae-based signaling in the response to
PCB 126 and LPS-induced inflammation, which could broaden our ability to apply fatty
acids as a nutritional intervention. Together these studies provide insight into the
regulation of coplanar PCB-induced inflammation and possible protection by omega-3
lipids.
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Figure 1.1 Polychlorinated biphenyl (PCB) structure, nomenclature and
classifications. PCBs consist of chlorine-substituted biphenyl rings. The chemical
name of each PCB congener includes the position and number of the chlorine
substituted carbons. The two major classifications of PCBs include the coplanar
PCBs, which do not have ortho- substitutions, and the noncoplanar or orthosubstituted congeners. For example, PCB 126 is a coplanar PCB named 3,3’,4,4’,5pentachlorobiphenyl. The ortho-substituted PCB 153 is noncoplanar and is named
2,2’,4,4’,5,5’-hexachlorobiphenyl.
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Figure 1.2 Summary of the eicosanoid and docosanoid metabolites formed
following

stressed-induced

phospholipase

A2

fatty

acid

release.

The

arachidonic acid (AA)-derived metabolites contribute to inflammation and oxidative
stress while eicosapentaenoic acid (EPA)-derived metabolites exhibit either
moderately inflammatory effects or anti-inflammatory effects. Docosahexaenoic acid
(DHA) metabolites are anti-inflammatory and pro-resolving. The metabolite class
names are as follows: prostaglandin (PG), thromboxane (TX), leukotriene (LT),
hydroxydocosahexaenoic

acid

(HDHA),

hydroperoxy

(HPETE), hydroxyeicosatetraenoic acid (HETE),
(HEPE),

eicosatetraenoic

acids

hydroxyeicosapentaenoic acid

epoxyeicosatrienoic acids (EET), epoxyeicosatetraenoic acid (EETeTr),

epoxydocosapentaenoic acid (EDP), hydroxydocosahexaenoic acid (HDHE).
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Figure 1.3 Overview of dissertation objectives and placement of chapters
within these goals.

Copyright © Katryn Elizabeth Eske 2013
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Chapter Two: PCB 77 dechlorination products modulate pro-inflammatory events
in vascular endothelial cells
Springer and Environmental Science and Pollution Research International, DOI
10.1007/s11356-013-1591-3, 2013, PCB 77 dechlorination products modulate proinflammatory events in vascular endothelial cells, Eske K, Newsome B, Han SG, Murphy
M, Bhattacharyya D, Hennig B is given to the publication in which the material was
originally published; with kind permission from Springer Science and Business Media.
2.1 Synopsis
Persistent organic pollutants such as polychlorinated biphenyls (PCBs) are associated
with detrimental health outcomes including cardiovascular diseases. Remediation of
these compounds is a critical component of environmental policy. Although remediation
efforts aim to completely remove toxicants, little is known about the effects of potential
remediation byproducts. We previously published that Fe/Pd nanoparticles effectively
dechlorinate PCB 77 to biphenyl, thus eliminating PCB-induced endothelial dysfunction
using primary vascular endothelial cells. Herein, we analyzed the toxic effects of PCB
congener mixtures (representative mixtures of commercial PCBs based on previous
dechlorination data) produced at multiple time points during the dechlorination of PCB 77
to biphenyl. Compared to pure PCB 77, exposing endothelial cells to lower chlorinated
PCB byproducts led to improved cellular viability, decreased superoxide production, and
decreased nuclear factor kappa B (NFкB) activation based on duration of remediation.
Presence of the parent compound, PCB 77, led to significant increases in mRNA and
protein inflammatory marker expression. These data implicate that PCB dechlorination
reduces biological toxicity to vascular endothelial cells.
2.2 Introduction
Polychlorinated biphenyls (PCBs) are a class of organic pollutants that were used
heavily as dielectric fluids in industrial and electrical applications until evidence surfaced
linking PCBs to cancer and cardiovascular disease. Remediation efforts for these highly
persistent pollutants have proven difficult, expensive and slow. Our laboratories have
developed new fast, low-cost techniques that employ Pd/Fe nanoparticles for reductive
PCB dechlorination, which systematically dechlorinate higher congener PCBs to
biphenyl, with lower chlorinated congeners produced as byproducts prior to complete
degradation. The goal of this work is to better understand the toxicological effects of
these byproducts and to further validate the importance of PCB dechlorination for
reducing cardiovascular risk factors and for improving overall public health.
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Even though PCB production has been banned in the US since the late 1970s, PCBs
remain concentrated in many waterways and Superfund sites, as well as in electrical
devices such as transformers and light ballasts. Additionally, recent research has
indicated that a variety of PCB congeners are still being generated as industrial
byproducts from pigment production and certain paper manufacturing 132, 133. PCBs
exhibit unique properties, such as high environmental persistence and resistance to
metabolism in organisms, which lead to difficulties for remediation. Additionally, the
costs associated with large-scale clean-up and removal of these and other chemical
pollutants is great, and thus the development of more efficient, cost effective
technologies continues to be important. Current remediation techniques rely on
expensive dredging followed by incineration or bioremediation techniques. Although
PCBs can be degraded through some natural processes such as bacterial degradation
134, 135

and photolysis 136-138, these processes are prohibitively slow for remediation of

larger scale contaminations. Our research group recently developed a Pd/Fe
nanoparticle system that catalyzes the dechlorination of PCBs to form biphenyl in order
to address this need for low cost, high throughput chlorinated aromatic degradation (139,
140

. During chlorinated aromatic degradation, hydrogen ions are used to displace

chlorine on biphenyl rings in stages, resulting in the production of lower chlorinated PCB
congeners prior to complete degradation to biphenyl. It is generally believed that lesschlorinated congeners are more water soluble, more volatile, and more likely to
biodegrade further 141. In a previous study, we compared the biological activity of the
parent compound (PCB 77) with the dechlorination end product (biphenyl), and found
that complete dechlorination markedly reduced the pro-inflammatory activity of PCB 77
140

.

Many environmental contaminants, and especially persistent organic pollutants, are risk
factors for cardiovascular diseases such as atherosclerosis because they can initiate or
exacerbate the underlying disease by altering gene expression patterns and subsequent
vascular inflammation 142, 143. Because the endothelium is in immediate contact with the
blood, endothelial cells are particularly susceptible to the effect of environmental
contaminants. The lining of blood vessels is protected by the endothelium, and
endothelial cells play an active role in physiological processes such as regulation of
vessel tone, blood coagulation, and vascular permeability. In turn, endothelial cell
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activation or dysfunction is a critical marker of the pathology of cardiovascular diseases
such as atherosclerosis.
Activated endothelial cells produce chemokines such as monocyte chemoattractant
protein 1 (MCP-1) and inflammatory cytokines, which attract monocytes from the blood
stream to the site of injury. Part of the resulting inflammatory process includes the
endothelial cell expression of adhesion molecules, like vascular adhesion molecule 1
(VCAM1), which allow the monocytes to attach to the endothelial layer and infiltrate this
barrier into the intimal space. We have demonstrated previously that coplanar PCBs
(e.g., PCB 77) can induce DNA-binding activity of the oxidative stress-sensitive
transcription factor nuclear factor kappa B (NFкB) and expression of VCAM1, which is
dependent on functional aryl hydrocarbon receptor (AhR) activity 73. Recently, we have
reported the mechanisms of PCB 77-mediated upregulation of MCP-1 125.
Little is known about vascular toxicity of PCBs, and especially about the toxicity of
dechlorination or remediation products. There is a clear need to evaluate products of
remediation (e.g., dechlorination products) for biological activity in mammalian systems
144

. It is important to know to what degree remediation processes of persistent organic

pollutants have to occur before toxicity and any vascular injury becomes negligible.
Thus, the present study was designed to test the effects of PCB 77 dechlorination
products on pro-inflammatory parameters in a vascular endothelial cell model system.
Data from this study suggest that the presence of the parent compound (e.g., PCB 77) is
necessary for maximal endothelial cell dysfunction and inflammation. These data also
suggest that dechlorination is a successful method for decreasing biological toxicity, with
overall toxicity linked to the level of degradation of the parent compound. Herein,
dechlorination is demonstrated to be an effective platform for addressing public health
concerns associated with these persistent chlorinated pollutants.
2.3 Materials and Methods
Biphenyl, 3-chlorobiphenyl (PCB 2), 4-chlorobiphenyl (PCB 3), 3,3’-dichlorobiphenyl
(PCB 11), 3,4-dichlorobiphenyl (PCB 12), 3,4’-dichlorobiphenyl (PCB 13), 4,4’dichlorobiphenyl (PCB 15), 3, 3’,4-trichlorobiphenyl (PCB 35), 3,4,4’-trichlorobiphenyl
(PCB 37) and 3, 3’, 4, 4’-tetrachlorobiphenyl (PCB 77) were purchased from
AccuStandard, Inc. (New Haven, CT). Experiments that included hazardous materials
such as PCBs were performed in accordance with institutional and federal guidelines
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(11). All cell culture reagents, including ProLong Gold antifade reagent with 4',6diamidino-2-phenylindole (DAPI), were purchased from Life Technologies (Carlsbad,
CA). All other chemicals were purchased from Sigma-Aldrich Corporation (St. Louis,
MO), unless otherwise specified.
Description of PCB 77 dechlorination treatment mixtures
Treatment mixtures were based on the composition of PCB 77 and its dechlorination
products at 0, 10, 24, and 48 hours of remediation as derived from GC-MS data
comparing the reductive efficiencies of 0.1 mg mL-1 400 nm Pd/Fe nanotubes and 1 mg
mL-1 Pd/Fe nanoparticles 139, 140. Dechlorination product compositions were determined
from these data (Table 2.1); treatments from each stage of the dechlorination are
described as percent by weight and as molarity. Stocks of individual PCB commercial
congeners were solubilized in fresh dimethyl sulfoxide (DMSO) at a concentration of 10
mM. Treatment mixtures were developed to delineate between the effects of the parent
compound and dechlorination products including treatments representing product
mixtures without PCB 77 (mixtures 4 and 6), treatments representing only the
concentration of PCB 77 at a particular stage of dechlorination (mixtures 9 and 10), and
a treatment representing the 24 h dechlorination products with the higher PCB 77
concentration found following 10 h dechlorination (mixture 7), to emphasize the role of
PCB 77 in overall toxicity (Table 2). Stock treatment mixtures were prepared in DMSO at
a 5 mM total concentration and diluted 1:1000 in cell culture medium for 5 µM final cell
culture treatments. PCB mixtures were kindly composed by Bradley Newsome.
Cell culture
Primary endothelial cells (ECs) were isolated from porcine pulmonary arteries as
described previously 145. Cell culture media consisted of medium 199 (M199) containing
10% fetal bovine serum (FBS). At 70-80% confluence, cells were incubated overnight
with treatment media (M199 with 1% FBS), followed by exposure to PCB 77 or
respective treatment mixtures for 24 h. Treatment mixtures were added to cell culture at
a final concentration of 5 µM, which represented a maximum concentration of 0.1% v/v
DMSO/media (see Tables 1 and 2 for PCB treatment concentrations). Cell viability was
tested in the presence of dechlorination products using the Vybrant MTT Cell
Proliferation Assay Kit (Invitrogen, Eugene, OR) according to manufacturer guidelines
and was kindly performed by Bradley Newsome.
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Assessment of superoxide (O2.-) levels
Superoxide levels were assessed as recently reported 92. Cells were grown to
confluence in 4-chamber culture slides (BD Biosciences, Bedford, MA). After 4 h
exposure to PCB treatments (5 µM total concentrations; Table 1), the cells were rinsed
2x with Krebs-Ringer buffer (KRB) and incubated with 5 µM dihydroethidium (DHE) or
KRB (blank) at 37oC for 30 min. Cells were rinsed with KRB, fixed with 10% buffered
formalin, and washed with PBS. Slides were mounted with ProLong Gold antifade
reagent with DAPI for nuclei staining. Slides were evaluated with an Olympus BX61W1
fluorescence microscope. Mean fluorescence intensity was quantified using ImageJ
1.42q (NIH, Bethesda, MD).
Assessment of NFкB activation
Nuclear extracts were prepared from endothelial cells cultured as described above in 10
cm dishes and treated with PCB 77 or dechlorination mixtures for 4 h. The nuclear
extraction was performed as described previously 146. EMSA (electrophoretic mobility
shift assay) of nuclear factor kappa B (NFкB) binding was kindly performed by Dr.
Seong-Su Han of the University of Iowa College of Medicine using the DNA-protein
binding detection kit (Gibco-BRL, Grand Island, NY) with radio-labeled oligonucleotides
130, 147

.

Measurement of CYP1A1, MCP-1 or VCAM1 mRNA
CYP1A1, MCP-1 and VCAM1 mRNA expression was assessed using real-time PCR
(RT-PCR), as described previously 125, 126. Briefly, mRNA was isolated using TRIzol
Reagent (Life Technologies, Carlsbad, CA) and quantified using a SmartSpec Plus
Spectrophotometer (BIO-RAD, Philadelphia, PA). cDNA was then generated using
Promega AMV reverse transcriptase (Fisher Scientific, Waltham, MA) and RT-PCR was
performed using Power SYBR Green PCR Master Mix (Life Technologies, Carlsbad, CA)
and the following porcine primer sequences: β-actin sense 5′-TCA TCA CCA TCG GCA
ACG-3′ and antisense, 5′-TTC CTG ATG TCC ACG TCG-3′; CYP1A1 sense 5’- TGG
AGA GGC AAG AGT AGT TGG-3’and anti-sense 5’-GGC ACA ACG GAG TAG CTC
ATA-3’; MCP-1 sense 5′-CGG CTG ATG AGC TAC AGA AGA GT-3′and antisense, 5′GCT TGG GTT CTG CAC AGA TCT-3′; and VCAM1 sense 5′-TGG AAA GAC ATG GCT
GCC TAT-3′ and antisense, 5′-ACA CCA CCC CAG TCA CCA TAT-3′. Assays were run
using the Applied Biosystems 7300 Real time PCR System (Life Technologies,
Carlsbad, CA) using absolute quantification. The raw data were quantified using a
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standard curve and analyzed with a manual CT threshold of 0.200. Sample data were
normalized to individual β-actin values.
Measurement of CYP1A1, MCP-1 and VCAM1 protein
CYP1A1 and VCAM1 protein levels were assessed by Western blotting, as described
previously 140. After semi-dry transfer, nitrocellulose membranes were incubated for 2 h
in blocking buffer (5% non-fat milk in Tris-buffered saline containing 0.05% Tween 20).
Rabbit polyclonal CYP1A1 (H-70) and VCAM1 (C-19)-R (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA) primary antibodies were diluted 1:1000 in blocking buffer and
incubated overnight at 4 °C, and the secondary antibody was diluted 1:4000. β-actin
primary and secondary antibodies were diluted 1:10,000 125. MCP-1 protein levels were
measured in cell culture media diluted 1:7 using an OptEIA Human MCP-1 ELISA Kit
(BD Biosciences, San Diego, CA) according to manufacturer guidelines.
Statistical analysis
Values are reported as means ± SEM obtained from a representative sample set of a
minimum of three independent experiments, unless otherwise stated. Comparisons were
made by one-way analysis of variance (ANOVA) with Tukeys test for post-hoc analysis,
using SigmaPlot 12.0 software (Systat Software, San Jose, CA). Statistical probability of
pvalue < 0.05 was considered significant. Different statistical marker letters indicate
statistical differences.
2.4 Results
Dechlorination alters cellular oxidative stress and viability
PCB-induced cellular dysfunction is characterized by increased oxidative stress and
subsequent activation of inflammatory pathways including NFкB. The uncoupling of
CYP1A1 leads to the generation of reactive oxygen species (ROS), such as superoxide.
Endothelial cell monolayers were exposed to representative dechlorination product
mixtures (Table 2.1) for 4 h before ROS were visualized with DHE fluorescence (Figure
2.1a). Strong staining was observed in cells exposed to 0 h (pure PCB 77) and 10 h
dechlorination products, whereas mixtures representing longer periods of dechlorination
showed decreased superoxide production. When DHE fluorescence was quantified and
normalized to DAPI nuclear staining, fluorescence from initial dechlorination mixtures (0
and 10 h of dechlorination) indicated higher ROS production which decreased to control
levels with further dechlorination (differences between groups approached significance,
p=0.052; See Figure 2.1b). A similar trend was observed with regard to viability, where
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no changes were observed in cells treated with PCB vehicle (DMSO) and the 48 h
dechlorination product, although cell viability was decreased in 0 h (parent compound,
PCB 77), 10 h and 24 h dechlorination product treatments to 69±1%, 61±3%, 87±2% of
control, respectively.
NFкB activation is attenuated by dechlorination
Data from an NFкB EMSA showed that cells treated for 4 h with the dechlorination
products exhibited a prominent increase in NFкB activation when treated with the 0 h
product, or pure PCB 77. Intermediate activation by the 10 and 24 h products was
observed; NFĸB:DNA binding for these treatments was significantly decreased
compared to exposure to the 0 h product but remained increased relative to the vehicle
control and biphenyl (48 h product; see Figure 2.2). Biphenyl was consistently within
control expression levels for superoxide fluorescence, viability, and NFкB:DNA binding.
The 10 and 24 h dechlorination products were increased from control but did not exhibit
a consistent linear change from parent PCB 77, 0 h of dechlorination, expression levels.
We, therefore, tested a series of treatment mixtures to delineate between the effects of
the dechlorination products and the residual PCB 77.

Dechlorination products alter CYP1A1, MCP-1 and VCAM1 mRNA expression
CYP1A1, VCAM1 and MCP-1 levels were assessed in mRNA using treatment groups 110 (Figure 2.3, Table 2.2). CYP1A1 expression is a sensitive marker of coplanar PCBmediated cellular activation and toxicity. Thus, significant response from all treatments
containing PCB 77 was expected (Figure 2.3a). Indeed, all treatments that contained
pure or some PCB 77 (treatments 2, 3, 5, 7, 9 and 10) exhibited almost maximal
CYP1A1 expression. There was no difference in CYP1A1 expression among the pure
PCB 77 (treatment 2) and both 10 h (treatment 3) and 24 h (treatment 5) dechlorination
mixtures. Interestingly, when 10 h and 24 h dechlorination treatments lacked PCB 77
(treatments 4 and 6, respectively), induction of CYP1A1 was reduced linearly. Both
MCP-1 and VCAM1 mRNA expression patterns (Figures 2.3b and 2.3c, respectively)
followed approximately the CYP1A1 treatment patterns, suggesting some correlation
between CYP1A1 induction and inflammatory markers in these dechlorination
experiments. As with CYP1A1 expression, MCP-1 and VCAM1 expression exhibited a
linear decrease to control levels when treated with mixtures representing 10, 24 and 48
h dechlorination products without PCB 77 (treatments 4, 6 and 8), indicating that any
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byproduct contribution to the inflammatory response was eliminated by further
dechlorination. Total dechlorination to biphenyl (48 h product) showed no statistical
difference from control, indicating that it was relatively benign in our EC model. The
presence of residual parent PCB dominated the inflammatory response in product
mixtures, but mRNA expression levels of PCB 77 alone were moderately attenuated at
the lower concentrations.
Degree of dechlorination affects CYP1A1, MCP-1 and VCAM1 protein expression
Endothelial cells were treated with the dechlorination mixtures mentioned above (Table
2.2) in order to determine the effects of PCB 77 dechlorination on endothelial cell
inflammatory response expressed in protein markers (Figure 2.4). Treatments
containing the parent compound showed strong correlations in both mRNA and protein.
Similar to the mRNA expression levels, CYP1A1 protein levels were highest for
treatments containing PCB 77 (Figure 2.4a). However, treatments that did not contain
PCB 77 showed a marked decrease in CYP1A1 and MCP-1 protein expression,
correlated to the degree of dechlorination. Significant increases in MCP-1 expression
were observed with the 0 h product (PCB 77, treatment 2) and, to a lesser degree, with
dechlorination products containing decreasing concentrations of PCB 77 (treatments 3,
5, and 8). VCAM1 protein expression of dechlorination product mixtures without PCB 77
(treatments 4 and 6) and biphenyl (treatment 8) were not significantly different from
control. The presence of PCB 77 in all treatment groups corresponded to significant
increases in VCAM1 protein expression above control levels. These data suggest a
complicated interplay between inflammatory parameters in response to PCB 77
dechlorination product exposure. Nevertheless, the presence of PCB 77 in the individual
treatments markedly induced vascular inflammation.
2.5 Discussion
PCBs are man-made chemicals that were used in hundreds of industrial and commercial
applications 148 and are byproducts of certain industries today 133. Even though their
mass production has been banned, PCBs are chemically stable, persistent
environmental toxicants that can cause harmful health effects. Remediation or
detoxification of contaminated sites is difficult and expensive, and it is not clear to what
extent these remediation processes have to occur before their disease potential is
mitigated. The present study was designed to test the hypothesis that dechlorination of
coplanar PCB 77 diminishes its pro-inflammatory potential in vascular endothelial cells.
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This is an important issue because PCBs can damage vascular tissues and thus
contribute to cardiovascular diseases such as atherosclerosis. In fact, a recent study
reported increased hospitalization rates for acute myocardial infarction and diabetes
mellitus in populations residing near areas contaminated with persistent organic
pollutants 149, 150. Furthermore, the administration of PCB 77 to male apolipoprotein E
(ApoE) -/- mice has been shown to promote atherosclerosis 151.
The lining of blood vessels is protected by the endothelium, and endothelial cells play an
active role in physiological processes such as regulation of vessel tone, blood
coagulation, and vascular permeability. Dysfunction of endothelial cells is a critical
underlying cause of the initiation of cardiovascular diseases such as atherosclerosis.
Coplanar PCBs are initiators of endothelial dysfunction and exert their toxicity through
binding to the AhR. AhR target genes, including CYP1A1, are considered a source of
oxidative stress in endothelial cells and subsequent vascular dysfunction 152, 153. We
confirmed in the present study the oxidative stress potential of coplanar PCBs. In fact,
CYP1A1 induction was maximal in cells exposed to pure PCB 77 and remained elevated
in all dechlorination mixtures that contained PCB 77, independent of its relative
concentration. When residual amounts of PCB 77 were excluded from the
dechlorination mixtures, CYP1A1 induction was markedly reduced, suggesting that the
presence of the parent coplanar PCB is necessary for maximal CYP1A1 expression.
Furthermore, we have previously shown that coplanar PCBs 77, 126 and 169 increased
expression of the CYP1A1 gene, oxidative stress (DCF fluorescence), and the DNAbinding activity of NF-кB 73. In the current study, oxidative stress and DNA-binding of
NF-кB decreased with increasing dechlorination. In fact, when PCB 77 was completely
dechlorinated to biphenyl, oxidative stress and NF-кB levels approached control levels.
This suggests that effective dechlorination should be as complete as possible to avoid
oxidative stress-mediated tissue toxicity.
Oxidative stress-induced transcription factors such as NF-кB, which regulate
inflammatory cytokine and adhesion molecule production, play critical roles in the
induction of inflammatory responses and subsequent atherosclerotic lesion formation.
We have demonstrated previously that coplanar PCBs can cause endothelial cell
dysfunction as determined by inflammatory markers, such as expression of inflammatory
cytokines and adhesion molecules, i.e. MCP-1 and VCAM1, respectively 91, 125, 154. In our
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analysis of the dechlorination product mixtures, we found that inflammatory patterns of
MCP-1 and VCAM1 were similar to CYP1A1 patterns induced by pure PCB 77 and the
dechlorination mixtures that contained residual PCB 77, suggesting that the parent
compound is necessary for an endothelial inflammatory response. The 10 h
dechlorination byproducts also induced an MCP-1 and VCAM1 response that was
alleviated by further dechlorination. Again, as was found with CYP1A1, total
dechlorination to biphenyl did not induce MCP-1 and VCAM1 inflammatory parameters
in our endothelial cell model system.
The dechlorination process decreased the parent PCB 77 but contributed to various
lower-chlorinated PCBs. Furthermore, the ratio and proportion of these lowerchlorinated PCBs changes with degree of dechlorination. Even though their level of
interaction with the AhR is not well characterized, lower-chlorinated PCBs may
contribute to cellular dysfunction. PCB cogeners with substitutions in both para positions
(4,4’) are reported to exhibit a level of AhR activity; this includes PCBs 15 and 37 in
addition to the parent compound PCB 775. For example, PCB 15, which was found in
relatively high concentrations in the dechlorination mixtures, can contribute to liver
carcinogenesis 155. PCB 11, another common PCB in our dechlorination mixtures,
recently has been discovered in relatively large amounts in commercial paint pigments
133

. Furthermore, other lower chlorinated PCBs generated during dechlorination have

been shown to be metabolically activated by electrophilic quinoid species, which can
bind to DNA, including PCBs 2, 3, 12 and 15156-158. Our data suggest that the temporary
formation of lower chlorinated PCBs during dechlorination can contribute in part to
induction of inflammatory parameters.
In addition, the lipophilic nature of PCBs enables them to perturb membrane structures.
We have evidence that membrane domains like caveolae are critically involved in
endothelial inflammation induced by exposure to PCBs. For example, PCB 77 can
accumulate in caveolae-rich fractions of endothelial cells 124, and upregulation of
endothelial MCP-1 by PCB 77 is caveolin-1-dependent 125. Evidence from our laboratory
implicates caveolae as a regulatory platform involved in endothelial activation and
inflammation by environmental contaminants (Figure 2.5). As a regulatory platform,
caveolae facilitate the interaction of PCBs with the AhR, which in turn promotes the
upregulation of CYP1A1, a phase I detoxifying enzyme. CYP1A1 metabolism of coplanar
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PCBs, like PCB 77, is inefficient, leading to protein uncoupling and release of
superoxide, which promotes the formation of reactive oxygen species (ROS) in the cell
38

. The cell responds to this change in redox status by activating the transcription factor

NFкB, which regulates enzymes and inflammatory parameters associated with
endothelial dysfunction and cell injury such as MCP1 and VCAM1 159. Further studies
are needed to understand whether caveolae have differential selectivity for various PCB
species such as those present in dechlorination mixtures and to determine if the
interaction of these congeners with caveolae has potential to induce endothelial cell
dysfunction.
In summary, our study provides evidence that dechlorination of highly chlorinated PCBs
is beneficial for protecting the vasculature from oxidative stress-induced inflammation
and subsequent pathologies like atherosclerosis. Highly chlorinated PCBs are persistent
and cytotoxic and a significant risk factor to endothelial injury and associated vasculature
pathologies. The pro-inflammatory potential of the dechlorination mixtures that we
observed appears to depend largely on the presence of the parent compound (e.g., PCB
77). Clearly, cytotoxicity decreased relative to degree of dechlorination, and the final
dechlorination product, biphenyl, was nontoxic in our endothelial cell model system.
More studies are needed to understand threshold concentrations of dechlorination
mixtures that are required to prevent or mitigate compromised health associated with
exposure to environmentally toxic chlorinated biphenyls.
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Table 2.1 Treatment mixtures representing PCB 77 dechlorination byproducts at
various time points during dechlorination.
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Treatment compositions representing different products at various points in the dechlorination process (see also Table 1).

Treatment compositions representing dechlorination products at 10 and 24 h of dechlorination without the parent compound,
PCB 77.

Treatment composition representing the dechlorination products of 24 h dechlorination with the increased concentration of
PCB 77 present at 10 h of dechlorination.

Treatment composition representing the concentrations of PCB 77 present at 10 and 24 h of dechlorination.

a

b

c

d

Concentrations listed represent final PCB concentrations in cell culture media.

Table 2.2 Original and modified treatment conditions based on PCB 77 dechlorination byproducts.

Figure 2.1 Dechlorination of PCB 77 alters cellular oxidative stress.

Cells

grown on chamber slides were treated with DMSO (vehicle control) or dechlorination
products with a total concentration of 5 µM total concentrations and were incubated
for 4 h. Cells were then treated with N,N'-(1,2-dihydroxyethylene) bisacrylamide,
(DHE, in red) for superoxide detection. Slides were fixed with DAPI (in blue) for
nuclear staining, (a) fluorescent images were recorded at 40X and (b) DHE
fluorescence was quantified and normalized to DAPI.
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Figure 2.2 Dechlorination of PCB 77 attenuates NFкB activation. Cells were
treated with vehicle control (DMSO), 0 h (PCB 77, 5 µM) 10 h, 24 h and 48 h
dechlorination mixtures (5 µM), and incubated for 4 h. Both PCB 77 and
dechlorination products (10 and 24 h product treatments) significantly increased
DNA binding of NFкB over DMSO and biphenyl (48 h treatment). Results are given
as mean ± SEM. Different statistical marker letters represent significant differences
among treatment groups (determined by pvalue ≤ 0.05).

32

Figure 2.3
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Figure 2.3 Dechlorination products alter CYP1A1 (A), MCP-1 (B) and VCAM1
(C) mRNA expression. The presence of PCB 77 significantly upregulated mRNA
inflammatory markers in ECs; inflammation decreased with further dechlorination of
the parent compound. Please see Table 2.2 for detailed treatment descriptions. The
vehicle, DMSO (treatment 1), was applied at 0.1% v/v for all treatments. Treatments
representing the dechlorination products at 0 h (treatment 2), 10 h (treatment 3), 24
h (treatment 5), and 48 h (treatment 8) are the same as those tested previously for
NFкB, superoxide production and viability. Treatments 4 and 6 excluded PCB 77
while maintaining the representative concentrations of the dechlorination products
found at 10 h and 24 h, respectively. In contrast, treatments 9 and 10 contained only
PCB 77 at the concentrations found in the 10 h and 24 h mixtures, respectively.
Treatment 7 consisted of the 24 h dechlorination mixture with the level of PCB 77
found in the 10 h mixture. Different statistical marker letters represent significant
differences among treatment groups (determined by Pvalue ≤ 0.05 using one-way
ANOVA with Tukey’s post hoc). For example, in CYP1A1, treatment 2 (statistical
marker “b”) is significantly different from treatment 1 (“a”) and treatment 4 (“c”).
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Figure 2.4
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Figure 2.4 Dechlorination mixtures alter CYP1A1 (A), MCP-1 (B) and VCAM1 (C)
protein expression. The presence of PCB 77 significantly upregulated protein
inflammatory markers in ECs; inflammation decreased with further dechlorination of
the parent compound. Treatments are the same as described in Figure 3 (please
see Table 2.2 for detailed treatment descriptions). Statistical differences among
treatment groups (determined by pvalue ≤ 0.05) are represented by marker letters, as
stated previously.
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Figure 2.5 PCB 77 increases ROS production and downstream cellular
dysfunction. PCB 77 interacts with caveolae in the plasma membrane, is
endocytosed into the cell, and interacts with the AhR and its chaperone ARNT (aryl
hydrocarbon receptor nuclear translocater), leading to nuclear translocation, XRE
(xenobiotic response element) binding and CYP1A1 upregulation. CYP1A1 protein
uncoupling occurs during PCB 77 metabolism and leads to an increase in cellular
ROS. NFкB is activated in response to the change in cellular redox status and
translocates to the nucleus where it acts as a transcription factor to upregulate
adhesion molecules and cytokines.
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Chapter Three: Assessment of toxicological and inflammatory endpoints following
acute exposure to increasing concentrations of PCB 126
3.1 Synopsis
Polychlorinated biphenyls (PCBs) are persistent organic pollutants. The dioxin-like
coplanar PCBs, such as PCB 77 and PCB 126, interact with the aryl hydrocarbon
receptor (AhR), and previous work has demonstrated that coplanar PCBs initiate
endothelial dysfunction which leads to inflammation, that can lead to diseases such as
atherosclerosis. Many of these animal studies utilized PCB 77; however, use of PCB
126, a coplanar PCB with a higher affinity for the AhR, has not been well characterized.
In order to determine the appropriate dose of PCB 126 in mice, a concentration range
was selected including 0.0, 0.5, 5.0, 50, and 150 μmol/kg, also expressed as 0.0, 0.16,
1.63, 16.3, and 49.0 mg/kg (ppm). Each group of C57BL/6 mice was gavaged twice with
the same concentration of PCB126 within a seven day period. After this acute exposure,
the mice were sacrificed and assessed for toxicological and inflammatory endpoints of
PCB 126 exposure. The goal of this study was to identify PCB 126 concentrations which
do not lead to wasting syndrome. Mice receiving the highest doses (50 and 150
μmol/kg) of PCB 126 exhibited a significant decrease in body weight, indicative of broad
toxicity. The lowest concentrations of 0.0 and 0.5 μmol/kg did not contribute to weight
loss or changes in inflammatory markers. All mice which received PCB 126 had
significant increases in cytochrome P4501A1 (CYP1A1) mRNA expression, while those
mice which received 5.0 μmol/kg of PCB 126 had significant increases in liver to body
weight ratio and the inflammatory marker monocyte chemoattractant protein-1 (MCP- 1).
Exposure to 5.0 μmol/kg PCB 126 did not contribute to weight loss. These data indicate
that a concentration of 5.0 μmol/kg PCB 126 may be used to study inflammation in
C57BL/6 mice without causing overt toxicity.
3.2 Introduction
General Overview
Persistent organic pollutants (POPs) present a chronic disease risk and are linked to a
range of vascular, neurological, and teratogenic outcomes65, 160-163. Our work with
coplanar PCBs addresses both dioxin-like toxicity and the toxicity of PCBs as a class of
compounds. We have demonstrated the role of PCB 77 in inducing vascular
inflammation, modulating molecular aspects of vascular tone and responding to
nutritional interventions73, 92, 164, 165. The literature suggests that PCB 77 is metabolized,
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and methodology to detect the hydroxylated products confirms the generation of these
metabolites which has led us and other researchers to question the persistent nature of
PCB 77166. Clearly, PCB 77 has been an effective tool for the study dioxin-like
inflammation and general knowledge of coplanar PCB activity, but PCB 126 presents a
more useful model for the study of POPs because of its persistence and resistance to
metabolism.
Chemical problem
Co-planar PCBs are model toxicants, but each PCB congener evokes a unique
biological response. PCB 77, for example, contains an open meta and two open ortho
positions on each phenol which facilitate metabolism by Phase I metabolizing enzymes,
such as CYP1A1, which form epoxides and cause hydroxyl substitution. In contrast,
PCB 126 contains only one open meta position making it less vulnerable to electrophilic
substitution and, therefore, more resistant to metabolism and more environmentally
persistent, a characteristic which better represents the nature of PCBs as a class of
compounds. When compared to dioxin, PCB 77 has a TEF of 0.0005 in contrast to the
more toxic PCB 126 with a TEF of 0.1167. Though both compounds are AhR ligands, the
theoretical potential of PCB 126 to induce oxidative stress and cellular damage is much
greater.
PCB 126 in health and disease
The National Toxicology Program (NTP) comparative study of PCB 126 and 2,3,7,8Tetrachlorodibenzo-p-dioxin (TCDD) concluded that vascular disease was a critical risk
factor following exposure to dioxin-like compounds168. The liver, as a highly vascularized
organ that is critically involved in toxicant metabolism, is also affected by exposure to
coplanar PCBs including PCB 126169. NHANES data suggests a statistical link between
elevated amino L transferase (ALT) and aspartate aminotransferase (AST) levels and
plasma levels of persistent organic pollutants, such as coplanar PCBs62.
Hypothesis and Rationale
We hypothesize that acute exposure to high doses of PCB 126 will cause wasting
syndrome and that low to median doses will induce inflammation and associated
toxicological endpoints without wasting symptoms. To establish the use of PCB 126 as a
model toxicant, we utilized a dose-response study that assessed basic toxicity and
inflammatory endpoints including PCB tissue distribution, liver to body weight ratio
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changes, and mRNA levels of inflammatory markers, such as CYP1A1 and MCP-1, in
liver.
3.3 Methods
Reagents and Materials
PCB 126 was obtained from AccuStandard (New Haven, CT). The Jackson Laboratory
provided the C57BL/6 mice (Bar Harbor, MN). Tocopherol-stripped safflower oil
(vehicle) was obtained from Dyets (Bethlehem, PA). Reverse transcriptase reagents
were purchased from Fisher Scientific (Waltham, MA). Western blotting reagents were
obtained from BioExpress (Kaysville, UT). Reagents used for mRNA isolation and
qPCR were purchased from Life Technologies (Grand Island, NY).
Animal Care
Male C57BL/6 mice were housed and handled according to a protocol approved by the
University of Kentucky IACUC. After acclimation, animals were treated with an initial
dose of 0.0, 0.5, 5.0, 50, or 150 μmol/kg PCB 126 in safflower oil (vehicle, Table 3.1) on
Day 1 and received a second gavage of the same dose on Day 7. Animals were
sacrificed 24 hours after the final dose and tissues were collected for analysis. For the
dose response study, C57BL/6 mice were maintained on standard chow.
PCB 126 Tissue Analysis
Analysis of tissues for PCB 126 was kindly performed by the lab of Dr. Yinan Wei in the
University of Kentucky Department of Chemistry70. Frozen tissue samples, including
liver, adipose, lung, muscle, and kidney, and sera were weighed and processed with an
internal standard (100 µL 0.35 ng/µL PCB 166 in isooctane). Samples were combined
with diatomaceous earth and extracted with hexane. The dry hexane extract was
combined with 10 µL of 0.1 ng/µL PCB 209, internal standard. Analysis was performed
using GC/MS with the Agilent 6890N GC, G2913A auto sampler, and 5975 MS detector
(Agilent Technologies, Santa Clara, CA) using an HP-5MS 5% phenyl methyl siloxane
column (30 m length, 0.25 mm internal diameter, 0.25 µm film thickness). Retention
times were used to identify standards and PCB 126. Internal standard values were used
to calculate recovery efficiency, and tissue amounts were normalized to sample weight
for µg of PCB 126/g of tissue.
Alanine Aminotransferase (ALT) ELISA
Serum was collected by cardiac puncture, incubated on ice to allow clotting and
centrifuged for 15 min at 12,000 rpm and 4°C. Serum was collected and stored at -80°C.
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Mouse alanine aminotransferase (ALT) ELISA kit (TSZ ELISA, Framingham, MA) was
used to measure serum ALT levels. Serum was diluted 1:5 in assay Sample Solution,
and the ELISA was performed according to manufacturer’s instructions. Sample
absorbances were measured at 450 nm using a SpectraMax M2 spectrophotometer
(Molecular Devices, Sunnyvale, CA), and sample values were calculated from the
standard curve using the SoftMax Pro 4.8 software (Molecular Devices, Sunnyvale, CA).
Western Blot
Protein was collected from liver tissue homogenates, was quantified using the Bradford
method, and run on 10% SDS-PAGE gels. Bax was detected using primary antibody
from Cell Signaling170.
Real time – PCR
RNA was isolated from homogenized liver tissues using the TRIzol® method. Isolated
mRNA was resuspended in RN/DNAse free water and quantified using UV-vis
spectroscopy at 260 nM. cDNA was made using Promega AMV reverse transcriptase.
CYP1A1, MCP-1, IL-6, VCAM1, HO-1, NQO1 and β-actin were analyzed with using
SYBR® Green reagent and assessed using the qPCR on the 7300 Real Time PCR
Systems (Life Technologies, Grand Island, NY ) 125, 126.
Statistical Analysis
Comparisons between treatments were made by one-way analysis of variance followed
by Tukey’s post-hoc test. Statistical probability of P0.05 was considered significant.
Statistical tests were performed using SigmaPlot©12.0.
3.4 Results
Gross Physiological Changes
PCB 126 was distributed throughout the animal, but as was consistent with current
literature, liver and adipose were the primary storage depots (Table 3.2). A very low
level of PCB was detected in animals that did not receive PCB 126 treatment, which is
consistent with the ubiquitous nature of PCB environmental contamination. As expected,
this baseline level of PCB 126 was found predominantly in adipose.
Significant changes in body weight following toxicant exposure are associated with toxic
wasting syndrome. The total body weights of animals receiving 0.0, 0.5 or 5.0 µmol/kg
PCB 126 were not changed due to treatment. The higher concentrations of PCB 126, 50
and 150 µmol/kg, caused significant decreases in total body weight when compared to
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vehicle treated animals (Table 3.3, Figure 3.1). Interestingly, the liver to body weight
ratio, another indicator of toxicant exposure, was only significantly changed in the 5.0
µmol/kg treatment when compared to both the 0.0 and 0.5 µmol/kg treatment groups
(Figure 3.2). The liver to body weight ratios of the 50 and 150 µmol/kg PCB 126 treated
mice were not different from vehicle and low dose treated animals. This unexpected
result led us to investigate Bcl-2-associated X protein (Bax) a key marker of apoptosis
and liver damage171. Bax protein expression was low in the 0.0, 0.5, and 5.0 µmol/kg
PCB 126 treated animals; in contrast significant increases were observed in 50 and 150
µmol/kg treated animals, an indicator of liver cell apoptosis (Figure 3.3). Interestingly,
when the serum samples were assessed by alanine aminotransferase (ALT) ELISA, an
indicator of liver damage, no significant increases were detected (Figure 3.4). Further
analysis was performed on liver mRNA to assess the PCB 126-induced inflammatory
response.
Markers of AhR activation and inflammatory response
CYP1A1 expression is a hallmark of AhR activation. As expected, all mice exposed to
PCB 126 had increased CYP1A1 mRNA expression regardless of treatment
concentration (Figure 3.5a). MCP-1, a down-stream target of CYP1A1 mediated
oxidative stress and NFĸB activation, was significantly increased only in the mRNA of 5
µmol/kg treated mice when compared to both the 0.0 and 0.5 µmol/kg groups (Figure
3.5b). IL-6 expression was similar to MCP-1 with a significant increase in the 5.0
µmol/kg group over all other treatment groups (Figure 3.5c). Interestingly, VCAM1
expression in the 50 and 150 µmol/kg groups was highly increased compared to 0.0
µmol/kg and the lower PCB 126 doses. This observation correlates with the indications
of cell death. Using the macrophage marker F4/80, the presence of macrophages was
assessed and correlated with the increase in VCAM1 expression reaching significance in
the 150 µmol/kg treatment group (Figure 3.6). In response to the cellular stress
associated with these inflammatory markers, the anti-oxidant response, as indicated by
hemeoxygenase 1 (HO-1) and NADPH:quinone oxidoreductase 1 (NQO1) enzyme
mRNA, was significantly increased with the highest doses of PCB 126 (Figure 3.7).
NQO1 was increased in the 5 µmol/kg group relative to the 0.0 and 0.5 µmol/kg doses
but was significantly lower than the highest doses. Together these data suggest that 5.0
µmol/kg was sufficient to produce moderate inflammation.
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3.5 Discussion
Differences exist between model species and their response to PCBs and other
environmental toxicants172, and the literature does not provide sufficient mouse data to
determine an inflammatory but not overtly toxic dose of PCB 126. For this reason, we
performed this dose-response assessment in C57BL/6 mice. The National Toxicology
Program (NTP) assessment of PCB 126 in rats corroborates our tissue distributions
data173. They and other investigators found the liver and the adipose to be the primary
depots for PCB 126 deposition. In our animals, the higher doses of PCB 126 resulted in
an increase in the percentage of PCB distributed to the adipose (Table 3.2). During a
study which included a 22-day observation period, liver levels of PCB 126 were reported
to remain stable174. These findings indicate that the PCB tissue levels are in keeping with
dose and duration of exposure. As is consistent with our results in mice, peripheral
tissues, i.e. lung, and serum contained detectable but much lower levels of PCB 126173.
When compared to TCDD, PCB 126 has greater tissue retention175. The PCB 126 tissue
retention levels in our mice were dose dependent with 150 µmol/kg mice having
estimated total body levels (µg) correlating to dose amount. The lower PCB 126 doses
did not correlate as well implicating metabolism and excretion through feces174, 176.
Concentrations of 50 µmol/kg PCB 126 and above induced wasting in C57BL/6 mice,
which is associated with metabolic and hormonal changes that affect the metabolism of
glucose and decrease appetite177, 178. A change in liver to body weight ratio was
observed in mice receiving two doses of 5 µmol/kg PCB 126. The hepatic response to
toxicants promotes an increase in liver fatty acid and protein content, which is supported
by both the increase in liver weight and gene expression179.
All treatment doses of PCB 126 upregulated Phase I enzyme CYP1A1. Previous work
from our laboratory has established CYP1A1 as a key response enzyme to PCB 77induced inflammation via critical interaction between AhR and Cav-1124. CYP1A1 is
responsible for the oxidative stress induced by PCB 126 and other aromatic
hydrocarbons which cause the release of hydroxyl radicals and uncoupling of the
enzyme38. In response to the cellular stress, multiple indicators of inflammation were
increased. The liver mRNA expression of the chemokine MCP-1 and the cytokine IL-6
were increased in the 5 µmol/kg PCB 126 exposure group. IL-6 is an acute phase
cytokine that stimulates protein synthesis and promotes tissue healing and is expressed
by hepatocytes, leukocytes, and endothelial cells180, 181. Mice deficient in IL-6 were
unable to induce normal protein synthesis in response to turpentine tissue damage or
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Gram-positive bacterial infection, though systemic response to LPS stimulation was near
normal182. The role of IL-6 in protein synthesis and tissue healing supports the
observation that 5 µmol/kg treated mice had higher liver to body weight ratios. Some
literature indicates that AhR agonists moderate the IL-6 response183, 184, which provides
a limited explanation for the low induction of IL-6 in higher PCB 126 doses. In vascular
disease, IL-6 is a marker of plaque instability185 and has been noted as a common risk
factor associated with low-grade inflammation and CVD risk186. Similarly, VCAM1 is a
common marker for vascular disease that is critical to lesion formation and the
recruitment of monocytes to regions of tissue damage and endothelial dysfunction44, 45,
. Coplanar PCBs promote VCAM1 expression and endothelial dysfunction126, as is
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supported by the increase in VCAM1 in the 50 and 150 µmol/kg PCB 126 treatment
groups. PCB 126-induced VCAM1 expression in the 50 and 150 µmol/kg treatment
groups indicates a dose and tissue-dependent effect that promotes macrophage
accumulation with the highest exposure. Further the oxidative stress resulting from the
50 and 150 µmol/kg exposure levels were sufficient to induce HO-1 and NQO1
expression, which is associated with the cellular ant-oxidant response. Oxidative stress
induces Nrf2 regulated anti-oxidant genes187, 188. This critical protective response is
positively regulated by lifestyle factors such as diet through phytochemicals including
flavonoids found in green tea, fruit and vegetables and through long-chain omega-3
polyunsaturated fatty acids including docosahexaenoic acid (DHA)189, 190. Our in vitro
work with epigallocatechin 3-gallate (EGCG), a green tea catechin, and oxidized DHA
neuroprostanes has implicated Nrf2 as a critical protective mechanism in response to
coplanar PCB-induced oxidative stress92, 129, 130. The protective nature of these dietary
factors warrants further exploration in vivo.
Previous work assessing different concentrations of PCB 126 have reported similar
dose-dependent expression patterns of CYP and anti-oxidant response genes175, 191.
PCB 126 exhibits a lower TEQ than TCDD, which induces more genes and exhibits
greater toxicity18. However, low levels of exposure and the persistent nature of PCB 126
is sufficient to alter the inflammatory and metabolic homeostasis, which promotes the
development of atherosclerosis and other diseases associated with inflammation192.
Together these changes indicate that acute exposure to 5 µmol PCB 126/kg body weight
is sufficient to produce a moderate inflammatory response without overt toxicity and
could be utilized for experimental designs that include, for example, nutritional
modulation of PCB 126-induced metabolic insults.
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Table 3.1 Treatment doses
shown in µmol/kg and mg/kg
(ppm). Mice were treated via
oral gavage. Each group of mice
(n=6) received two doses of
PCB 126 in tocopherol stripped
safflower oil (vehicle, Dyets®) at
the respective concentrations.

PCB 126 Treatments
µmol/kg mg/kg
0.00
0.00
0.50
0.16
5.00
1.63
50.0
16.3
150
49.0
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Table 3.2 PCB 126 tissue concentration and distributions represented by dose.
Each group of mice received two doses of PCB 126 at the respective concentrations.
Total average tissue concentration is represented in µg of PCB 126 per g of tissue
and is the summation of the tissue averages from each group as a representation of
body burden. The distribution of PCB 126 within the representative tissues was
calculated as a percentage of the total for the respective concentrations.

Group
(μmol/kg)
0.00
0.50
5.00
50.0
150

Total
Average
Recovery
(μg/g tissue)
1.03
31.4
143
937
2148

Percentage of Total PCB 126 by Treatment and Tissue
(average µg PCB 126/g tissue)
Serum
0.00 (0.00)
0.00 (0.00)
0.07 (0.09)
0.18 (1.67)
0.40 (8.67)

Liver
Adipose
27.0 (0.28) 69.4 (0.71)
37.9 (11.9) 4.28 (1.34)
55.7 (79.9) 15.0 (21.6)
29.0 (272) 54.5 (510)
22.0 (473) 56.0 (1200)
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Muscle
0.00 (0.00)
56.7 (17.8)
25.6 (36.7)
7.24 (67.8)
11.9 (256)

Kidney
3.65 (0.04)
0.82 (0.26)
2.84 (4.08)
7.09 (66.4)
5.57 (119)

Lung
0.00 (0.00)
0.27 (0.08)
0.80 (1.15)
2.00 (18.8)
4.07 (87.4)

Table 3.3 Body weight was decreased by treatment with high-doses of PCB
126. Average pre- and post-treatment whole body weights were calculated. The
changes in body weight were calculated and were compared to vehicle treated
animals (0.0 µmol/kg).

PCB126
Dose
(µmol/kg)
0.00
0.50
5.00
50.0
150

Average
Average
PCB126 Average
Change
PostPreDose in
treatment in Weight Standard
treament
ppm
(g)
Deviation
(mg/kg) Weight (g) Weight (g)
0.00
23.00
24.13
1.15
1.13
0.16
23.58
24.73
1.13
0.62
1.63
22.97
23.62
0.65
0.82
16.3
23.92
22.37
-1.55
1.71
49.0
23.97
22.00
-1.97
0.55
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SEM
0.128
0.251
0.334
0.700
0.226

P value
1.000
0.897
<0.001
<0.001

Weight Change (g)

2
1
0
-1

0

0.5

5

*

*

50

150

-2
-3

PCB126 Concentration (μmol/kg)

Figure 3.1 PCB 126 treatment causes a decrease in body weight at higher
concentrations. Mice were orally gavaged twice with PCB 126. Weights were
recorded before and after treatment with PCB 126. The average weight change is
expressed as a positive or negative change from baseline weight. Results are the
mean ± SEM, n=6. Significantly different compared with 0.0 µmol/kg at *P < 0.001.
(See also Table 3.3)
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Figure 3.2 PCB 126 treatment at 5 µmol PCB 126/kg mouse causes a
significant increase in liver wet weight compared to body weight. Liver weights
were recorded after sacrifice and set over the final body weight to determine the
ratio. Results are the mean ± SEM, n=6. Significantly different compared with 0.0
+

µmol/kg at * P<0.001 and compared with 0.5 µmol/kg at P < 0.05.
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Figure 3.3 PCB 126 induced dose-dependent increases in
Bax protein expression. Bax results are the mean ± SEM, n=6.
Significantly different compared with 0.0 µmol/kg at *P<0.05 and
0.5 µmol/kg at + P<0.05.
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Figure 3.4 PCB 126 did not significantly increase the serum ALT
levels. Alanine aminotransferase (ALT) results are the mean ± SEM
P<0.05, n=6.
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Figure 3.5 Expression of inflammatory markers increased following PCB 126
exposure. (A) CYP1A1 mRNA results are significantly different compared with 0.0
+

µmol/kg (Oil) at * P<0.005 and significantly different from 50 µmol/kg P < 0.02. (B)
For MCP-1, the 5.0 µmol/kg group was significantly different from 0.0 and 0.5
µmol/kg treatments at * P<0.02. (C) VCAM-1 expression was significantly increased
in the 50 and 150 µmol/kg treatments P≤0.001. (D) 5.0 µmol/kg PCB 126 treatment
caused a significant increase in IL-6 expression, * P<0.05.
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Figure 3.6 The highest dose, 150 µmol PCB 126/kg mouse, initiated infiltration
of macrophages after acute exposure. F4/80 mRNA expression was significantly
increased in the 150 µmol/kg treatment group, * P<0.03.
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Figure 3.7 Anti-oxidant enzyme mRNA expression increased with higher
concentrations of PCB 126. (A) HO-1 expression was significantly increased in the
50 and 150 µmol/kg treatments, * P≤0.007. (B) NQO1 mRNA increased significantly
over vehicle (0.0 µmol/kg) and 0.5 µmol/kg at * P<0.05. The 5.0 µmol/kg expression
+

level was significantly less than 50 and 150 µmol/kg levels, P < 0.001.
Copyright © Katryn Elizabeth Eske 2013
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Chapter Four: DHA feeding modulates the inflammatory profile of C57BL/6 mice
exposed to coplanar PCB 126
4.1 Synopsis
Consumption of fish oil is associated with improved coronary health outcomes, but the
mechanism of protection is not fully understood. Environmental stressors, such as
polychlorinated biphenyls (PCBs), contribute to the development of cardiovascular
diseases like atherosclerosis. We study the protective benefits of nutrients such as the
polyunsaturated omega-3 fatty acids found in fish oil in reducing the inflammatory
response to PCBs. Higher consumption of fatty fish or fish oil supplementation has been
associated with improved cardiac outcomes in high-risk patients193, 194. To further our
understanding of the mechanism by which the omega-3 fatty acid, docosahexaenoic
acid (DHA), is protective, we fed C57BL/6 mice diets enriched in DHA (3% DHA/22%
safflower oil in % kcal) or a safflower control diet for four weeks before administration of
the coplanar PCB 126 via oral gavage at week five. DHA feeding moderately attenuated
serum expression of pro-inflammatory cytokines following PCB 126 gavage. CYP1A1
mRNA expression was reduced in DHA-fed/PCB 126-treated mice. CYP1A1 activity
promotes oxidative stress, yet 8-iso-prostaglandin 2 alpha (8-iso-PGF2α), a measure of
tissue oxidative stress, was not changed by PCB 126. DHA monohydroxy lipoxygenase
(LOX) metabolites were increased with DHA-enriched diet and compensatory decreases
in omega-6 fatty acids and metabolites were observed. In DHA-fed mice, peroxisome
proliferator-activated receptor gamma (PPARγ), a positive co-activator of Nrf2, had
increased mRNA expression which indicate priming of the anti-oxidant response even in
the absence of oxidative stress. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) mRNA
was increased following DHA/PCB 126 treatment. Real time- PCR analysis revealed
increased expression levels of Nrf2 activated anti-oxidant enzymes NAD(P)H
dehydrogenase (quinone 1) (NQO1) and hemeoxygenase 1 (HO-1) in PCB treated mice
on a DHA diet. Liver samples were analyzed by microarray to examine the interactive
effects of PCBs and DHA and identify potential pathways for future investigation.
Together these data suggest that DHA promotes an anti-oxidant response in mice
exposed to environmental pollutants such as PCBs.
4.2 Introduction
Inflammation is a key characteristic of many disorders including atherosclerosis, Type 2
diabetes mellitus and obesity58, 195, 196. Patients who suffer from a chronic inflammatory
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disease state, such rheumatoid arthritis and diabetes, have an accelerated risk for
vascular disease development56, 57, 197. Inflammation is a response to a range of stimuli
which includes the oxidative stress caused by environmental pollutants and is linked by
the nuclear factor kappa B (NFкB) signaling pathway which drives the expression of an
array of genes including cytokines and adhesion molecules198. Coplanar PCBs, such as
PCB 77 and PCB 126, initiate an oxidative stress response in the vascular endothelium,
which disrupts barrier function and promotes the expression of adhesion molecules like
vascular cell adhesion molecule 1 (VCAM1) and chemokines such as monocyte
chemoattractant protein 1 (MCP-1)14, 125, 126. The inflammatory response that is initiated
by coplanar PCBs is sensitive to fatty acid exposure. For example, the omega-6 fatty
acid linoleic acid promotes endothelial inflammation199, 200, and increasing the ratio of
omega-3 fatty acids attenuates this response16. Further, oxidized docosahexaenoic acid
(DHA) neuroprostanes promote an anti-oxidant response to coplanar PCB-induced
inflammation through activation of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2)
pathway92. Others have reported that the disruption of lipid rafts, called caveolae, by
DHA prevents an oxidative stress response by displacing lipid raft-based signaling
proteins201. Omega-3 fatty acids, especially those found in fish oil, are of interest in the
treatment of inflammation based diseases, such as atherosclerosis.
Fish oil supplementation has been a subject of much study as epidemiological data
reveal lower rates of heart disease in populations such as the Japanese who have diets
high in omega-3 fatty acids202. Many clinical trials have tested fish oil supplementation in
cardiac patients, and some have concluded that supplementation following a cardiac
event reduces secondary events94, 193. A Finnish study compared the effects of fish
consumption and exposure to pollutants on low-grade inflammation and indicators of
vascular and metabolic health; insulin sensitivity was decreased in association with
pollutant exposure while high omega-3 consumption was associated with lower serum
interleukin-6 (IL-6), a marker of inflammation203. Though not conclusive, higher fish
intake in the presence of higher pollutant exposure produced a null effect on plaque
formation, indicating a compensatory effect203. The long-chain omega-3 fatty acids, such
as EPA and DHA which are found in fish oil, are reported to be more efficacious than αlinolenic acid in the prevention of primary and secondary cardiac events194.
The beneficial nature of long-chain, omega-3 fatty acids may be due in part to the
generation of oxidized and enzymatically derived metabolites. Our observations of
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oxidized-DHA A4/J4-neuroprostane support their role in the anti-oxidant response92. The
research of the Morrow laboratory has demonstrated neuroprostane-derived protection
from the LPS-induced NFкB signaling response and that oxidized long-chain omega-3
fatty acids disrupt the Kelch-like ECH-associated protein 1 (Keap1) inhibition of Nrf2204,
205

. Further, their laboratory has detected the presence of oxidized long-chain fatty acids

in vivo in brain, cerebrospinal fluid and small amounts in plasma204, 206. The
enzymatically derived long-chain, omega-3 fatty acid metabolites include the resolvins
and protectins, which promote macrophage clearance of the inflammatory
polymorphonuclear neutrophils (PMNs), which is a critical step in the resolution of local
inflammation207, 208. Protectins and resolvins are the products of lipoxygenase (LOX) and
cycloxygenase (COX) metabolism of EPA and DHA, and the activity of these enzymes is
part of the response to the inflammatory states associated with allergies, obesity,
diabetes and cardiovascular disease102. In epithelial cells, resolvin E1 promotes the
expression of CD55, which disrupts neutrophil interaction with intercellular adhesion
molecule 1 (ICAM1) and reduces transepithelial migration209. Human aortic endothelial
cells (HAECs) activated by TNF-α and exposed to protectin D1 expressed lower levels of
the inflammatory cytokines MCP-1 and interleukin 8 (IL-8)208. Taken together, a diet
enriched in long-chain, omega-3 fatty acids provides substrate for the generation of
these metabolites which have great potential as protective mediators that intervene in
the development of the inflammatory pathology associated with disease states such as
atherosclerosis. In addition, the metabolic actions of long-chain omega-3 fatty acids,
such as DHA, promote an anti-oxidant response that is critical in the presence of
oxidative stress caused by coplanar PCBs and other inflammatory stimuli.
Hypothesis and Rationale
We hypothesize that long-chain omega-3 fatty acids can be protective by modulating the
inflammatory profile in mice following exposure to coplanar PCB 126. The protective
nature of omega-3 fatty acids common in fish oil was tested in mice supplemented with
dietary DHA and exposed to PCB 126. To characterize the role of DHA in response to
PCB 126-induced inflammation in C57BL/6 mice, we monitored changes in body
composition and metabolic endpoints, measured fatty acid incorporation into animal
tissues, and reviewed the shift in cytokine expression, DHA metabolite levels, and antioxidant enzyme expression following PCB 126 challenge. We anticipate that the
inflammatory environment will be shifted toward a pro-resolving phenotype.
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4.3 Methods
Reagents and Materials
PCB 126 was obtained from AccuStandard (New Haven, CT). The Jackson Laboratory
provided the C57BL/6 mice (Bar Harbor, MN). Tocopherol-stripped safflower oil
(vehicle) and specialized diet were obtained from Dyets (Bethlehem, PA). Reverse
transcriptase reagents were purchased from Fisher Scientific (Waltham, MA). Western
blotting reagents were obtained from BioExpress (Kaysville, UT). Reagents used for
mRNA isolation and qPCR were purchased from Life Technologies (Grand Island, NY).
Animal Work
Male C57BL/6 mice were housed and handled according to a protocol approved by the
University of Kentucky IACUC. A summary of the experimental design is provided in
Table 4.1. After acclimation, baseline body compositions were assessed by ECHO MRI,
and animals were trained in the Techniplast cages from which were taken baseline
urine, feces, and food consumption data. Following the baseline measurements, animals
were fed a semi-purified safflower oil control diet (25%kcal fat, Table 4.2) or a DHAenriched diet for 4 weeks (3%kcalDHA/22%kcal safflower, Table 4.2)99, 210-212. Body
composition was assessed by ECHO MRI at the end of the third week and after the first
gavage. During the fourth week, animals were individually housed in the Techniplast
cages and underwent a glucose tolerance test (GTT). During the final week, animals
were gavaged on the first and seventh day with 5.0 μmol/kg of PCB 126. Following the
initial gavage, the animals were assessed by Techniplast cage observation, GTT, and
ECHO MRI. The final gavage was performed 24 h before the animals were sacrificed.
Liver and adipose were collected and divided between storage in RNALater for mRNA
extraction or flash frozen in liquid nitrogen. All tissues were stored at -80°C. Serum was
collected by cardiac puncture, kept on ice, centrifuged to separate serum from red blood
cells, aliquoted and stored at -80°C. Unless otherwise stated, all animals from a group
were used in the analysis, n= 9 or 10.
The ECHO MRI for body composition analysis was available through the support of the
Center of Obesity and Cardiovascular Disease (COCVD) Center for Biomedical
Research Excellence (COBRE) grant from the National Institute of General Medical
Sciences (8 P20 GM103527-05) of the National Institutes of Health. Techniplast solo
mouse metabolic cages were used to collect urine and feces and monitor individual food
consumption. Mice were placed in individual metabolic cages with free access to water
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and food for 24 h. Animals and diet were weighed before and after placement into the
cage, and the mice were returned to their normal social housing environment.
For the glucose tolerance test (GTT), animals were fasted for 6 h. Blood was collected
from the tail vein by use of a 0.5 inch 27 gauge sterile needle and measured using a
glucometer to record fasting blood glucose levels. Mice were intraperitoneally (i.p.)
injected with 20% sterile glucose solution (2 g dextrose in 10 mL of 0.9% saline solution)
at 2 mg glucose/g body weight. For example, a 20 g mouse would receive 200 µL of
20% glucose solution. Blood glucose levels were measured by glucometer at 15, 30, 60,
and 120 minutes after glucose i.p. injection.
Real Time - PCR
Messenger RNA (mRNA) was isolated from homogenized liver tissues using the Trizol®
method. Isolated mRNA was resuspended in RNA/DNAse free water and quantified
using UV-vis spectroscopy at 260 nM. Complementary DNA (cDNA) was made using
Promega AMV Reverse Transcriptase (Madison, WI) and followed a modified Promega
protocol. For cDNA synthesis, 1 µg of mRNA per 10 µL reaction volume was used.
Water volume was adjusted for volume of 1 µg mRNA to a total of 4.95 µl/10 µL reaction
volume, and mRNA was heat denatured at 70°C for 10 min. Reverse transcription was
run using the following thermocycler protocol: 25°C for 10 min, 42°C for 60 min, 95°C for
5 min and 4°C hold. RT-PCR was performed using SYBR® Green reagent and run on
the 7300 Real Time PCR System (Life Technologies, Grand Island, NY)126. Primer
sequences are found in Table 4.3.
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Measurements in Serum
Alanine Aminotransferase (ALT) ELISA
Serum was collected by cardiac puncture, incubated on ice and centrifuged for 15 min
at 12,000 rpm and 4°C. Serum was collected and stored at -80°C. Mouse alanine
aminotransferase (ALT) ELISA kit (TSZ ELISA, Framingham, MA) was used to measure
serum ALT levels. Serum was diluted 1:5 in assay Sample Solution, and the ELISA was
performed according to manufacturer’s instructions. Sample absorbances were
measured at 450 nm using a SpectraMax M2 spectrophotometer (Molecular Devices,
Sunnyvale, CA), and sample values were calculated from the standard curve using the
SoftMax Pro 4.8 software (Molecular Devices, Sunnyvale, CA).
Total Serum Cholesterol and Fast Protein Liquid Chromatography (FPLC) Analysis
Total serum cholesterol was measured using the Wako Cholesterol E colorimetric assay
(Wako Chemicals USA, Inc., #439-17501, Richmond, VA) and serum samples were
diluted 1:25 in H2O (n = 4 or 5). Fast Protein Liquid Chromatography (FPLC) was
performed in collaboration with the laboratory of Dr. Allen Daugherty, University of
Kentucky, using the Bio-Rad Biological DuoFlow System with BioFrac Fraction Collector
and a Superose 6 10/300GL Column (GE Healthcare, #17-5172-01)213. Serum samples
(n= 4 or 5) were eluted with a 1.0 mM EDTA/0.15 M NaCl/0.02% wt/vol Azide buffer
solution and a total of thirty-two fractions were collected in Fraction Collection Tubes in a
96-well rack (BioRad, #233-9390). Fractions were stored at 4°C for less than a week and
analyzed for cholesterol content using the Wako Cholesterol E colorimetric assay. Area
under the curves (AUCs) and elution times were assessed using PeakFit software
(Systat Software, Inc., San Jose, CA). The Center parameter was used as a proxy for
elution time and lipoprotein fractions were classified using the following parameters: 0-15
were VLDL, 16-20 were LDL/IDL, and 21-28 were HDL. C57BL/6 mice are
normolipidemic mice214.
Serum Cytokine Measurements
Serum cytokines were analyzed using a mouse cytokine/chemokine 16X custom
multiplex assay from Millipore (Milliplex MAP Kit, Billerica, MA) and run on a Bioplex 200
system from Biorad (Hercules, CA). Frozen serum aliquots were selected from each
group (n=5) and diluted 1:1 in Assay Buffer. Standards and reagents were prepared
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according to manufacturer’s directions, and the assay was performed as stated in the
manufacture’s protocol.
Lipid, DHA Metabolite and Isoprostane Extraction
Lipids, DHA metabolites and isoprostanes were assessed in collaboration with the
laboratory of Dr. Morris, University of Kentucky using a Shimadzu UFLC coupled with
an ABI 4000-Qtrap hybrid linearion trap triple quadrupole MS.
Tissue Lipid Extraction
Frozen liver and adipose (20-30 mg, n= 9 or 10) was homogenized in 1 mL of methanol
using 4 mm stainless steel ball bearings and a Geno/Grinder homogenizer (SPEX
SamplePrep, Metuchen, NJ). Homogenized samples were transferred to 8 mL
borosilicate glass tubes with Teflon cap, and 1 mL of MeOH was added to the
homogenate. The following were added to each tube in sequence: 1 mL chloroform, 500
µL of 0.1 M HCL, 50 µL of 1 µM C17 internal standard. Samples were vortexed for 5 min
and were stored at 4°C for a minimum of 1 hr. After incubation, 1 mL of chloroform and
1.3 mL of 0.1 M HCl was added to separate the phases. The samples were vortexed for
5 min and centrifuged for 10 min at 4000 rpm. The lower phase was transferred to 4 mL
screw cap vials with a Pasteur pipette. Care was taken to avoid the upper phase and the
protein interface. Using N2 in a N2-evaporation system, the lower phase was evaporated
to dryness. Each sample was resuspended in 100 µL of methanol which was split for the
respective experiments: 10 µL for phosphate assay and 90 µL for derivitization and
further processing. Samples were evaporated to dryness and stored at -20°C. Samples
were resuspended in 100 µL of methanol for liver and for adipose 100 µL
methanol:chloroform 1:1, loaded to autosampler vials and run on the LC/MS according
to protocols described previously215. Samples were normalized to C17 and phosphate.
DHA Metabolite and Isoprostane Extraction
For solid phase extraction, approximately 30 mg of liver or adipose tissue (n= 9 or 10)
was ground in 1 mL of 0.5% acetic acid in ethyl acetate:methanol (5:1 v/v). Each sample
received 100 µL 10 µM isoprostane standards and 50 µL 1 µM DHA/EPA standards,
were vortexed to mix, and were centrifuged for 10 min at room temperature and 2500 x
g. Supernatants were transferred to a glass tube and dried under nitrogen. Dried
samples were reconstituted in 200 µL of methanol, vortexed, diluted in 3 mL of 0.5%
acetic acid and vortexed. Solid phase extraction columns (Supelco Supel Select HLB
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SPE, 60 mg/3 mL SPE tube, #54182-U, Sigma Aldrich, St. Louis, MO) were
preconditioned with 3 mL of methanol and 3 mL of 0.5% acetic acid. The samples were
applied to the columns and washed with 3 mL of 0.5% acetic acid and 3 mL of 0.5%
acetic acid with 20% methanol. Columns were dried for 5 min and samples were eluted
into glass vials with 3 mL of methanol. Samples were dried under nitrogen and stored at
-20°C. Samples were resuspended in 100 µL of methanol, loaded to autosampler vials
and run on the LC/MS according to protocols described previously216-218. Samples were
normalized to internal standard and/or tissue weight.

Microarray
Microarray was performed in conjunction with University of Kentucky Microarray Core
Facility using Affymetrix Genechip Mouse Exon 1.0 ST Arrays (Affymetrix Genechips,
Santa Clara, CA). Liver mRNA was isolated from tissues frozen in RNALater via the
TRIzol® method. RNA integrity number (RIN) values were measured in isolated mRNA
samples. Samples from 3 mice were pooled and applied to one microarray chip with a
total of 3 chips per treatment group representing nine total samples.
Statistical analyses
Comparisons of data were made by two-way analysis of variance (ANOVA) followed by
Tukey’s post-hoc testing using SigmaPlot 12.0 software (Systat Software, Inc., San
Jose, CA). Due to the nature of our study, animals which did not receive DHA-enriched
diet or did not receive PCB 126 treatment did not necessarily express detectible levels of
DHA metabolites, inflammatory cytokines, etc. For this reason, certain data sets
contained zero values that proved problematic for statistical assumptions associated
with normality and variance made by parametric tests and variance for non-parametric
tests. For example, the data associated with the DHA metabolite 14-HDHA failed both
normality and variance tests because the safflower/vehicle group did not have
detectable levels of this metabolite (Supplemental Figure 4.1a). In contrast, 4-HDHA was
produced by all groups and failed to reject the statistical assumption tests (Supplemental
Figure 4.1b). In observing the data for 14-HDHA, the levels of 14-DHDA are increased
for DHA-fed mice, and sufficient differences beteen the groups are present for both
parametric and non-parametric analyses detected overall differences between diets. For
the parametric two-way ANOVA, the overall difference between diets had p<0.001 with
statistically significant differences between diets in the vehicle treatments (p<0.001) and
62

PCB treatments (p= 0.029). Following consultation with the University of Kentucky
Department of Statistics, it was determined that the parametric two-way ANOVA was the
most appropriate method for determining the statistical differences for these data.
Statistical probability of p0.05 was considered significant.
Microarray data were analyzed in collaboration with the University of Kentucky,
Department of Statistics. Affymetrix MAS 5 was used to normalization the chip
expression levels and to determine probe set expression measurements. For quality
control, distributions of gene expression for each chip and correlations between chips
were confirmed. Each probe set was fit to a 2 × 2 ANOVA model, and changes in gene
expression were determined using overall significance of the model with a significant
difference of p ≤ 0.01. Increases and decreases in expression between treatment group
pairs were determined by t-tests. The resulting gene list was sorted for overall
significance and upregulated or downregulated gene expression between the
safflower/PCB 126 treated and the DHA/PCB 126 treated groups. Supplemental data
was generated by sorting for significant difference (p ≤ 0.01) in the safflower-fed groups.
4.4 Results
Food consumption and body composition
Following baseline measurements, animals were placed on safflower control diet and
DHA-enriched diet. Assessment of food consumption during 24 h isolation in the
Techniplast cages at weeks four and five did not reveal statistical differences between
diet or treatment (Figure 4.1). Animals fed diet enriched in DHA had significant increases
in DHA and eicosapentaenoic acid (EPA) free fatty acid levels in both adipose and liver
(Figure 4.2) but not in the serum of our DHA-fed animals. Arachidonic acid (AA) free
fatty acid levels were decreased in DHA-fed animals compared to safflower-fed animals.
PCB treatment significantly decreased tissue free fatty acid content AA levels in adipose
(Figure 4.2a) and EPA levels in liver (Figure 4.2b). In addition, body weights were not
different between groups prior to PCB gavage (Figure 4.3). Following treatment with 5
µmol PCB 126/kg body weight, PCB 126 treated mice weighed significantly more than
vehicle treated mice (Figure 4.3, Figure 4.4). The PCB 126 treated mice had diet
independent increases in lean mass, but fat mass was not changed between groups
(Figure 4.4). We attributed this increase in lean mass in part to the PCB 126-induced
increase in liver weight to body weight ratio (Figure 4.5). The increase in liver size
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demonstrated a clear response to the environmental toxicant; however, serum ALT
levels were not increased by PCB 126 treatment (Figure 4.6). We concluded from this
that there was no significant liver damage or cell death following this acute exposure to
PCB 126.
Metabolic assessment
In order to gain a complete overview of the diet and toxicant interaction, we assessed
basic metabolic parameters including glucose tolerance and serum cholesterol with
lipoprotein profiles. Prior to treatment with PCB 126, glucose challenge did not result in
significant changes in glucose clearance (Figure 4.7a&b). However, following a single
gavage with 5 µmol/ kg of PCB 126, mice on a DHA-enriched diet had a significantly
lower area under the curve (AUC) response to glucose challenge than both controls and
safflower/PCB 126-treated mice (Figure4.7d). During the glucose tolerance test (GTT),
DHA/PCB 126-treated animals had significantly lower glucose levels by 60 min, and at
120 min, mice receiving PCB 126 had significantly lower glucose levels than dietary
controls (Figure 4.7c). Similarly, total serum cholesterol was decreased in PCB 126treated mice (Figure 4.8). DHA-enriched diet produced an overall decrease in the serum
cholesterol levels (Figure 4.8). The FPLC data revealed major changes in the high
density lipoprotein (HDL) fraction with overall cholesterol decreases in response to
dietary DHA and PCB 126 treatment (Figure 4.9). The safflower/PCB 126 treated
animals had lower very low density lipoprotein (VLDL) cholesterol compared to
safflower/control mice (Figure 4.9b). Similarly, all the VLDL, low density
lipoprotein/intermediate density lipoprotein (LDL/IDL), and HDL fractions of the
DHA/PCB 126 treated animals had lower levels of cholesterol compared to the
DHA/control treated animals. Liver metabolic function was clearly affected by the
presence of both dietary DHA and coplanar PCB 126. To assess the inflammatory and
anti-oxidant response, we tested serum and liver for changes in markers of inflammation
and oxidative stress.
Markers of inflammation and oxidative stress
Serum levels of sixteen cytokines were measured using the Milleplex MAP Kit for mouse
cytokines and chemokines. Ten of the sixteen cytokines had detectable protein levels
and were assessed for differences (Figure 4.10). Granulocyte colony-stimulating factor
(G-CSF) and IL-6 were significantly increased only in the safflower/PCB 126 treated
animals (Figure 4.10a&c). MCP-1 and MIG, mitokine induced by gamma-interferon or
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CXCL9, were increased by PCB 126 in both diets (Figure 4.10f&h). Interleukin-12 (p70)
(IL-12 p70) demonstrated an interactive effect between diet and treatment (Figure
4.10d). The safflower/PCB 126 treated group was significantly increased; in comparison,
the DHA/PCB 126 treated group was significantly decreased. The other cytokines were
not significantly affected by diet or PCB 126 treatment including interleukin-1 alpha (IL1α), keratinocyte chemoattrant (KC), macrophage colony-stimulating factor (M-CSF),
macrophage inflammatory protein 1 alpha (MIP-1α) and macrophage inflammatory
protein 1 beta (MIP-1β) (Figure 4.12b,e,g,i,&j, respectively). The cytokine protein
expression changes implicate a moderate inflammatory response to PCB 126 treatment
with a slightly higher response in safflower fed animals. With an exception for IL-12
expression, dietary DHA did not alter the cytokine profile to the extent that we had
hypothesized. The lack of significant data from the other cytokines may be attributed in
part to the high variability between animals in each group. There was moderate
attenuation of the PCB 126-induced serum cytokine levels in mice fed a DHA-enriched
diet when compared to the overall response of safflower/PCB 126 treated mice.
The liver is the primary site for toxicant metabolism and excretion. We expected a
strong inflammatory response given the metabolic changes that we observed in glucose
tolerance and lipoprotein cholesterol levels. Cytochrome P450 1A1 (CYP1A1) is an
important Phase I metabolizing enzyme that responds to aryl hydrocarbon receptor
(AhR) induction by PCB 126 and other dioxin-like molecules124. CYP1A1 mRNA
expression was significantly increased above dietary controls, but DHA-fed animals had
lower CYP1A1 expression than their safflower-fed counterparts (Figure 4.11a). In
contrast to the serum protein expression (Figure 4.10c), IL-6 had a significant mRNA
increase only in the DHA/PCB 126-treated animals (Figure 4.11b). MCP-1 mRNA was
increase following PCB treatment in both diets which is similar to the protein expression
levels (Figures 4.11c and 4.10f, respectively); however, the fold change in the DHA/PCB
126-treated animals was greater that the safflower/PCB 126-treated animals. In contrast,
VCAM1 expression was not affected by either diet or treatment with PCB 126 (Figure
4.11d). The overall expression patterns in Figure 4.11 resemble the moderate
inflammatory profile of 5 µmol PCB 126/kg body weight that was observed in chapter
three (Figure 3.5). Given the decrease in CYP1A1 mRNA expression in DHA-fed mice,
we had expected to observe compensatory decreases in the inflammatory profile.
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CYP1A1 is prone to enzyme uncoupling during the metabolism of coplanar PCBs; the
consequence of the unsuccessful reaction is the release of superoxide which increases
cellular oxidative stress38, 39, 73. 8-iso-prostaglandin 2 alpha (8-iso-PGF2α) is an
arachidonic acid metabolite that serves as an in vivo marker of oxidative stress219-221.
When measured in adipose and liver, PCB 126 did not induce significant increases in
the relative levels of 8-iso-PGF2α, but in the DHA/PCB 126 treated animals, there was a
significant decrease in adipose levels compared to DHA diet control (Figure 4.12). The
only change in the 8-iso-PGF2α levels implicated a baseline decrease in oxidative stress
for animals exposed to both DHA and PCB 126.
DHA Metabolism Products
The literature indicates that metabolites of DHA, such as the protectins, promote the
resolution of an inflammatory state222. Adipose and liver tissues were assessed for the
presence of hydroxydocosahexaenoic acid (HDHA) lipoxygenanse (LOX) derived
metabolites (see also Figure 1.2). Tissue levels of DHA and EPA were verified in these
sample preparations with significant diet-dependent increases in both fatty acids (Figure
4.13a and 4.14a). The levels of DHA and EPA were significantly decreased in adipose
following treatment with PCB 126 (Figure 4.13a); a similar trend was observed in the
liver (Figure 4.14a). 5-LOX generates leukotriene E4, an arachidonic acid metabolite and
DHA-derived 4-HDHA and 7-HDHA222-224. The generation of these metabolites in both
adipose and liver was not altered by either diet or PCB treatment (Figure 4.13b and
4.14b, respectively). Tissue levels of 12-LOX and 15-LOX HDHA metabolites were
significantly increased in response to administration of dietary DHA but not PCB 126
(Figures 4.13c and 4.14c). In particular, 14-HDHA is the monohydroxy marker from the
12-LOX pathway that generates maresin 1222. Protectin D1 (PD1) biosynthesis is
indicated by the presence of 17-hydroxyl-docosa-4Z,7Z,10Z,13Z,15E,19Z-hexaenoic
acid (17-HDHA)207, and 17S-HDHA is the product of DHA metabolism by 15lipoxygenase (15-LOX)102. In comparison to the overall trend observed in the DHAlipoxygenase metabolites, the 15-LOX products derived from the omega-6 fatty acid
linoleic acid, 9-HODE and 13-HODE, were increased significantly only in the
safflower/PCB 126 groups 225, and there was a significant difference in metabolite levels
between diets (Figure 4.13d and 4.14d). The implication is that there is a compensatory
shift from omega-6 to omega-3 fatty acid substrate following consumption of a DHAenriched diet.
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Anti-oxidant response
We would expect a minimal anti-oxidant response to PCB 126 given the unchanged
oxidative stress levels of 8-iso-PGF2α following treatment (Figure 4.12). Interestingly, the
anti-oxidant profile would suggest that the underlying anti-oxidant phenotype is changed
by dietary DHA. The anti-inflammatory arachidonic acid metabolite, 15-deoxy-∆12,14-PGJ2
with an m/z of 315.2 to 217.1, was significantly increased only in the DHA-fed control
group (Figure 4.15a). 15-deoxy-∆12,14-PGJ2 is the dehydration product of cyclooxygenase
derived PGD2 and an activator of PPAR and Nrf2 226, 227. PPAR gamma isoform 2
(PPARγ2) also had increased expression in the DHA control group (Figure 4.15b), which
was attributed to the heightened levels of 15-deoxy-∆12,14-PGJ2228. In contrast, exposure
to PCB 126 significantly reduced the level of 15-deoxy-∆12,14-PGJ2 and PPARγ2 to levels
equivalent to the safflower-fed groups (Figure 4.15a&b). Nrf2, the nuclear transcription
factor that regulates anti-oxidant response, was increased in mRNA of animals exposed
to PCB 126 (Figure 4.15c). Further, the Nrf2 regulatory element Keap1 had reduced
expression in the DHA-fed/PCB 126 treated animals (Figure 4.15d). In response to the
changes in Nrf2 and Keap1, the anti-oxidant genes HO-1 and NQO1 were both
significantly increased following PCB 126 exposure, but the DHA/PCB 126 group had
higher NQO1 expression than the safflower/PCB 126 group (Figure 4.15e&f). Together,
these data indicate that the presence of dietary DHA sensitizes the anti-oxidant
response by dampening Nrf2 regulation to promote a heightened anti-oxidant response
to moderate inflammation induced by PCB 126.
Microarray overview
Of the 35,000 probes assessed by the Agilent mouse chip, 624 probes had a significant
interaction between PCB 126 treatment and dietary feeding, pvalue≤0.01. Of these genes,
495 have known functions and were sorted for increased or decreased expression
between the safflower/PCB 126 treated and the DHA/PCB 126 treated groups. The
resulting genes sets were applied to the DAVID© software system and were sorted for
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway interactions229. The major
metabolic pathways that were down-regulated in animals fed a DHA-enriched diet and
exposed to PCB 126 when compared to the safflower/PCB 126 group include the
glycine, serine, threonine metabolism pathway, the terpenoid backbone biosynthesis
pathway, the proteasome pathway, and the porphyrin and chlorypyll metabolism
pathway (Table 4.4). These are indicators that the cell modified the rate of enzyme
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metabolism to modulate the xenobiotic response which includes Phase I and II enzymes
and the anti-oxidant response enzymes. The gene expression of control animals, e.g.
safflower fed animals with or without 5 µmol/kg PCB 126 treatment, were compared;
genes associated with biosynthesis of fatty acids and steroid hormones, insulin
signaling, PPAR (peroxisome proliferator-activated receptor) signaling, and drug
metabolism were down-regulated (Supplemental Table 4.1) Major upregulated
pathways in the DHA/PCB 126 group include several pathways related to the cytotoxic
response including cytokine/chemokine receptor interactions, chemokine and calcium
signaling pathways, and adhesion molecule expression (Table 4.5). Increased
expression was detected for genes associated with hematopoietic cell lineages and
melanoma. For the direct comparison of safflower oil-fed animals with or without PCB
126 treatment, expression of genes associated with xenobiotic metabolism, energy
metabolism, and certain cancers were increased by PCB 126 treatment (Supplemental
Table 4.2).
4.5 Discussion
Others have demonstrated the incorporation of omega-3 fatty acids into tissues after
only three weeks of feeding and have observed relative decreases in arachidonic acid
with increased dietary DHA or EPA, which are similar to our observations230. The DHAenriched algal oil, derived from Crypthecodinium cohnii , a microalga, that was used in
our diet carried the fatty acids primarily in triglyceride form231. The DHASCO product
contains minor constituents (5%) which are not triglycerides; these include tocopherols
and other phenolic compounds, which promote the stability of the DHASCO product in
various light and oxidizing conditions232. In addition, fish bioaccummulate PCBs, which
makes fish oil a potential source of pollutant exposure233. This is not a concern for the
microalgal oil. In a 72 h study of omega-3 fatty acid incorporation in plasma
phospholipids, natural oils had the highest incorporation level followed by re-esterified
triglycerides < ethyl esters234. The highest omega-3 plasma levels were achieved at 24
hr post-supplementation and no differences were observed between EPA and DHA
incorporation. In a study comparing healthy young and elderly subjects who consumed a
meal containing 13C-DHA, the total omega-3 lipid profile increased at 24 h, but the
triglyceride and free fatty acid profiles for 13C-DHA peaked at 4 h235. These data along
with our observations indicate that long chain, omega-3 fatty acids have relatively short
half-lives in plasma compared to tissues. The DHASCO product in our diet contained
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negligible levels of EPA, <0.03% of the fat content, yet EPA tissue levels were increased
following DHA feeding (Figure 4.2). Liver peroxisomes retroconvert DHA to EPA236.
Retroconversion of DHA to EPA was observed at an average rate of 9.4% in human
subjects receiving DHA supplementation for six weeks237. These findings were confirmed
in a study of post-menopausal women, and interestingly, those who received hormone
replacement therapy had lower rates of retroconversion, which was attributed to possible
estrogen-mediated changes in both peroxisomal and mitochondrial β-oxidation238. As
discussed in chapter three, coplanar PCB 126 toxicity mediates an increase in liver
protein content179, which is supported both by our observations of total and lean body
mass increases resulting in significant increases in liver to body weight ratio (Figures
4.3-4.5). Further, as in chapter three, we did not detect toxicant-induced increases in
serum ALT levels (Figure 4.6).
The metabolic changes observed in this study present some interesting points for
discussion. Our glucose tolerance data is in keeping with other reports of heightened
insulin sensitivity in obese mice fed omega-3 fatty acids239 (Figure 4.7). Both PCBs and
obesity promote a certain level of inflammatory stress240. DHA metabolites have been
studied for their similar binding potentials to thiazolidinediones and may promote insulin
sensitization through PPAR activation103, 241. Interestingly, changes to insulin sensitivity
are only observed following the stress of PCB treatment indicating the formation of
unidentified DHA oxidation products that activate PPAR103, 242. In addition, IL-6 is a
critical mediator in adiponectin induced insulin sensitivity243. IL-6 mRNA levels were
significantly increased in the DHA/PCB 126 treatment group in which heightened
sensitivity was observed (Figure 4.11b). Cholesterol levels are affected by both the
presence of PCB 126 and DHA diet. In contrast to our data, significant increases in total
and HDL cholesterol have been reported in rats65. In a PCB 126 dosing study, also in
rats, investigators observed both increases in cholesterol and decreases in serum
glucose levels following exposure to 0.1 ppm PCB 126 for thirteen weeks244. These
studies used different exposure routes and dosing models but assessed the outcome of
chronic PCB 126 exposure as opposed to the acute nature of this study. We previously
reported that a high fat, omega-6 fatty acid-enriched diet increased genes involved in
triglyceride synthesis, fatty acid metabolism and cholesterol catabolism which was
reversed following coplanar PCB 77 exposure in C57BL/6 mice245. The contribution of
dietary DHA to the observed reduction in cholesterol is supported by studies that
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suggest that dietary omega-3 fatty acids are suppressors of sterol-regulatory elementbinding proteins (SREBPs) and 3-hydroxy-3-methylglutaryl-Coenzyme A reductase
(HMGCR), which are both critical to cholesterol production246, 247 (Figures 4.8 and 4.9).
Interestingly, the cytokine expression pattern reveals moderate attenuation by DHA diet
(Figure 4.10). Of the ten cytokines, five were significantly increased in the safflower/PCB
126 group when compared to diet control. In contrast, only two, MCP-1 and MIG, were
significantly increased in the DHA/PCB 126 group compared to DHA diet control. Our
data demonstrates increased MCP-1 expression in both the cytokine assay and mRNA
(Figure 4.10f and 4.11c). This observation contrasts with our in vitro findings in which
PCB 77-induced MCP-1 expression is attenuated by oxidized DHA neuroprostanes92.
Other groups have demonstrated similar findings with DHA or EPA248 and oxidized
EPA249 in which NFкB activation of MCP-1 expression was mitigated in a PPARγ- or
PPARα -dependent manner, respectively. The omega-3 oxidation products have been
implicated in PPAR activation63, and our findings indicate increases in enzymatically
produced DHA metabolites in the plasma or liver which suggest an environment where
oxidized metabolites may be formed. IL-12 (p70) was the only cytokine in which the
DHA/PCB 126 group levels were significantly less than the safflower/PCB 126 group
levels (Figure 4.10d). IL-12 stimulates interferon gamma (INF-γ) secretion by natural
killer and T helper cells and facilitates the transition from the innate immune response to
the adaptive immune response250. In dendritic cells, DHA inhibits NFкB-induced
expression of IL-12 by activating PPARγ100. In protein, IL-6 was increased only in the
safflower/PCB 126 treatment group (Figure 4.10c); in contrast, the DHA/PCB 126 group
had increased in IL-6 mRNA expression (Figure 4.11b). Data from a study of allergic
lung inflammation reported heterogeneity within the inflammatory endpoints as well.
Following ovalbumin challenge, they observed that EPA and DHA-fed mice produced
high IL-5 and IL-13 levels while suppressing F2-isoprostanes99.
The formation of LTE4, 4-HDHA and 7-HDHA metabolites were not altered by either
DHA-enriched diet or PCB 126, which implicates minimal activity of 5-LOX in both liver
and adipose (Figures 4.13b and 4.14b). Phospholipids that contain DHA have been
reported to inhibit 5-LOX activity251. As a result, we would have expected altered
metabolite generation in DHA-fed animals. Others have found that the omega-3 to
omega-6 ratio and the total amount of dietary fat alter the leukotriene levels252. High fat
diet (20% fat) alone reduces leukotriene levels, and animals fed a high fat diet require a
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high ratio of omega-3 to omega-6 fatty acids to observe a decrease in inflammationinduced LTE4 levels252. We have reported that the ratio of omega-3 to omega-6 fatty
acids influences the inflammatory response to coplanar PCB-induced inflammation16.
Together these data suggest that at 25% kcal the fat content in our diet was sufficient to
alter leukotriene and other eicosanoid levels and the 3% kcal DHA enrichment was not
robust enough to mitigate the inflammatory response to PCB 126. We did not observe
overall changes in eicosanoid metabolites as demonstrated by the 8-iso-PGF2α data, a
phenomena which is supported by the insight that a high fat diet suppress the
eicosanoid levels and a low omega-3 to omega-6 ratio with high fat diet is inefficacious
in altering the inflammatory response Figure 4.12). Despite the impact of this
observation on our findings, 3% kcal from DHA altered tissue fatty acid content and was
sufficient for DHA monohydroxy metabolite formation (Figures 4.2, 4.13 and 4.14).
The omega-6 metabolites 9-HODE, 13-HODE and 15-deoxy-∆12,14-PGJ2 are
endogenous PPARγ ligands and as such contribute to PPAR-activated vascular
remodeling, vasoprotection and anti-inflammatory potential253 (figures 4.13d, 4.13d and
4.15a). 15-deoxy-∆12,14-PGJ2 promotes Nrf2 activation by binding to the intervening
region of Keap1and facilitating the release of Nrf2227. Similarly, the oxidized DHA and
EPA products have potential as nuclear receptor activators of both Nrf2 and PPAR92, 249.
Resolvin E1 is also a potent PPARγ inducer102, 239. Our DHA control mRNA data
supports increased expression of PPARγ2 (Figure 4.15b), and the changes in glucose
clearance in the DHA/PCB 126 treated mice support PPARγ activity102, 239, 246. PPARγ
has had a controversial role in the field of DHA metabolite activity. Some have
demonstrated that the oxidized DHA neuroprostanes exhibited anti-oxidant properties
independent of the PPARs204. In contrast, the structural compatibility and the PPARγ
transactivation potency of DHA oxidation products have been reported103. Our research
supports the role of PPARs in the attenuation of PCB-induced inflammation254, 255. DHA
metabolite interaction with Nrf2 has not been well characterized. In the DHA/PCB 126
treated group, we observe a trend toward increased anti-oxidant response due to
reduced Keap1 expression and heighted NQO1 expression, which cannot be correlated
to an increase in the oxidative stress marker, 8-iso-PGF2α (Figures 4.15 and 4.12,
respectively). Others have demonstrated in vitro with 3T3-L1 cells that EPA and DHA
are protective against hydrogen peroxide-derived oxidative stress through Nrf2dependent anti-oxidant gene expression, an effect which is attenuated by Nrf2
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silencing104. Of interest to us, the promoter regions of Nrf2 and PPARγ contain the
alternate’s binding elements256. By extension, the heightened levels of PPARγ2 prior to
PCB exposure would prime the hepatocytes for increased Nrf2 expression after PCB
challenge (Figure 4.15).
The microarray data support the idea that the enzymatic response is selectively
regulated to sustain xenobiotic clearance and anti-oxidant enzyme activity when
comparing safflower/PCB 126 and DHA/PCB 126 treatment groups. For example,
porphyrins are intermediates in heme biosynthesis, and the genes included in this
pathway, such as hydroxymethylbilane synthase (HMBS, also known as porphobilinogen
deaminase) are essential to heme formation and the production of oxidative stress
inducing cytochrome P450’s257. The attenuated level of CYP1A1 is supported by the
suppression of the porphyrin metabolism pathway (Figure 4.11a). Further, it is not
surprising that proteasome pathway genes are decreased to regulate xenobiotic
response. Oxidative stress conditions modify the efficacy of specific proteasomal
activities which ensures the resolution of inflammation through inhibition of the NFкB
response and the support of the anti-oxidant response through sustained Keap1
degradation (Figure 4.15c&d)258. The reduced expression of proteasome regulated
genes supports the observed increase in liver protein content259, 260. In addition, the
inhibition of proteasomes has been attributed to a decrease in cholesterol261. Similarly,
products of the terpenoid backbone biosynthesis pathway feed into cholesterol
biosynthesis, which is reduced in this model262. The suppression of these two pathways
supports a mechanism that explains the reduction in total and specifically HDL
cholesterol levels (Figures 4.8&4.9, respectively). The KEGG pathways associated with
increased gene expression in the safflower/PCB 126 and DHA/PCB 126 treatment
groups (Table 4.5) indicate subtle changes in the inflammatory response including
higher expression of cytokine receptors and adhesion molecules including VCAM1
expression, which was unchanged in the mRNA. For comparison, we assessed changes
in the safflower diet response following PCB 126 exposure.
Animals fed the safflower oil control diet and exposed to 5 µmol/kg PCB 126 exhibited
dysregulation of a variety of metabolic processes (Supplemental Tables 4.1 and 4.2).
For example, the microarray indicates suppression of acyl-CoA synthetase 1 (ACSL1) in
control diet, PCB 126-treated animals (Supplemental Table 4.1). ACSL1 is associated
with the PPAR signaling pathway and plays a role in both fatty acid efflux and insulin72

mediated glucose uptake263, which supports the changes indicated by the microarray in
the insulin signaling pathway and links the PPAR family with metabolic homeostasis264.
Treatmen with PCB 126 decreases in the expression of certain CYP enzymes including
constitutively expressed CYP3A25265. On the other hand, PCB 126 activation of the
AhR induces the CYP1 family, including CYP1A1 and CYP1B1 (Supplemental Table
4.2). Upregulated genes from the safflower diet groups indicates expression changes in
KEGG pathways associated with colorectal, pancreatic, and small cell lung cancer.
Sustained activation of the AhR induces gene expression that potentiates the induction
of cancer266. In a two-year chronic exposure study conducted by the National Toxicology
Program (NTP), rats exposed to PCB 126 developed cancerous lesions173. Further, AhR
activation promotes increased expression of Phase II metabolizing enzymes including
glutathionine S- transferases and UDP- glucuronosyltransferases35. The gene
expression changes in safflower-fed mice acutely exposed to PCB 126 are sufficient to
disrupt a variety of cellular processes and initiate an inflammatory response.
Omega-3 fatty acids may modulate the cellular response through several mechanisms
including changing the membrane signaling capacity by alterations in the membrane
structure, antagonizing signaling through key receptors, or activating critical cellular
response mechanisms96. The data presented here demonstrate a shift in the
inflammatory response and implicate activation of key anti-oxidant pathways which may
be linked to the generation of DHA metabolites (Figure 4.16). Long-chain, omega-3 fatty
acids also selectively alter the composition of membrane lipid rafts, by which they may
reduce the pro-inflammatory potential of toxicants, such as coplanar PCBs267, 268. In
chapter five, we will explore this third aspect of the inflammatory pathway by studying
the activation of lipid raft-based signaling molecules.

73

Table 4.1 Experimental design.
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Table 4.2 Control and DHA-enriched diet compositions. Semi-purified diets
were manufactured by Dyets (Bethlehem, PA). Dietary compositions represent
the composition for one kilogram of diet. The DHASCO product was generously
provided by Martek Biosciences Corporation (Columbia, MD). The diets were
matched for kilocalorie composition.
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Table 4.3 Relative Real Time-PCR sequences.
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Category
KEGG_PATHWAY
KEGG_PATHWAY
KEGG_PATHWAY
KEGG_PATHWAY

Term
mmu00260:Glycine, serine and threonine metabolism
mmu00900:Terpenoid backbone biosynthesis
mmu03050:Proteasome
mmu00860:Porphyrin and chlorophyll metabolism

Count
4
3
4
3

%
PValue
Genes
1.754 0.012 GCAT, SARDH, AGXT, GLDC
1.316 0.018 LOC674674, LOC637711, GM5873, FDPS, GM3571, MVK, GM8163, LOC634846, PMVK
1.754 0.033 PSMF1, PSMC3, PSMD3, PSMD4
1.316 0.074 HMBS, UROD, MMAB

shared metabolic pathways. (pvalue≤0.01)
List Total Pop Hits Pop Total Fold Enrichment Bonferroni Benjamini FDR
87
32
5738
8.244
0.702
0.702
12.373
87
14
5738
14.133
0.843
0.604
18.298
87
47
5738
5.613
0.967
0.679
31.060
87
30
5738
6.595
1.000
0.858
57.384

down-regulated gene transcripts was generated using the DAVID© software system, which assessed the genes for activity in

were further sorted by a decrease of DHA/PCB 126 expression in comparison to safflower/PCB 126 expression. Analysis of 232

Of the approximately 35,000 gene transcripts, 624 were significantly affected by the interaction of PCB treatment and diet and

Table 4.4 Genes down-regulated by 5 µmol/kg PCB 126 treatment and DHA feeding affect multiple metabolic pathways.
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Term

KEGG_PATHWAY mmu04020:Calcium signaling pathway

KEGG_PATHWAY mmu04640:Hematopoietic cell lineage

KEGG_PATHWAY mmu04062:Chemokine signaling pathway

KEGG_PATHWAY mmu05218:Melanoma

KEGG_PATHWAY mmu04514:Cell adhesion molecules (CAMs)

KEGG_PATHWAY mmu04060:Cytokine‐cytokine receptor interaction

Category

metabolic pathways.
Count
9
7
4
6
4
6

%
3.846
2.991
1.709
2.564
1.709
2.564

PValue
0.013
0.014
0.063
0.085
0.094
0.099

Genes
LOC100048875, CXCR4, LOC100047704, TGFBR1, CCR2, CX3CR1, EDA2R, CXCR2, HGF, IL15, PDGFD
VCAM1, PTPRC, CADM1, CD80, SELL, NRXN1, JAM2
PIK3CG, MITF, HGF, PDGFD
PIK3CG, LOC100048875, CXCR4, LOC100047704, CCR2, CX3CR1, GNG2, CXCR2
CD3G, CD33, ITGA1, CD24A
ATP2B1, SLC8A1, SLC25A4, CYSLTR1, CYSLTR2, PTAFR

List Total Pop Hits Pop Total Fold Enrichment Bonferroni Benjamini FDR
75
244
5738
2.822
0.699
0.699 13.085
75
154
5738
3.478
0.734
0.484 14.329
75
71
5738
4.310
0.998
0.870 51.099
75
182
5738
2.522
1.000
0.875 62.176
75
84
5738
3.643
1.000
0.843 66.012
75
191
5738
2.403
1.000
0.805 68.218

regulated gene transcripts was generated using the DAVID© software system, which assessed the genes for activity in shared

further sorted by an increase of DHA/PCB 126 expression in comparison to safflower/PCB 126 expression. Analysis of 263 up-

the approximately 35,000 gene transcripts, 624 were significantly affected by the interaction of PCB treatment and diet and were

Table 4.5 Genes up-regulated by 5 µmol/kg PCB 126 treatment and DHA feeding affect multiple metabolic pathways. Of

Figure 4.1 Neither diet nor PCB 126 treatment caused significant
differences in food consumption. (A) Pre-treatment food consumption
averages based on animals individually housed in urine/feces collection
cages for 24 hr, and (B) food consumption following initial gavage with 5
µmol PCB 126/kg body weight from animals housed in urine/feces
collection cages.
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Figure 4.2 DHA-enriched dietary feeding promotes accumulation of
DHA and EPA in both (A) adipose and (B) liver tissues. Both tissues
have a significant overall increase in free fatty acids between diets for
EPA and DHA and an overall significant decrease in arachidonic acid
(AA). There is an overall effect of PCB 126 treatment on adipose AA
fatty acid levels and liver EPA fatty acid levels. A difference was
detected between safflower/PCB 126 and DHA/PCB 126 treatments *
pvalue <0.05, and a difference was detected between safflower/saline and
DHA/saline treatments,

+

pvalue < 0.05. Significant differences between

DHA/saline and DHA/PCB 126 are represented by

$

pvalue<0.05.

Significant differences between safflower/saline and safflower/PCB 126
are represented by

#

pvalue<0.05. Overall difference between dietary

feeding is represented by a bar.
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Figure 4.3 Body weights were affected by treatment but not by diet. Control
safflower oil diet is represented by black circles and a dashed line, and control
safflower oil diet with PCB 126 treatment is represented by open circles with a
dashed line. DHA diet only is represented by black squares and a solid line, and
DHA-fed, PCB 126 treated animals are represented by open triangles and a solid
line. Significant differences in body weight were observed following treatment with
PCB 126 regardless of diet, *pvalue <0.05 significantly different from treatment
controls of both diets.
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Figure 4.4 Body compositions were affected by PCB 126 treatment
but not by diet. (A) Total body mass was significantly increased
following PCB 126 treatment. (B) Fat composition was not affected by
PCB 126 treatment. (C) Lean body composition was significantly
increased in the groups receiving PCB 126 treatment. Significantly
difference found when compared to their respective treatment controls,
*pvalue <0.05.
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Figure 4.5 Liver weight to body weight ratio is increased with PCB
126 treatment. Liver weight divided by total body weight in the PCB 126
treated animals was significantly increased when compared to their
respective treatment controls, *pvalue <0.05.
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Figure 4.6 PCB 126 did not significantly increase the serum ALT
levels. Alanine aminotransferase (ALT) results are the mean + SEM
pvalue <0.05, n=5.
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85

+

pvalue<0.05. Blood glucose levels at 120

other treatment groups, + pvalue <0.05.

controls, *pvalue <0.05. The DHA-fed, PCB 126 treated animals (D) had a significantly lower AUC when compared to all

min were significantly decreased in the groups receiving PCB 126 treatment compared to their respective treatment

significantly lower blood glucose levels at 60 min than all other treatments,

126/kg body weight gavage in week 5. In (C) the post-treatment GTT, the DHA-fed, PCB 126 treated animals had

area under the curve (AUC) in arbitrary units. (C) and (D) represent the GTT and respective AUC post 5 µmol PCB

(C). (A) and (B) represent the oral glucose tolerance test (GTT) at week 4 (before PCB 126 treatment) with respective

solid line in (A) and (C), and DHA-fed, PCB 126 treated animals are represented by open triangles and a solid line in

treatment is represented by open circles with a dashed line in (C). DHA diet only is represented by black squares and a

oil diet is represented by black circles and a dashed line in (A) and (C), and control safflower oil diet with PCB 126

Figure 4.7 DHA-fed, PCB 126 treated mice have a heightened response to glucose challenge. Control safflower

Figure 4.8 Treatment with PCB 126 decreases total serum
cholesterol. Total serum cholesterol (mg/dL) in the PCB 126 treated
animals was significantly decreased when compared to their respective
treatment controls, * pvalue <0.001, and an overall difference was
detected between diets,

+

pvalue = 0.032, with DHA/control being

significantly less than Safflower/control, # pvalue = 0.01, n = 4 or 5.
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Figure 4.9 Acute exposure to PCB 126 reduces lipoprotein cholesterol
content in C57BL/6 mice. (A) Average FPLC chromatograms representing
cholesterol distribution within the lipoprotein fraction for normolipodemic
C57BL/6 mice. (B) Significant overall differences were observed between
PCB 126-treated and control animals. Differences between safflower/control
and safflower/PCB 126 treatment were designated by

#

pvalue<0.05.

Differences between in DHA/control and DHA/PCB 126 were designated by
$

pvalue<0.05.

HDL

was

significantly

decreased

when

comparing

safflower/control and DHA/control, + pvalue <0.05, and an overall difference
was detected between diets in the HDL lipoprotein fraction, * pvalue< 0.05, n =
4 or 5.
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Figure 4.10
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Figure 4.10 Treatment with PCB 126 induces cytokine expression
in serum with a trend toward increased expression in safflower fed
mice. Overall differences between PCB 126 and vehicle treatment were
found for (A) G-CSF, (C) IL-6, (F) MCP-1, and (H) MIG. (A) G-CSF and
(C) IL-6 were significantly increased only in the safflower/PCB 126
treated group. (D) IL-12 (p70) had an interactive effect between diet and
treatment with significant differences between safflower/PCB 126 and
both safflower/vehicle and DHA/PCB 126. (F) MCP-1 and (H) MIG were
significantly increased for both PCB treated groups when compared to
their respective dietary controls. There were no significant differences in
cytokine expression for (B) IL-1α, (E) KC, (G) M-CSF, (I) MIP-1α, and
(J) MIP-1β. Significant differences between safflower/saline and
safflower/PCB 126 are represented by

#

pvalue<0.05. Differences

detected between safflower/PCB 126 and DHA/PCB 126 treatments are
represented by * pvalue <0.05, and significant differences between
DHA/saline and DHA/PCB 126 are represented by $ pvalue<0.05, n=5.
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Figure 4.11 PCB 126 promotes an inflammatory response in
acutely exposed mice. Overall differences between PCB 126 and
vehicle treatment were found for (A) CYP1A1, (B) IL-6 and (C) MCP-1.
(A) CYP1A1 had overall differences between diets with reduced
expression in the DHA-fed/PCB 126-treated animals. PCB 126
significantly increased CYP1A1 expression over the control treated
animals. (B) IL-6 had increased expression for DHA/PCB 126- treated
mice in comparison to the untreated controls. PCB 126 signficantly
increased (C) MCP-1 expression over controls, and DHA/PCB 126treated animals had higher MCP-1 expression than the safflower/PCB
126 treated group. There were no significant differences in (D) VCAM1
expression for treatment or diet. Significant differences between
safflower/saline and safflower/PCB 126 are represented by # pvalue<0.05.
Differences detected between safflower/PCB 126 and DHA/PCB 126
treatments are represented by * pvalue <0.05, and significant differences
between DHA/saline and DHA/PCB 126 are represented by
pvalue<0.05.
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Figure 4.12 Oxidative stress is not increased in the adipose and liver of
mice acutely exposed to PCB 126. 8-iso-prostaglandin F2 alpha (8-isoPGF2α) is a marker of oxidative stress, and neither adipose nor liver tissues
contained significant increases of 8-iso-PGF2α following PCB 126 exposure.
DHA-fed mice had lower levels following PCB 126 exposure. Significant
differences between DHA/saline and DHA/PCB 126 are represented by
pvalue<0.05.
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Figure 4.13 Treatment with PCB 126 promotes DHA metabolite
formation in the adipose of DHA fed mice. For DHA and EPA, there
is an interactive effect between diet and treatment with a significant
decrease in the DHA/PCB 126 treated group. LTE4, 4-HDHA and 7HDHA have no significant differences. For 9-HODE and 13-HODE,
there are overall difference between diets and treatments with an
increase in the safflower/PCB 126 treatment group. For 10-HDHA, 11HDHA, 13-HDHA, 14-HDHA, 16-HDHA, 17S-HDHA and 20-HDHA,
there were overall differences between diets. Samples were normalized
to tissue weight. A difference was detected between safflower/PCB 126
and DHA/PCB 126 treatments * pvalue <0.05, and a difference was
detected between safflower/saline and DHA/saline treatments,

+

pvalue <

0.05. Significant differences between DHA/saline and DHA/PCB 126 are
represented

by

$

pvalue<0.05.

Significant

differences

between

#

safflower/saline and safflower/PCB 126 are represented by pvalue<0.05.
Overall difference between dietary feeding is represented by a bar.
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Figure 4.14 Treatment with PCB 126 promotes DHA metabolite
formation in the livers of DHA fed mice. For DHA, there is a
significant overall increase between diets. For EPA, there is an
interactive effect between diet and treatment with a significant decrease
in the DHA/PCB 126 treated group. LTE4, 4-HDHA and 7-HDHA have
no significant differences. For 10-HDHA, 11-HDHA, 13-HDHA, 14HDHA, 16-HDHA, 17S-HDHA and 20-HDHA, there were overall
differences between diets. For 9-HODE, there is almost an interactive
effect with an overall difference between diets and an increase in the
safflower/PCB 126 treatment group. 13-HODE had an interactive effect
between diet and treatment. Samples were normalized to tissue weight.
A difference was detected between safflower/PCB 126 and DHA/PCB
126 treatments * pvalue <0.05, and a difference was detected between
safflower/saline and DHA/saline treatments,

+

pvalue < 0.05. Significant

differences between DHA/saline and DHA/PCB 126 are represented by
$

pvalue<0.05. Significant differences between safflower/saline and

safflower/PCB 126 are represented by

#

pvalue<0.05. Overall difference

between dietary feeding is represented by a bar.
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Figure

4.15

DHA-feeding

inflammatory

15-deoxy-∆

promotes
12,14

PGJ2

the
and

formation

of

anti-oxidant

antigene

expression in response to PCB 126-induced inflammation. Overall
differences between PCB 126 and vehicle treatment and diet were
found for (A) arachidonic acid metabolite 15-deoxy-∆12,14PGJ2 and (B)
PPARγ2, though PCB 126 treatment reduces this response. Overall
differences between PCB 126 and vehicle treatment were found for (C)
Nrf2, (D) Keap1, (E) HO-1, and (F) NQO1. (D) Keap1 mRNA expression
is significantly decreased in the DHA/PCB 126 group when compared to
control. (F) NQO1 is significantly increased in the DHA/PCB 126 treated
group above both control and safflower/PCB 126 treated animals.
Differences

detected

between

treatments are represented by

+

safflower/control

and

DHA/control

pvalue <0.05, and significant differences

between DHA/saline and DHA/PCB 126 are represented by
pvalue<0.05.

Significant

differences

between

safflower/saline

safflower/PCB 126 are represented by # pvalue<0.05.
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and

Figure 4.16 DHA and DHA metabolites positively regulate antiinflammatory signaling pathways. The cell utilizes DHA to activate
anti-oxidant enzyme systems through increased activity of the nuclear
transcription factors, PPARγ and Nrf-2. PCB 126 binding with the AhR
promotes an inflammatory response which is mitigated by increased
anti-oxidant enzyme expression.
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mmu03320:PPAR signaling pathway

mmu00910:Nitrogen metabolism

mmu04910:Insulin signaling pathway

KEGG_PATHWAY

KEGG_PATHWAY

6

3

6

4

mmu01040:Biosynthesis of unsaturated fatty
acids

KEGG_PATHWAY

KEGG_PATHWAY

5

mmu00140:Steroid hormone biosynthesis

6

Count

KEGG_PATHWAY

Term

mmu00983:Drug metabolism

KEGG_PATHWAY

Category

for activity in shared metabolic pathways.

2.39

1.195

2.39

1.594

1.992

2.39

%

0.095

0.061

0.012

0.011

0.008

0.001

PValue

SCD3, ACSL1, SORBS1, FABP2,
ACAA1B, SCP2
CAR14, HAL, CPS1
SREBF1, SORBS1, GCK, PYGL,
PKLR, GYS2

SCD3, FADS1, ELOVL2, ACAA1B

Genes
TYMP, CYP3A25, CYP3A41A,
CYP3A59, DPYD, ES31, TK1
HSD3B2, CYP3A25, CYP3A41A,
HSD3B5, CYP3A59, SRD5A1

102

102

102

102

102

102

138

23

79

27

45

48

5738

5738

5738

5738

5738

5738

2.446

7.338

4.273

8.334

6.251

7.032

1.000

0.998

0.714

0.686

0.544

0.135

0.815

0.720

0.269

0.320

0.325

0.135

67.16

50.38

12.89

12.0

8.289

1.587

List Total Pop Hits Pop Total Fold Enrichment Bonferroni Benjamini FDR

Analysis of 102 down-regulated gene transcripts was generated using the DAVID© software system, which assessed the genes

Supplemental Table 4.1 Genes down-regulated by 5 µmol/kg PCB 126 treatment affect multiple metabolic pathways.
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mmu00240:Pyrimidine metabolism

mmu04110:Cell cycle

mmu05222:Small cell lung cancer
mmu05210:Colorectal cancer
mmu00140:Steroid hormone biosynthesis
mmu03010:Ribosome
mmu00010:Glycolysis / Gluconeogenesis
mmu03050:Proteasome
mmu00983:Drug metabolism
mmu05212:Pancreatic cancer
mmu03030:DNA replication
mmu00040:Pentose and glucuronate
interconversions

mmu00051:Fructose and mannose metabolism

mmu00350:Tyrosine metabolism
mmu00380:Tryptophan metabolism

KEGG_PATHWAY

KEGG_PATHWAY

KEGG_PATHWAY

KEGG_PATHWAY
KEGG_PATHWAY
KEGG_PATHWAY
KEGG_PATHWAY
KEGG_PATHWAY
KEGG_PATHWAY
KEGG_PATHWAY
KEGG_PATHWAY
KEGG_PATHWAY

KEGG_PATHWAY

KEGG_PATHWAY
KEGG_PATHWAY

KEGG_PATHWAY

mmu00480:Glutathione metabolism

mmu00230:Purine metabolism

KEGG_PATHWAY

%

4
4

1.114
1.114

1.114

0.836

3

2.507

2.507

3.343

0.092
0.098

0.082

0.079

0.030
0.031
0.035
0.036
0.039
0.040
0.043
0.049
0.072

0.025

0.005

0.004

2.786 1.02E-05

3.343 1.51E-06

1.95
1.95
1.393
1.95
1.671
1.393
1.393
1.671
1.114

4

PValue

3.621 7.81E-07

7
7
5
7
6
5
5
6
4

9

9

12

10

12

mmu00980:Metabolism of xenobiotics by
cytochrome P450

KEGG_PATHWAY

Count
13

Term

mmu00982:Drug metabolism

KEGG_PATHWAY

Category

activity in shared metabolic pathways.

AOX1, WBSCR22, COMT1, ALDH3B1
CYP1B1, CYP1A1, AOX1, CYP1A2

AKR1B3, HK3, FBP1, PMM1

UGT1A9, AKR1B3, UGDH

160
160

160

160

39
40

37

17

5738
5738

5738

5738

3.68
3.59

3.88

6.33

1.000
1.000

1.000

1.000

0.562
0.564

0.536

0.545

Genes
List Total Pop Hits Pop Total Fold Enrichment Bonferroni Benjamini
GSTA1, GSTA2, CYP1A2, ALDH3B1, GSTM7, GSTM1,
160
75
5738
6.22
0.000
0.000
GSTM2, GSTM3, UGT1A9, GSTM4, FMO2, AOX1, FMO3
GSTM1, GSTA1, GSTA2, GSTM2, UGT1A9, GSTM3, GSTM4,
160
66
5738
6.52
0.000
0.000
CYP1B1, CYP1A1, CYP1A2, ALDH3B1, GSTM7
GSTM1, GSS, GSTA1, GSTA2, GSTM2, GSR, GSTM3,
160
52
5738
6.90
0.002
0.001
GSTM4, PGD, GSTM7
XDH, FHIT, NME2, ITPA, POLE2, ATIC, NME1, PKM2,
160
157
5738
2.74
0.459
0.142
ENTPD5, POLR3A, POLR2D, ENTPD2
UMPS, NME2, ITPA, POLE2, UPRT, NME1, ENTPD5,
160
96
5738
3.36
0.528
0.139
POLR3A, POLR2D
CCND1, TGFB3, BUB1, CDC23, MCM2, MCM3, MYC, MCM5,
160
128
5738
2.52
0.980
0.478
TGFB2
FHIT, CCND1, RXRG, PIK3R3, TRAF5, MYC, TRAF3
160
85
5738
2.95
0.990
0.484
CCND1, RAC3, TGFB3, PIK3R3, MYC, FZD7, TGFB2
160
86
5738
2.92
0.992
0.457
UGT1A9, CYP1B1, CYP1A1, HSD17B2, COMT1
160
45
5738
3.98
0.996
0.455
RPSA, RPS28, RPL13, RPLP0, RPLP1, RPLP2, UBB
160
89
5738
2.82
0.996
0.432
AKR1A4, HK3, PKM2, FBP1, PGAM1, ALDH3B1
160
68
5738
3.16
0.998
0.429
PSMF1, PSMC3, PSMD4, PSMB8, PSMB9
160
47
5738
3.82
0.998
0.408
XDH, UMPS, UGT1A9, ITPA, 2210023G05RIK
160
48
5738
3.74
0.999
0.404
CCND1, RAC3, TGFB3, STAT1, PIK3R3, TGFB2
160
72
5738
2.99
1.000
0.420
POLE2, MCM2, MCM3, MCM5
160
35
5738
4.10
1.000
0.532

68.746
70.965

64.029

62.737

30.450
31.753
34.809
35.774
38.277
38.883
40.946
44.930
58.976

26.312

5.708

4.694

0.012

0.002

0.001

FDR

Analysis of 160 up- regulated gene transcripts was generated using the DAVID© software system, which assessed the genes for

Supplemental Table 4.2 Genes up-regulated by 5 µmol/kg PCB 126 treatment affect multiple metabolic pathways.

Supplemental Figure 4.1 Data containing zero numbers do not meet all the
assumptions of parametric and non-parametric tests. (A) 14-HDHA is not
formed in safflower-fed, vehicle treated mice and the zero values are incompatible
with assumptions of normality and equal variance. In contrast, 4-HDHA (B) is a
metabolite found in all mice, and thus, the presence of non-zero data values
satisfies both the normality and variance assumptions. Data are represented as
averages ± SEM or as scatter plots of individual data points.
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Chapter Five: Mechanisms of PCB-induced Inflammation
5.1 Synopsis
Inflammation has been identified as a critical risk factor for a host of diseases including
cardiovascular diseases (CVDs) such as atherosclerosis58. One of the many contributors
to endothelial dysfunction and CVDs are environmental pollutants, e.g., polychlorinated
biphenyls (PCBs), a class of persistent organic pollutants. Our laboratory has explored
the role of coplanar PCBs in endothelial dysfunction and atherosclerosis. PCBs, and
especially coplanar PCBs, induce inflammation by interaction with lipid rafts called
caveolae that promote signaling through the aryl hydrocarbon receptor (AhR). Lipid rafts
are also essential for toll-like receptor 4 (TLR4) signaling, an innate immune receptor
associated with inflammation and atherosclerosis. Both TLR4 and PCBs induce
inflammation through NFкB signaling pathways. There is limited evidence to suggest that
environmental toxins interact with TLR4 or its associated proteins to induce inflammatory
signaling. Thus, the potential interaction of PCBs with TLR4 to induce endothelial
dysfunction is not well understood. We investigated the interaction of coplanar PCB 126
with caveolae based TLR4 signaling to induce NFкB inflammatory targets and
subsequent initiation of endothelial dysfunction.
5.2 Introduction
General Overview
Environmental toxicants, such as polychlorinated biphenyls (PCBs), promote the lowgrade inflammation that contributes to the development of a host of diseases including
diabetes and cardiovascular disease (CVD)59, 143, 160, 269. Our laboratory’s work with the
vascular endothelium promotes the understanding of the molecular mechanisms by
which coplanar PCBs induce inflammation and promote endothelial dysfunction270.
These changes in the vascular homeostasis create an ideal environment for the
development of atherosclerotic plaques151. PCBs initiate endothelial inflammation
through interaction with caveolae, a form of lipid rafts which harbor receptors and
signaling domains126. Caveolae also host innate immune receptors including Toll-like
receptor 4 (TLR4), which is the receptor of bacterial lipopolysaccharide (LPS), and is
linked to the development of CVD78. Evidence suggests that environmental stimuli
interact with TLR4 to promote an inflammatory response. Here we investigated PCB 126
interaction with TLR4.
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PCBs, CVD and Inflammation
National Health and Nutrition Examination Survey (NHANES) and a study in elderly
patients revealed that circulating levels of PCBs are significantly associated with
hypertension271 and atherosclerosis64, respectively. Further, angiotensin II-infused
apolipoprotein E–deficient mice exposed to coplanar PCBs developed more extensive
atherosclerotic lesions151. The endothelium is a critical component of inflammation and
disease progression in atherosclerosis. Our studies using primary endothelial cells (ECs)
have demonstrated that silencing or deficiency of caveolin-1 (Cav-1), a major structural
and signaling protein of caveolae, decreases PCB–mediated extracellular signalregulated kinase-1/2 (ERK1/2) phosphorylation leading to a reduction in associated
vascular cell adhesion molecule-1 (VCAM-1) expression and monocyte adhesion126.
PCB-mediated endothelial dysfunction has classically been attributed to AhR activation
and subsequent upregulation of cytochrome P4501A1 (CYP1A1) and other xenobiotic
metabolizing proteins124. CYP1A1 causes an increase of reactive oxygen and nitrogen
species (ROS/RNS) which promote cellular damage and NFкB activation73, 152. The
classical model of AhR-induced inflammation has not explained other interactions of
coplanar PCBs with membrane based domains; our work with caveolae addresses this
question.
Caveolae and Molecular Signaling
Caveolae are a specific sub-class of lipid rafts that form sphingolipid and cholesterol rich
invaginations on the plasma membrane, and cholesterol depletion or buoyancy
separation have been classical methodologies for defining and studying these
domains272. Caveolin-1 (Cav-1) is the major structural protein located within the rafts of
endothelial cells, and is required for caveolae formation270. Caveolae have been
identified as critical components in vascular homeostasis and tone272, and our work with
PCBs and endothelial nitric oxide synthase (eNOS) have clearly demonstrated the role
that caveolae play in mediating environmental pollutant-induced changes on vascular
homeostasis164. Caveolae are involved in intracellular trafficking in which the endocytosis
of caveolae is followed by merging to endosomes273-276. PCBs appear to exacerbate
caveolae endocytosis124. Caveolar endocytosis may act as mitigating response to
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negative stimuli helping the cell to “sort” and develop a specific response277, and
caveolae are critical to the signaling of the innate immune response.
TLR4 and Associated Signaling Outcomes
Lipid rafts are complex signaling domains that play host to a variety of receptors and
associated scaffolding proteins including TLR4 and Cav-1. TLR4 signaling requires
dimerization and migration to lipid domains from which downstream activation of NFкB
occurs107, 117. It has been proposed that TLR4 scaffolding in caveolae stimulates
endocytosis of caveolae which is essential for the induction of down-stream
inflammatory signaling278. Activation of TLR4 promotes signaling through an array of
pathways. The “classical” signaling pathways include signaling through MyD88
scaffolding pathway to IRAK/TRAF6/TAK1 pathway to induce both NFĸB and MAPkinase family signaling279. A second MyD88-dependent signaling pathway utilizes the
TIRAP/Mal adapter proteins, which also lead to NFĸB signaling, and both the MyD88dependent pathways are associated with “early” phase NFĸB signaling280. Alternative
and complimentary to the MyD88-dependent pathway is the TRIF-dependent signaling
pathway281. MyD88-independent TRIF associates with TLR4 via the TRAM adaptor
molecule which initiates TRAF3/IRF3 for interferon activation and TRAF6 for NFĸBinduced chemokine and cytokine expression, RIP1/caspase 8-dependent induction of
apoptosis and RIP3-activated ROS-dependent necrosis282. Together these TLR4
initiated signaling pathways induce a range of inflammatory responses.
The nuances of the innate immune response continue to unfold as investigators report
changing specificity depending on chaperone molecules, adaptor protein recruitment,
and a host of other modifications that dictate the type of cellular response given to a
particular ligand. The following studies explore the concept of toxicant interaction with
TLR4; these interactions may be facilitated by chaperone proteins such as
lipopolysaccharide binding protein (LBP) and CD14. In a study of macrophages
stimulated with LPS to induce TLR4, cells demonstrated a hyperactive cytokine
response when challenged with environmental toxicants283. In a lung inflammation
model, cigarette smoke-induced inflammatory cytokine production and neutrophil
infiltration were attenuated in knockout (KO) mice for TLR4 and interleukin-1 receptor 1
(IL-1R1)284. (Cigarette smoke contains polycyclic aromatic hydrocarbons (PAHs) which
like PCBs are AhR ligands.) Inflammation in astroglial cells, which was caused by low
101

concentrations of ethanol, was attributed to the caveolae-dependent endocytosis of IL1R1/TLR4 and activation of associated downstream pathways278. Finally, a recent study
demonstrated that PCBs modified intestinal and blood brain barrier function through
activation of TLR467. Together these studies indicate that TLR4 plays a critical role in
environmental pollutant-induced inflammation.
Hypothesis and Rationale
We hypothesize that PCB 126-induced inflammation is mediated through caveolaebased TLR4 signaling. A growing body of literature has associated TLR4 with
atherosclerotic development285-289. For example, a study examining human Stage VI
lesions found that the endothelium and macrophages (MΦ) had increased expression of
TLR4 and p65, a subunit of NFкB 78. Coplanar PCBs, also, contribute to endothelial
dysfunction and vascular inflammation. Evidence suggests that both sources of
inflammation may be sensitive to nutritional modulation, and the proposed mechanism
would provide a platform with which to test potential nutritional interventions. The
hypothesis proposed here seeks to clarify the critical role of membrane domains,
caveolae, in mediating PCB-induced inflammation by studying the activation of TLR4associated signaling (Figure 5.1).
5.3 Methods and Materials
Reagents and Materials
PCB 126 was obtained from AccuStandard (New Haven, CT). Western blotting reagents
were obtained from BioExpress (Kaysville, UT). Reverse transcriptase reagents were
purchased from Fisher Scientific (Waltham, MA). Reagents used for mRNA isolation
and qPCR were purchased from Life Technologies (Grand Island, NY). Unless otherwise
stated, chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
Sucrose Gradient
Discontinuous sucrose gradients were performed to separate caveolae-rich lipid
fractions129. Primary porcine endothelial cells (ECs) were grown to 90% confluence in
150 mm culture dishes. Cells were normalized overnight with 1% FBS M199 and treated
for 30 min or 16 hr with 0.25 µM PCB 126, 0.1 ug/mL LPS, or DMSO (vehicle). Treated
cells were harvested by scraping with morpholine ethanesulfonic acid (MES)-buffered
saline (MBS), and fractions were separated by layering 45% (equal volume sample:90%
sucrose/MBS solution), 35% and 5% sucrose/MBS solutions which were centrifuged at
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39,000 rpm with a SW41 rotor. Western blotting was performed using equal volume
protein fractions loaded on to 8% SDS-PAGE gels, and blots were probed using TLR4
(H-80) sc-10741 (1:500 primary and 1:4,000 secondary), Santa Cruz Biotechnology,
Inc., Dallas, TX) and Cav-1 #3238S (1:10,000 primary and secondary, Cell Signaling
Technology, Inc,, Danvers, MA), Anti-rabbit secondary antibody was from Cell Signaling.
Cholesterol Depletion Assay
M199 treatment media with 1% L-glutamine was prepared with 10 mM methyl-βcyclodextrin (MβCD)116, 290-292. Confluent 150 mm culture dishes were conditioned with
1% FBS M199 overnight and were pre-treated with treatment media with or without 10
mM MβCD for 30 or 60 minutes at 37°C. Plates were washed three times with HANKS
buffer and were given 0.5% M199 with 1% L-glutamine and 1% penicillin/streptomycin.
Samples were treated with DMSO or 0.25 µM PCB 126 in DMSO for 8 hr and were cotreated with 0.1 µg/mL LPS for an additional 4 hr. Cultures were harvested and
fractionated by sucrose gradient as described earlier. Sucrose gradient fractions were
assessed by Western blot using 10% SDS-PAGE gels.
Inhibition Assays and MCP-1 ELISA
For the inhibition assays, ECs were grown in 12-well plates. Cardiolipin (CL) was
suspended in PBS at 0.5 mg/mL stock concentration293. For treatment, CL was diluted
from 10 to 1000 ng/mL in 1% FBS M199 treatment media. Cultures were treated with
DMSO, 1000 ng/mL CL, 0.5 µM PCB 126, 10 ng/mL LPS, or co-treatment of PCB 126 or
LPS with different concentrations of CL. CLI-095, also reported as TAK-242, (InvivoGen,
San Diego, CA) was suspended in DMSO and working stocks were diluted to 200
µg/mL in 1% FBS M199294. Cultures were treated with DMSO, 1000 ng/mL CLI-095, 0.25
µM PCB 126, 10 ng/mL LPS, or co-treatment of PCB 126 or LPS with 10 to 1000 ng/mL
CLI-095. After 24 hr incubation, supernatant was collected and centrifuged at 4°C and
7500 rpm for 5 min. An aliquot was removed and stored at -80°C until analysis by MCP1 ELISA. Cell culture supernatants were diluted 1:1 and analyzed using the OptEIA
Human MCP-1 ELISA Kit (BD Biosciences, San Diego, CA) according to manufacturer
guidelines.
Real Time – PCR
ECs were grown to confluence using 6-well plates, and mRNA was isolated using the
Trizol® method125, 126. Isolated mRNA was resuspended in RNAse/DNAse free water
and quantified using UV-vis spectroscopy at 260 nM. cDNA was made using a reverse
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transcriptase reaction. SYBR® Green reagent was used to perform the real time-PCR
reactions, and absolute quantification was run using the7300 Real Time PCR Systems
(Life Technologies, Grand Island, NY). The housekeeping gene, β-actin, was used to
normalize VCAM1, and data are presented as a ratio of VCAM1/ β-actin.
Western Blot
Western blots were performed as described previously140. ECs were grown to
confluence in 6-well plates and treated with 0.025%v/v DMSO (vehicle), 0.25 µM PCB
126, and/or 0.01-1.0 µg/mL LPS for 8 hr. Protein was collected using 1X RIPA buffer,
sonicated for 10 s, incubated on ice for 30 min, and centrifuged at 4°C and12, 000 rpm
for 15 min. Supernatants were collected and quantified using the Bradford method.
Aliquots containing 30 µg of protein were made and run on 10% SDS-PAGE gels.
Following semi-dry transfer, nitrocellulose membranes were incubated for 2 h in blocking
buffer (5% non-fat milk in Tris-buffered saline containing 0.05% Tween 20). VCAM1(C19)-R (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) primary antibody was diluted
1:1000 in 5% milk and incubated overnight at 4°C . Anti-rabbit secondary was applied at
1:4000 dilution. β-actin primary and secondary antibodies were diluted 1:10,000 125.
Statistical Analysis
Comparisons between treatments were made by one-way analysis of variance followed
by Tukey’s post-hoc test. Statistical probability of P0.05 was considered significant.
SigmaPlot version 12.0 software (Systat Software, San Jose, CA) was used to perform
the data analysis. When letters are used to indicate differences in significance, shared
marker letters between treatments indicate no statistical difference. Values are reported
as the mean +SEM.
5.4 Results
To investigate the interactions of PCBs with TLR4, EC cultures were treated with PCB
126 or LPS for 30 minutes (Figure 5.2) or 16 hours (Figure 5.3). Using sucrose gradients
to separate cellular domains by density, we found that PCB 126 and LPS, the primary
ligand of TLR4 and positive control, both shifted to a more buoyant lipid raft fraction for
Cav-1 (Figure 5.2A) and TLR4 (Figure 5.2B) suggesting interaction by both ligands with
these domains at 30 minutes. After 16 hr of treatment, both Cav-1 (Figure 5.3A) and
TLR4 (Figure 5.3B) proteins were distributed throughout the gradient implicating
association with other proteins either to promote signaling or because of migration into
the cytoplasm. Looking at endothelial dysfunction markers, cells treated with PCB 126 or
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LPS showed an increase in VCAM-1 mRNA expression (Figure 5.4). Previous work in
our laboratory demonstrated that PCBs increase caveolae endocytosis (as does
activation of TLR4278) and that treatment with PCBs increases the coimmunoprecipitation of AhR with Cav-1 linking the activation of Cav-1 with the
downstream consequences of AhR stimulation124. Caveolae activation and trafficking
provide a link between the diverse NFкB activation pathways of TLR4 and AhR.
Several groups have explored the protective role of certain long-chain fatty acids,
phospholipids, and their oxidized products. In one study, the phospholipid cardiolipin
(CL) was shown to inhibit activation of TLR4 via chaperone protein binding293; we utilized
CL as an inhibitor of TLR4 activation to determine if downstream inflammatory markers
were modulated similarly for both PCB and LPS. When cells were co-treated with CL
and PCB or LPS, monocyte chemoattractant protein-1 (MCP-1) protein, a chemokine
indicative of endothelial cell activation, was decreased (Figure 5.5). To confirm the
activity of TLR4 in PCB-induced inflammation, TAK-242, a TLR4-specific inhibitor, was
tested294. PCB 126 treated groups displayed a significant increase of MCP-1 over TAK242 alone (brand name CLI-095, InvivoGen, San Diego, CA) except for the 250 ng/mL
CLI-095 treated group, which had a pvalue = 0.055 (Figure 5.6A). In contrast, the LPS
treated groups displayed only a significant increase for MCP-1 protein over inhibitor
alone with 10 and 50 ng/mL CLI-095, which were also significantly increased over the
1000 ng/mL and LPS co-treated group (Figure 5.6B). The 1000 ng/mL CLI-095 (TAK242) showed the greatest inhibition of MCP-1 protein expression in the presence of LPS
treatment which was not replicated with PCB 126 treatment.
Though the TLR4-specific inhibitor assay indicates that PCB 126 (at the dose and time
points studied) does not activate the TLR4 signaling mechanism, similarities exist
between LPS and PCB-induced Cav-1 localization in the sucrose gradient data and
inflammatory endpoint expression. We, therefore, focused on caveolae and Cav-1 to
confirm shared activity. Using a cholesterol depletion assay, we observed changes in the
localization of Cav-1 following treatment with PCB 126 and/or LPS. Previously, work with
mRNA indicated that LPS stimulated an increase in VCAM1 expression in half the time
of PCB 126 (see for example, Figure 5.4); for this reason cultures were treated for 4 hr
with LPS and 8 hr with PCB 126 and were harvested and subjected to sucrose gradient
fractionation. In the vehicle treated gradient, Cav-1 had a broad presence including the
most buoyant fractions to fraction 10 with the highest protein density in fractions 4-6
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(Figure 5.7A). PCB 126 treatment stimulated a shift from the most buoyant fractions to
fractions 5-12 (Figure 5.7B); similarly, LPS treatment caused a shift away from fractions
1-3 (Figure 5.7C). Cholesterol depletion with MβCD reduced the total Cav-1 and forced
Cav-1 out of the buoyant lipid raft fractions into fractions 5-10 regardless of treatment
(Figure 5.7). Interestingly, co-stimulation with both PCB 126 and LPS caused a shift in
Cav-1 localization to fractions 5-11 and was sufficient to overcome the effects of
cholesterol depletion on Cav-1 expression (Figure 5.7D). To further assess the
inflammatory response to PCB 126, LPS, or LPS/PCB 126 co-treatment, we probed for
Cav-1 and VCAM1 protein in the sucrose gradient fractions. All treatments demonstrated
a shift of Cav-1 away the most buoyant fractions when compared to vehicle, but PCB
126 and the PCB 126/LPS co-treatment caused tighter grouping of Cav-1 in the less
buoyant fractions. For VCAM1, vehicle and PCB 126 treated fractions only displayed
non-specific binding above the protein ladder at fractions 10-13. LPS and the co-treated
gradients also displayed this non-specific binding. The LPS treated group had a faint
VCAM1 band around fraction 7, outside of the buoyant membrane fractions; in contrast,
the LPS/PCB 126 co-treated fractions clearly presented VCAM1 in lipid raft fraction 4
(Figure 5.8B). To confirm the observation that PCB 126 and LPS strengthened the
expression of inflammatory markers, we assessed VCAM1 expression following
treatment with PCB 126 with co-treatment using different concentrations of LPS. Cotreatment with LPS increased VCAM1 expression in mRNA when compared to control,
PCB 126 alone, and LPS alone (Figure 5.9), and a similar trend was observed in protein
expression (Figure 5.10).
5.5 Discussion
The data presented here seem to suggest a similar phenomenon, in which PCB 126
stimulates a TLR4 interaction with the Cav-1 fractions, but we were unable to
substantiate a clear link between this interaction and an inflammatory response. There
are multiple explanations for this observation; the following will be discussed (a)
differences in coplanar PCB structure, (b) differences in signaling pathways with
overlapping endpoints, and (c) loss of key chaperone proteins. The final discussion
points will highlight the aspects of this research that are important for future studies of
protective omega-3 fatty acids.
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Previous work with PCB 77 and here with PCB 126 demonstrates coplanar PCB-induced
Cav-1 activity. PCB 77 promotes Cav-1:AhR interaction 124 and activates endothelial
nitric oxide synthase (eNOS) through PI3K/Akt signaling164. MCP-1 expression is
induced by PCB 77 in a Cav-1-dependent manner through p38 and JNK signaling 125.
Because of their similar structure and AhR binding activity, both PCB 77 and PCB 126
are thought to have similar modes of action. However, in this study, PCB 126 did not
mimic the typically robust inflammation that PCB 77 induces, despite having a higher
TEF167. PCB 77 is metabolized and excreted; in one study, approximately 85% of the
original dose was excreted after five days295, 296. In a similar five day excretion and
metabolism study, only low levels of a single PCB 126 metabolite were detected, and
this metabolite was associated with detoxification for excretion rather than toxicity176.
The resistance of PCB 126 to cellular metabolism may also alter the development of the
inflammatory response following AhR activation.
Modulation of the inflammatory response is becoming a field of intense study297, 298.
Researchers are investigating the immune response and intensity following multiple
exposures and/or doses of LPS. Environmental pollutants present another set of
potential stimuli and in concert with other factors such as stress, infection, and diet, are
likely modulators of body’s ability to cope, protect, and recover from injury. In this study,
co-stimulation by both PCB 126 and LPS elicited expression of the inflammatory marker,
VCAM1. Others have demonstrated that LPS treatment of ECs promotes Cav-1 and
adhesion molecule co-localization in caveolae299, and our work suggests that PCB
treatment also enhances VCAM1 and MCP-1 expression in a caveolae-dependent
manner125, 126. Similar endpoints do not mandate a common signaling pathway. As
reviewed in the introduction of this chapter, TLR4 stimulation utilizes multiple sets of
adapter molecules that initiate different signaling pathways. The research presented
here was unable to substantiate a productive interaction between TLR4 and PCB 126,
meaning we could not directly link the membrane interaction observed in the sucrose
gradients with the cytokine or adhesion molecule response. However, TLR4 is sensitive
to ligands other than LPS. For example, hemin, an iron-containing porphyrin with a
chlorine ligand, also promotes TLR4/Cav-1 binding, but when compared to LPS, different
signaling pathways are initiated through this interaction123. In addition, caveolae are
promiscuous domains that harbor multiple receptors and are sensitive to disruptions to
the lipid balance in the plasma membrane268, 300, 301. These realities further promote the
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idea of caveolae as a common signaling platform for both LPS and PCB 126 and help
explain the enhanced suppression of MCP-1 following exposure to lipophilic inhibitors in
the ELISA assays. We propose that different molecular pathways are activated in
response to LPS and PCB 126 but both utilize caveolae as a common base for signal
initiation and both culminate with NFкB-directed inflammation.
Another puzzling aspect of this study is the relative insensitivity of the ECs to LPS
stimulation. Multiple forms of LPS were tested, but no differences were observed (data
not shown). Others have reported that TLR4 is expressed primarily in the cytosol of
endothelial cells rather than at the cells surface and that membrane and external
chaperone proteins are required for the internalization of LPS302. For example, CD14, a
critical chaperone for LPS trafficking and TLR4 activation/migration, can be lost in
primary cell lines following passaging303, 304. Further the presence of soluble and
membrane bound forms of CD14 contribute to the sensitivity of the endothelial response;
however, very high doses of LPS, 1000 ng/mL, activated TLR4 signaling without
CD14305. Here we report that TLR4 is present in the caveolae rich fraction, and LPS or
PCB 126 stimulation of ECs is sufficient to see TLR4 migration with Cav-1, but it is not
sufficient to produce a consistent inflammatory response. Therefore, it is possible that
the necessary chaperone proteins were not expressed in our cell line. Combined
stimulation of PCB 126 and LPS may have overcome the lack of chaperones; in other
words, the two stimuli may have promoted sufficient caveolar internalization to initiate
the inflammatory response without the assistance of chaperone proteins.
Caveolae are important regulatory platforms that are sensitive to nutritional modulation,
such as omega-3 lipids105. The phospholipid cardiolipin was effective in disrupting
caveolae-based chemokine response in the inhibition assay (Figure 5.5). Others have
reported that incorporation of omega-3 fatty acids into the plasma membrane alters the
lipid raft microdomain composition97. For this reason, we are interested in signaling
changes caused by omega-3 fatty acid incorporation into caveolae. This localized
change in lipid content also alters the amount of Cav-1, eNOS, and certain Ras protein
in the caveolae97. Our laboratory has observed changes in PCB-induced signaling
following treatment with differing ratios of omega-3 and omega-6 fatty acids16. Similarly,
TLR4 signaling is disrupted by omega-3 fatty acids, such as DHA, through inhibition of
the PI3K/Akt signaling pathway 106. We have demonstrated that PI3K/Akt signaling is
also critical to the inflammatory signaling induced by the omega-6, linoleic acid, in
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vascular endothelial cells199. Together both our work with PCBs and the work with TLR4
indicate polyunsaturated fatty acids, primarily omega-3 fatty acids, as a promising
nutritional intervention96. Future work should continue to explore caveolae-based
signaling mechanisms that are sensitive to nutritional modulation.
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Figure 5.1 Summary of the proposed mechanism of action. Similar to LPS, PCB
interaction with TLR4 in caveolae initiates endocytosis. PCB-activated TLR4 causes
NFкB-induced inflammation, which contributes to AhR-mediated inflammation and
oxidative stress.
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Figure 5.2 PCB 126 and LPS treatments stimulate a localization shift in
caveolae fractions. Sucrose gradient lipid fractions 1-4 of 12 fractions showing
localization of Cav-1 (A), and TLR4 (B) in lipid raft fractions after 30 minute
treatment with DMSO vehicle (0.005%), PCB 126 (<1ppm), or LPS (0.1 μg/mL).
(Higher molecular weight TLR4 bands are glycosylated proteins.)
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Figure 5.3 PCB 126 and LPS treatments promote Cav-1 and TLR4
migration within cellular fractions. Sucrose gradient fractions
showing density localization of Cav-1 (A), and TLR4 (B) in lipid raft and
non-raft fractions after 16 hr treatment with DMSO vehicle (0.005%),
PCB 126 (<1ppm), or LPS (0.1 μg/mL). Fractions range from most (1) to
least (14) buoyant.
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Figure 5.4 PCB 126 and LPS treatments significantly increase adhesion
molecule expression. VCAM1 mRNA expression of primary porcine vascular
ECs treated with PCB 126 (~ 1 ppm) with DMSO, vehicle control, and LPS
(0.1 μg/mL) with PBS, vehicle control at 8 and 24 hours. Results are the mean
+ SEM, n=3. Significantly different compared with vehicle control at * P≤0.002
+

and significantly different from PCB 126 at P≤0.05.
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Figure 5.5 MCP-1 protein expression is attenuated by cardiolipin (CL) in
(A) PCB 126 and (B) LPS treated cells. ELISA of MCP-1 protein expression
in cell culture media collected from ECs treated with DMSO, vehicle control,
(A) PCB 126 (<1ppm), or (B) LPS (10 ng/mL) and co-treated with 10 ng/mL
cardiolipin (CL) for 24 hours. Significantly different compared with PCB or
LPS, respectively at * P≤0.002.
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Figure 5.6 MCP-1 protein expression is not attenuated by CLI-095 in (A)
PCB 126 but is attenuated in (B) LPS treated cells. ELISA of MCP-1 protein
expression in cell culture media collected from ECs treated with DMSO,
vehicle control, (A) PCB 126 (<1ppm), or (B) LPS (10 ng/mL) and co-treated
with 10 ng/mL CLI-095 (TAK-242) for 24 hours. Significantly different from
untreated 1000 ng/mL CLI-095, at * P≤0.05, and significantly different from
1000 ng/mL CLI-095 with LPS treatment, + P≤0.05.
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µg/mL LPS co-treatment.

with either (A) DMSO (vehicle control), (B) 0.25 µM PCB 126, (C) 0.10 µg/mL LPS or (D) 0.25 µM PCB 126 with 0.10

gradient fractions with no cholesterol depletion by MβCD, 30 min 10 mM MβCD or 60 min 10 mM MβCD and treatment

Figure 5.7 Membrane cholesterol depletion mitigates PCB 126 and LPS induced redistribution of Cav-1. Sucrose

Figure 5.8 PCB 126, LPS and PCB126/LPS co-treated cells exhibit
different patterns of (A) Cav-1 and (B) VCAM1 protein expression. DMSO
(vehicle control), PCB 126 (0.25 µM), LPS (0.10 µg/mL) or PCB 126/LPS cotreated cell cultures produced different sucrose gradient fractionation patterns.
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Figure 5.9 PCB 126 co-treatment with varying concentrations of LPS
promotes different patterns of VCAM1 mRNA expression. Cell cultures
were treated with PCB 126 for 16 hr and co-treated with LPS at 10, 100 or
1000 ng/mL for an additional 8 hr, and LPS treated for 24 hr at 1000 ng/mL.
Statistical differences at pvalue <0.05 is indicated by different letters; shared
letters indicate no statistical difference between treatments.

118

Figure 5.10 PCB 126, co-treated with varying concentrations of LPS
exhibit different patterns of VCAM1 protein expression. Cell cultures were
treated with PCB 126 for 16 h and co-treated with LPS at 10, 100 or 1000
ng/mL for an additional 8 hr. Western blot includes samples a and b of LPS 24
h treatment at 1000 ng/mL.
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Chapter Six: Final Discussion – coplanar PCB-induced inflammation and
nutritional modulation
6.1 Synopsis
Inflammation links multiple disease processes58. As persistent environmental pollutants,
coplanar PCBs accumulate in human adipose6, 173, and this toxic body burden promotes
oxidative stress and endothelial dysfunction73, 306. PCB 77 and its dechlorination products
are pro-inflammatory and promote oxidative stress in a primary endothelial cell model307.
The persistence of coplanar PCB 126 in human tissues presents it as a more
representative model for PCB-induced toxicity. We identified 5 µmol PCB 126/kg body
weight as a pro-inflammatory but not overtly toxic dose in mice. Mitigating the effects of
PCB-induced inflammation through nutrition is the most pro-active means of responding
to environmental stressors. Omega-3 fatty acids and their neuroprostane metabolites
have effectively attenuated PCB-induced oxidative stress in primary endothelial cells16,
92

. We, therefore, fed mice a DHA-enriched diet and challenged them with PCB 126 to

observe the metabolic and anti-oxidant response. At the same time, we pursued the
caveolae based-TLR4 inflammatory signaling mechanism as a potential platform for
better understanding the modulation of PCB-induced signaling through lipid rafts.
Coplanar PCBs represents one class of many environmental stressors that promote
inflammation. The anti-oxidant response mediated by Nrf2 and PPARγ and caveolaebased signaling are both mechanism which are sensitive to nutritional modulation by
omega-3 fatty acids and as such present viable options for future investigation.
6.2 Dechlorination and inflammation
Remediation of persistent organic pollutants has been a significant portion of the
response to environmental pollution. Our ability to assess the outcome of the
remediation techniques is critical to verifying the effectiveness of emerging remediation
strategies. In addition, the field of environmental toxicology needs to develop sensitive,
high- throughput in vitro models that may be used to test dose, pharmacokinetic and
toxicological implications of environmental toxins308. The products of dechlorination that
were assessed in chapter two reveal the necessity of complete remediation307.
6.2.2 Limitations and Future work
The inflammatory capacity of PCB 77 and its remediation products necessitated
complete dechlorination. Biphenyl, though not toxic to our primary endothelial cell model,
exhibits toxicity in the renal and neurological systems309, 310. In response to this
challenge, the Chloro-Organic Degradation Project Research Team at the University of
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Kentucky, College of Engineering has developed a more complete system that
remediates the PCBs to biphenyl and biphenyl to mono- and di-hydroxybipheyls and
benzoic acid311.
Studying mixture toxicity has been one of the challenges for environmental toxicology.
Thus, cell models which can be used to assess the total toxicity of a mixture rather than
select or known constituents are beneficial. One system that is being tested to detect
polycyclic aromatic hydrocarbons (PAHs), which are AhR agonists, utilizes a reporter
assay that has an AhR sensitive promoter coupled to luciferase enzyme312. The assay,
which is based in a mammalian cell line and utilizes benzo[a]pyrene as the reference
molecule, is reported to produce a more meaningful assessment of complex mixtures
than current assays which assess only known constituents. An alternative approach to
the mixture problem is to define calculations that can combine toxicological data from
individual toxicants and produce an accurate toxicity value for the mixture. In a model
testing sex hormone synthesis, a generalized concentration addition model was most
successful in predicting the testosterone effects of a mixture313. Together these
approaches represent the next generation of toxicity assessment.
6.2.3 Contribution to our knowledge as a whole
The inflammatory potential of coplanar PCB 77 was sufficient to induce inflammation in
our endothelial cell model, and the dechlorination products had reduced inflammatory
potential but were not inert307. The human environment is saturated with chemical
mixtures that activate an array of receptors and biological processes. Our work as well
as the work of others focuses primarily on a specific toxicant or family of toxicants; as a
result, many chemical stressors are not included in traditional risk assessment314. For
this reason, a proactive response to environmental stress requires the identification of
nutritional or lifestyle modulators of toxicological response and inflammatory stress315.
6.3 PCB 126 as a model toxicant
PCB 126 distributes throughout the body but is primarily sequestered in liver and
adipose. The highest doses of PCB 126 (50 and 150 µmol PCB 126/kg body weight)
promoted wasting syndrome, increased expression of Bax protein, a key regulator of
apoptosis, and increased VCAM1 protein expression. In contrast, the lowest dose (0
and 0.5 µmol PCB 126/kg body weight) did not contribute to weight change, increased
expression of inflammatory endpoints, or indications of cellular apoptosis. Only the 5
µmol PCB 126/kg body weight dose produced a significant change in liver to body
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weight ratio without significant weight lose, promoted the expression of MCP-1 and did
not initiate Bax protein.
6.3.2 Limitations and Future work
As with any study, we had to limit the number of parameters that we examined. We
choose a wide dose range which included 150 µmol/kg, a concentration that is
equivalent to the dose of PCB 77 that was utilized in our previous animal work and is
expected to be overtly toxic for PCB 12691, 125. The acute time point provides a limited
view of the inflammatory response, and unlike studies of atherosclerosis this window
was not sufficient to determine vascular outcomes in our animals. Previous work with
PCB 77, indicates that vessel inflammation and lesion development are increased in
animals challenged with PCB91, 151. The overview of this study would have been
improved by some additional measurement. For example, an assessment of oxidative
stress could have been made using tissue or urinary measures of 8-iso-prostaglandin
F2α. Measurements of PCB 126 hydroxylated metabolites in the tissues and feces would
have provided an indication of PCB 126 metabolism. Future optimization of this model
should include collection of urine and feces for measures of oxidative stress and PCB
126 hydroxylated metabolites and include later time points to determine the progression
of inflammation following acute exposure.
In fact, PCB 126 is very persistent in human tissues. A review of the general population
revealed that levels of PCB 126 remained relatively static from 1989-2008 which is in
contrast to decreased population levels of polychlorinated dibenzofurans (PCDFs) and
polychlorinated dibenzo-para-dioxins (PCDDs)316. One possible explanation for the
stable levels of PCB 126 in the human population is a species difference in rodent and
human CYP1A1 binding pockets that prevents proper orientation of PCB 126 with the
human heme for hydroxyl- metabolite formation317. The authors do not comment on
whether this ineffective binding promotes CYP1A1 enzyme uncoupling and reactive
oxygen species formation which would promotes cellular oxidative stress and
inflammation. In a study of human intake, PCB 126 was not one the top congeners
consumed but did contribute 67% of the TEF value, yet for all the toxicants consumed,
the subjects did not exceed the current threshold set for allowable human
consumption318.
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6.3.3 Contribution to our knowledge as a whole
As an acute exposure model, two doses of 5 µmol PCB 126/kg body weight are
sufficient to elicit moderate inflammation. The long-term consequences of this exposure
level have not been identified.
6.4 Omega-3 fatty acids and PCB 126-induced inflammation
Inflammation resolution is a major topic emerging in the omega-3 fatty acid literature. At
present, there has not been a consensus on the inflammatory profile representing the
changes expected from omega-3 immunomodulation. In some studies, the data include
decreases in inflammatory cytokines like tumor necrosis factor alpha (TNFα), IL-6, and
IL-8101, 127. Alternatively, others have reported sustained cytokine levels but reductions in
F2-isoprostanes99. The oxidized products and enzymatic metabolites of omega-3 fatty
acids are active in inflammation resolution by promoting phagocytosis and class
switching in leukoctyes and in cellular anti-oxidant and anti-inflammatory response
processes that utilize nuclear receptors, i.e. Nrf2 and PPAR102, 207, 319.
Organic pollutants, such as polychlorinated biphenyls, contribute to sustained systemic
inflammation and promote diseases such as atherosclerosis73, 320. Dietary changes
present a means of mitigating the inflammatory effects of pollutant exposure92, 320. The
introduction of polyphenols, such as quercetin from vegetables and epigallocatechin
gallate (EGCG) from green tea, and omega-3 fatty acids, such as α-linolenic acid from
flax and DHA from fish oil, promote the expression of anti-oxidant enzymes and
counteract PCB promotion of NFкB-induced inflammation16, 92, 128, 130. Nutritional
modulation of Nrf2 and the PPARs is critical to the attenuation of PCB-induced
inflammation92, 130, 255.
6.4.2 Limitations and Future work
The DHA diet was developed following a literature search of diets in which feeding of
diets with 2%-4% DHA from 4 to 12 weeks improved molecular and inflammatory
outcomes99, 210-212, 321. In one feeding study, changes in plasma, eye, spleen, brain, and
liver fatty acid composition were detected in Balb/c mice as early as three weeks of
dietary feeding230; similarly, in a 10 week feeding study, they observed arachidonic acid
decreases in lung at 2 weeks and by 3 weeks omega-3 fatty acid levels had reached a
steady state99. PCB 126 is a persistent organic pollutant which promotes the
development of inflammatory diseases over time; therefore, future studies might assess
the interaction of PCB-induced inflammation and dietary DHA over a broader time range
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which will allow us to assess when DHA modulates acute inflammation and inflammation
resolution. Example time points may include submandibular blood collection 24 h and 4
days after the initial gavage and takedowns 24 h, 2 weeks, and 4 weeks after the final
gavage. These time points are inferred from a study of impaired glucose tolerance which
observed glucose intolerance in mice receiving coplanar PCB 77 beginning after the
second gavage on week 2 through the duration of the 12 week study322. The tissue
levels of coplanar PCB 77 were decreased well below 50% by week 4 of the study, yet
the metabolic disturbance and TNFα levels in the adipose persisted322. From these
observations, we may imply that the inflammatory actions of coplanar PCBs are
sustained and thus extended observation would be advised. The investigation of PCB
77-induced glucose tolerance revealed an interesting role for dietary fat which indicates
that modulation of the PCB-77 induced insulin disturbance and TNFα tissue levels may
be influenced by dietary fat composition70. Those mice receiving a high fat diet (60% kcal
from fat) did not experience PCB-induced differences in glucose tolerance; however,
after weight loss on low fat (10% kcal from fat), the mice experienced coplanar PCBinduced decreases in glucose and insulin tolerance. The recommended human
consumption of fat is 30% kcal or less, which makes this diet of 25% kcal from fat a
moderate representative of human consumption323, yet a recommended rodent diet
contains only 10% kcal from fat324. The present study of dietary DHA as intervention for
PCB 126-induced inflammation may be limited by the moderate fat content of 25% kcal
from fat, which may promote storage rather than metabolism of PCB 126. Future
studies of dietary DHA as a modulator of PCB-induced inflammation should consider the
use of both low and high fat diets and multiple ratios of omega-3 fatty acid to determine
the most effective intervention252.
A significant portion of the omega-3 fatty acid literature assesses the changes in
leukocyte behavior following an inflammatory stimulus85, 207, 225, 325. Continued
investigation into the role of omega-3 fatty acids in mitigating coplanar PCB-induced
inflammation should include and assessment of inflammatory capacity, e.g. cytokine
response/profile, and phagocytic ability in macrophages and natural killer cells. In
addition, a follow-up DHA feeding study designed to include atherosclerotic lesion
assessment would enable us to visualize changes in both inflammatory markers, such
as MCP-1 and VCAM1, and macrophage accumulation. We would expect that the
improved cellular anti-oxidant environment of DHA-fed mice would reduce lesion
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formation to model baseline. DHA feeding promotes the expression of PPARγ, which is
protective against atherosclerotic lesion development326.
The changes in cholesterol and glucose tolerance are indicative of underlying metabolic
changes, which may be driven by novel DHA oxidation products103. Identification of the
novel lipid mediators could be accomplished through a comparison study of the lipid
mediators produced in mice challenged by PCB 126 or LPS. Our present assessment
was limited primarily to monohydroxy- metabolites and did not investigate potential
oxidized DHA metabolites92, 204, 205, 249. Investigation into novel lipid mediators should also
include nitro fatty acids. Polyunsaturated fatty acid-derived nitro fatty acids are potential
modulators of PPARγ, Nrf2, and the NFĸB subunit p65327-330. The activities of these
novel lipid mediators involve interactions with PPARγ and Nrf2 nuclear receptors. For
this reason, subsequent in vitro studies should begin by exploring the interactions of Nrf2
and the PPARs with novel lipid mediators following coplanar PCB stimulation.
6.4.3 Contribution to our knowledge as a whole
The 25% kcal from fat content of the diet may have mitigated the overall response to
DHA-enriched diet as was indicated by others in a different model of inflammation252.
The dietary fat content could also moderate the metabolic and inflammatory response to
PCB 126 exposure. In a study of coplanar PCB-induced metabolic dysregulation after
weight loss, the authors demonstrated that mice fed a high fat diet did not experience
the negative changes in glucose and insulin tolerance that affected mice who underwent
weight loss and mobilization of PCBs from the adipose depots70. Together dietary fat
content greater than 10%, low fat, may dampen the effects of both PCBs and omega-3
fatty acids by promoting storage rather than metabolism.
The literature emphasizes the role of enzymatic and oxidized metabolites in the
regulation of inflammation resolution and metabolism205, 207, 331. Research from our
laboratory has demonstrated the anti-inflammatory potential of oxidized DHA in the
activation of Nrf2 inflammatory response92. In a similar study, activation of Nrf2 was
observed with oxidized eicosapentaenoic acid (EPA) neuroprostanes205. 15-deoxy-∆12,14PGJ3, an EPA cyclooxygenase dehydration product, also activates PPAR to induce
adiponectin, which promotes insulin sensitivity243, 331. Our work supports the activity of
arachidonic acid-derived,15-deoxy-∆12,14-PGJ2, which activates Nrf2227. These
observations alter the previous paradigm which focused on the pro-inflammatory effects
of arachidonic acid metabolism, LDL oxidation and lipid peroxidation332, 333. The
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activation of pro-resolving, anti-inflammatory and metabolism stabilizing lipid mediators
requires dietary supplementation to proactively modulate the inflammatory response334.
6.5 Synergy of innate immunity and PCB-induced inflammation
One of the mechanisms by which DHA and other omega-3 FAs provide protection
involve interactions with lipid domains and may be similar to that of the signaling
changes induced by the phospholipid cardiolipin267, 293. Lipid rafts, like caveolae, are
sensitive to changes in membrane lipid homeostasis and are responsive to dietary
modulation which alters the functional role of lipid rafts in disease335. Caveolae host
critical signaling domains, which include the LPS receptor toll-like receptor 4 (TLR4)278,
336

. Caveolae are sensitive to lipophilic pollutants and facilitate the inflammatory

cascade which leads to NFкB activation124-126.
Caveolae have been established as critical inflammatory mediators105. In our research,
response to stimulation from PCBs and LPS required the presence of caveolin-1 in the
plasma membrane. Activation of caveolin-1 by PCBs displaced TLR4 from the lipid raft
fractions. The response was not linked to direct TLR4 activation by PCBs but signaling
changes occurring within the caveolae domain. In this context, we were able to observe
the additive effect of PCB and LPS co-stimulation.
6.5.2 Limitations and Future work
Primary endothelial cells are caveolin-1 (Cav-1) rich, and provide a sensitive model for
the study of endothelial dysfunction and inflammation126, 276. A comparison of
immortalized endothelial cell lines and human umbilical vein endothelial cells (HUVECs)
indicates that certain inflammatory and immunological signaling factors, such as VCAM1
and MHC class II antigens, are not mutually expressed337. The primary pulmonary
porcine endothelial cells used for the experiments in chapters two and five have
inducible expression of key inflammatory markers including VCAM1 and MCP-1125, 126.
However, primary cell lines may not consistently express certain markers after
passaging as is the case with CD14, a TLR4 chaperone protein304. Future studies should
include an immortalized endothelial cell line, such as the EAhy926 cells, which would
serve as a control for potential loss of key signaling proteins. In our experience, the
EAhy926 cells produced similar but less robust MCP-1 protein expression in response to
PCB 126 or LPS in the cardiolipin inhibition assay when compared to the primary
endothelial cells (data not shown).
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Caveolae are critical to the signaling of cellular stressors such as LPS and PCBs, and
these domains are also necessary for the protective signaling response that comes from
interaction with certain phytochemicals such as quercetin and EGCG128, 129. The
signaling controls which modulate the differences between response to environmental
pollutants and nutritional interventions are not well understood, and thus, the role and
function of caveolae domains remain an important aspect of future studies.
The additive nature of PCB 126 and LPS co-stimulation presents an interesting dynamic
for future study. Others have published that PCBs promote barrier dysfunction and
PCB/LPS co-stimulation enhances PCB-induced dysfunction of the blood brain barrier67.
One avenue through which TLR4/MyD88 and TLR4/TRIF signaling are initiated is the
PI3K/Akt pathway338. LPS induction of TLR4/PI3K has been modulated by the saturated
fatty acid, lauric acid, which promotes transient Akt phosphorylation; in contrast, the
polyunsaturated fatty acid, DHA, suppresses NFĸB activation in a TLR4/PI3K-dependent
manner339. Further, investigation of TLR4/PI3K signaling suggests that PI3K functions as
a regulator that limits TLR4 signaling through modification of the local phospholipid
composition340. Our research has also demonstrated both PI3K-associated signaling and
fatty acid-dependent modulation of PCB-induced inflammatory response, providing PI3K
as a potential link between the membrane-based TLR4 signaling in caveolae and the
downstream activities of PCBs. Further lipid rafts are known to be critical modulators of
Src activated PI3K/Akt signaling341. We established that PCBs modulate the
phosphorylation of endothelial nitric oxide synthase (eNOS) through Src mediated
PI3K/Akt activation164. Akt is a critical initiator of many cellular processes and is therefore
is a potential regulator of PCB/LPS co-stimulatory events.
The cellular inflammatory response is sensitive to different stimuli and combination of
stimuli. Emerging research suggests that low level exposure to an inflammatory stimulus
disengages negative feedback mechanism and prolongs the inflammatory response297.
When applied to our work, low level chronic exposure to PCBs has the potential to
disrupt the negative feedback response to inflammatory stimuli and promote chronic
inflammation that leads to atherosclerosis and other chronic disorders. Further, the
“deprogramming” of low dose inflammatory stimuli establishes a condition in which a
higher secondary stimulus initiates a hyperactive response due to insufficient negative
feedback342. As of yet, the role of environmental pollutants in this mechanism have not
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been studied, but PI3K and Akt are key regulators of this pathway, the actions of which
warrant further study in our model.
6.5.3 Contribution to our knowledge as a whole
This work substantiates previous research which has indicated the role of caveolin-1 as
being critical to the inflammatory response to lipophilic environmental stresses, such as
coplanar PCBs124, 126. Caveolae have the capacity to respond to multiple stressors. The
strength or specificity of the inflammatory stimuli activates different receptors and
signaling pathways to culminate in an inflammatory response, yet caveolae are sensitive
to modulation by omega-3 fatty acids and phytochemicals which activate anti-oxidant
pathways97, 128.
6.6 Implications
The environment that we live in contains a mixture of pollutants that includes legacy
chemicals like PCBs and newly synthesized toxicants that have not yet been recognized
as health hazards343. The risk for heart disease, diabetes, liver disease, and other
inflammation- related disorders increase with exposure to PCBs and other persistent
organic pollutants59, 62, 64, 66, 71. When studying subjects who have high dietary fish intake
and as a result have both increased pollutant exposure and increased omega-3 intake,
the increased pollutant exposure has negative outcomes such as increased arterial
stiffness, but the vascular inflammation is reduced in response to a high intake of
omega-3 fatty acids203. Our observations suggest that even low exposures to coplanar
PCBs, such as PCB 77 and its dechlorination products, promote inflammation in
vascular endothelial cells. PCB 77 promotes endothelial dysfunction and vascular
inflammation, by for example, increasing the expression of VCAM1 in the artery wall14, 91.
Lipid exposure regulates the extent of the PCB 77-induced inflammatory response with
omega-6 linoleic acid promoting inflammation while omega-3 α-linoleic acid and high
oleic acid-olive oil counter regulate the inflammation, respectively15, 16, 91.
As a coplanar PCB, PCB 126 is an AhR ligand, and the pro-inflammatory potential of
PCB 126 is demonstrated by the induction of IL-8 and MCP-1 in pre-adipocytes and
differentiated adipocytes344. These findings implicate that PCB 126 promotes
inflammatory markers which are generally associated with obesity and diabetes345, 346.
PCB 126 affects cardiovascular outcomes as well. For example, in the 1999-2002
NHANES (National Health and Nutrition Examination Survey) data, heightened serum
PCB 126 was strongly associated with a risk for hypertension347, and animal models
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suggest an association between PCB 126 and the development of vascular lesions168.
PCB 126 is a very stable dioxin-like congener which is detectable in human blood
samples and is consumed through the human diet 316, 318. These studies substantiate
human exposure through dietary sources, but implicate a limited human capacity to
metabolize and excrete PCB 126. The literature does not define whether the toxicity of
PCB 126 is primarily derived from the parent compound or the hydroxylated metabolites.
In our in vivo exposure model, PCB 126 activates a moderate inflammatory response
including the upregulation of CYP1A1 and MCP-1, which we attribute to the activity of
the parent PCB and the AhR. The epidemiological literature suggests that PCB 126
contributes to inflammatory disease states, but the human experience includes exposure
to mixtures of PCBs and other toxicants. In a comparison of persistent organic
pollutants (POPs) and plastic-associated chemicals (PACs), such as bisphenol A and
phthalates, there was more evidence supporting the role of POPs in cardiovascular
disease, yet sufficient literature supports a link between the PACs and vascular disease
that it could not be excluded from consideration348. In conclusion, avoiding a single
toxicant over another does not eliminate disease risk.
For this reason, nutrition and other healthy lifestyle choices are the best option for
maintaining health. Omega-3 fatty acids and the metabolites resolvin E1 and protectin
D1 promote insulin sensitization in an ob/ob mouse model239. The protectins and
resolvins promote inflammation resolution by directing leukocyte class switching which
promotes cytokine expression patterns that drive wound healing334. The oxidized DHA
neuroprostanes promote Nrf2 mediated protection against coplanar-PCB induced
inflammation92, and EGCG, a green tea catechin, provides protection against TNFαinduced inflammation via a similar mechanism129, 349. Omega-3 fatty acids and
phytochemicals both inhibit LPS-induced inflammation through TLR4107, 350. The former
inhibits dimer formation and migration into lipid rafts107, and the latter alters
phosphorylation patterns of the TLR4 cysteine residues; thus, altering dimer formation,
which is required for associated inflammatory signaling350. Our data suggest that the
presence of DHA or its metabolites promote the anti-oxidant activities of PPARγ and
Nrf2, which increase HO-1 and NQO1 expression to mitigate PCB-induced inflammation.
Together these studies substantiate the hypothesis that modulation of diet promotes an
anti-inflammatory environment within a living organism.
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Appendix
Electrophoretic Mobility Shift Assay (EMSA)
Harvesting cells for nuclear extraction:
1) Aspirate media from 10 cm plates.
2) Rinse 2X with 10 mL cold 1X PBS.
3) Add 2 mL of PBS and scrap plates.
4) Transfer to 15 mL conical tubes (on ice) and pelleted cells at 500 x g for 5 min at
4°C.
5) Remove the supernatant leaving the cell pellet as dry as possible.
6) Premade buffers for 10-15 ul cell volume for a 100 mm plate (keep on ice):
a. Reagent volumes per sample for the NE-PER Nuclear and Cytoplasmic
Extraction Reagents kit (Thermo Scientific):
Packed Cell Volume (µL) CER I (µL)
CER II (µL)
NER (µL)
10
20
50
100
Protease Inhibitor (Halt)
Required

100
200
500
1000
Yes

5.5
11
27.5
55

50
100
250
500
Yes

7) Add ice-cold CER I buffer and vortex on high for 15 s to suspend the pellet.
8) Let stand on ice for 10 min.
9) Add ice-cold CER II to the tube.
10) Vortex for 5 s on the highest setting and incubate on ice for 1 min.
11) Vortex for 5 s on the highest setting. Centrifuge the tube for 5 min at max speed
in a microcentrifuge. (16, 000 x g, 4°C, 5 min)
12) Immediately transfer the supernatant (cytoplasmic extract) to a clean prechilled tube. Hold tube on ice to assess protein concentration or for storage.
(Measure the protein concentration by BCA or store at -80°C.)
13) Suspend the nuclear pellet in ice-cold NER.
14) Vortex on high for 15 s. Place the samples on ice and vortex for 15 s every 10
minutes, for a total of 40 min.
15) Centrifuge tubes at 16, 000 x g, 4°C for 10 min.
16) Immediately transfer the supernatant (nuclear extract) to a clean pre-chilled
tube. Place on ice.
17) Perform BCA or Bradford to determine protein concentration and store at - 80°C.
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Prepare and run EMSA:
1) Set up gel cassette molds.
2) Prepare 6% (or 4.5%) Acrylamide Gel (EMSA does not require a stacking gel):
Reagent
6% gel
6% gel
4.5% gel
4.5% gel
diH2O
(mL)
10X TBE buffer
40% bis-acrylamide
10% APS
(uL)
TEMED
Total
3)
4)
5)
6)

14.1

28.2

2.5
3.125
250

5.0
6.25
500

20
20 mL

40
40 mL

20 mL

80 mL

Fill the cassette to just over the edge and insert comb.
Allow gel to set until solidified and wells are well-formed. (1h-1.5hrs)
Pre-run the gel with 0.5X TBE buffer for 30 min. or more at 60V, RT.
Meanwhile, prepare samples for gel electrophoresis:

a. Set up EMSA reactions in order with a 5 min incubation before adding the
biotin labeled probe:
no
Reagents
1
2
3
4
5
cold extract
Ultrapure Water
11.0 11.4 11.5 11.6 11.6 10.0 15.0
10X Binding Buffer
2.0
2.0
2.0
2.0
2.0
2.0
2.0
1 ug/ul Poly(dI*dC)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
cold (10 µM) or bio-mutant
(100 nM)
2.0
Nuclear Ext (5 µg)
4.0
3.6
3.5
3.4
3.4
3.0
0.0
Incubate 5 minutes.
Biotin-Probe (100 nM)
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Total Volume
20
20
20
20
20
20
20
b. Incubate for 20 min at RT.
7) Add 4 µL of 6X orange/blue loading dye with triturating to each sample.
8) Check wells; if not well formed, flush with 0.5X TBE buffer to clear.
9) Load samples into gel and run at 70 V at RT for ~ 1 h.
10) Pre-soak the pads and nylon membrane for a minimum of 10 min in 0.5X TBE
buffer.
11) Rinse gels in 0.5X TBE buffer and assemble for semi-dry transfer.
12) Transfer via semi-dry transfer at 300 mA for 30 min at RT.
13) Remove membrans and allow to dry face up on a Kim wipe. (2-5 min)
14) Cross-link for ~ 45 s (use automatic setting) at 120 mJ/cm3 using a commercial
UV cross-linker.
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Detection of the biotin binding
1) Block the nylon membrane for 30 min in blocking buffer with shaking on an orbital
shaker.
2) Prep the Conjugate/blocking buffer cocktail (66.7 μL stabilized streptavidinehorseradish peroxidase conjugate to 20 mL blocking buffer (1:300 dilution)).
3) Decant blocking buffer and replace with the Conjugate/blocking buffer cocktail for
15 min on orbital shaker.
4) Prepare 1X wash solution 30 mL 4X wash solution to 90 mL H2O.
5) In fresh boxes, wash membranes for 4X at 5 min each with wash solution.
6) Prepare the substrate working solution. (Start with the following dilution and
incrementally increase as necessary):
1 mL each Luminol Enhancer Solution and Stable Peroxide Solution plus 8 mL
dH2O for a total of 10 mL.
7) In a fresh box, cover nylon membranes with substrate working solution for 5 min,
and gently rock by hand to maintain coverage of the membranes.
8) In a cassette, place membranes in a plastic sheath and photograph in the dark
room starting with 1 min.
9) Store nylon membranes in dH2O, if necessary.
Ordering probe from IDT
1) Determine probe sequence from literature. If a porcine sequence is not available,
use a validated human sequence.
2) On the IDT website select “Custom DNA Oligos.”
3) Select duplex, and a space will appear for the insertion of a second sequence.
4) Name the sequence.
5) Paste the sequence and press the complement button. (The complement should
appear in the alternate space.)
6) No additional purification required. Select amount based on needed; generally
the lowest is sufficient for us.
7) For each sequence, go to the bottom and select “5’ modification”.
8) Select /5Biosg/, 5’ Biotin.
9) To order cold probe, do the same set-up, but do not add the biotin tag.
Preparing probe for EMSA
1) Reconstitute the lyophilized stock based on nmol of product, e.g., 94.8 nmol
make Stock 1: 100 μM with 948 µL of diH2O.
2) To make Stock 2 for the biotin labeled probe, dilute Stock 1 - 1:1000 to 100 nM
(for the ChemiEMSA).
3) To make Stock 2 for the cold probe, dilute Stock 1 - 1:10 to 10 µM (for the
ChemiEMSA).
Protein Isolation from Cells
1) Aspirate media.
2) Rinse 2X with 2mL cold 1X PBS.
3) Carefully, remove residual PBS by pipette.
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4) Apply premade lysis buffer, 200 ul for a 35mm plate (keep on ice); 100-150 uL
per 6 -well:
a. Lysis buffer Option A:
Reagent
1 mL
2.5 mL
5 mL
10 mL
diH2O
(mL)
10X RIPA buffer
10% SDS
100X EDTA
(uL)
Protease Inhibitor
(Halt)

Reagent

0.780

1.95

3.90

7.8

0.100
0.100
10
10

0.25
0.25
25
25

0.50
0.50
50
50

1.0
1.0
100
100

b. Lysis buffer Option B:
1 mL
2.5 mL

diH2O
(mL)
10X RIPA buffer
10% SDS
Aprotinin
(uL)
Pepstatin A
PMSF
NaF

0.750
0.125
0.125
0.25
1.25
12.5
6.25

2.00
0.25
0.25
0.50
2.50
25
12.5

c. Lysis buffer Option C:
1 mL
1.5 mL
Lysis (-) (mL)
0.974 1.464
NP-40 (uL)
5
7.5
PMSF
10
15
Na3VO4
1
1.5
Protease Inhib.
10
15
Cocktail

5 mL

10 mL

3.92
0.50
0.50
1.0
5.0
50
25

7.84
1.0
1.0
2.0
10.0
100
50

2 mL
1.948
10
20
2
20

3 mL
2.922
15
30
3
30

4 mL
3.896
20
40
4
40

5 mL
4.87
25
50
5
50

6 mL
5.84
30
60
6
60

5) Scrap plates, pipette up and down 10-20X, and transfer lysate to 1.5 Eppendorf
tubes.
6) Sonicate for 10 sec. with the sonicator set at 20 and 4.
7) Let stand on ice for 30 min.
8) Centrifuge for 15 min. @ 13,000rpm and 4°C.
9) Transfer supernatant to chilled Eppies and freeze on dry ice.
10) Store at -80°C.
11) Measure the protein concentration by BCA.
Protein Isolation from Tissues
Equipment: forceps, scalpel, weigh boats, autoclaved mortar and pestle, power drill,
labeled 1.5mL tubes on ice, 1X RIPA buffer (no SDS) on ice, 2 mL serological pipettes
and pipette aid, diH2O & 70% EtOH for cleaning/sterilization
1) Make 1X RIPA buffer and set on ice. Label tubes and set on ice.
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Reagent

1 mL

2.5 mL

5 mL

10 mL

diH2O
(mL)
10X RIPA buffer
100X EDTA
(uL)
Protease Inhibitor (Halt)

0.880
0.100
10
10

2.25
0.25
25
25

4.40
0.50
50
50

8.8
1.0
100
100

2) Tare weigh boat on analytical balance. Quickly open frozen tissue sample and
remove a piece of tissue with the scalpel using forceps to transfer to weigh boat.
(Tissue should weigh between 0.04-0.08g.)
3) Insert mortar into power drill. Add 300uL of 1X RIPA buffer to the pestle and
insert the tissue sample. Homogenize the sample using the mortar/power drill,
moving mortar up and down as necessary to homogenize the entire sample.
4) Carefully, remove the homogenized sample by pipette and place in chilled 1.5mL
tubes.
5) Sterilize the equipment with EtOH and remove residual sample matter with diH2O
after each sample.
6) Once sample have been collected, sonicate for 10 sec. with the sonicator set at
20 and 4.
7) Let stand on ice for 30 min.
8) Centrifuge for 15 min. @ 13,000rpm and 4°C.
9) Transfer supernatant to chilled Eppies and add 600uL of DN/RNase free H2O to
dilute.
10) Freeze on dry ice, and store at -80°C. Or, proceed to BCA.
11) Measure the protein concentration by BCA. In the BCA plate, dilute each sample
1:5 (1uL sample: 4uL diH2O).

Sucrose Gradient Procedure
Harvesting
1. Cells grown on 150mm x25mm plate/treatment were washed with 1X PBS twice
(around 5 ml a time), then lysed with 2 mL of ice-cold MES buffered saline (MBS;
25mM MES (morpholineethanesulfonic acid, pH 6.5) 150 NaCl) containing 500
mM Na2CO3. Scrape plates.
a. Prepare:
i. 25mM MES: 2.4405g (MEShydride, Sigma # M2933-100g) in 500
ml water. Adjust PH to 6.5.
ii. Then add 4.383 NaCl into MES to make MBS.
iii. For lysis buffer, take 50mL MBS, add 2.65g Na2Co3, get 500mM.
2. Homogenization was carried out with 10 strokes of a loose-fitting Dounce
homogenizer (7mL) (aka the adapter homogenizing tips fitted to the power drill,
10 strokes with samples in the special glass tubes [volume 2mL lower part]).
Make sure to wash adapters and tubes with DI water and 70% ethanol between
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samples. After homogenizing, pour into 15ml conical tubes for sonication: 15
strokes set at 4.
3. After sonication, centrifuge at 3000rpm for 10 min at 4°C.
4. Collect supernatant into centrifuge tubes (14x89mm), if it’s not exactly 2ml, add
more MBS to reach 2ml.
Ultracentrifugation
1. Make your sucrose solutions
a. 90% Sucrose: 45g sucrose and make final volume to 50ml using MBS
solution. Heat in water bath and/or sonicator to dissolve.
b. 35% Sucrose: 17.5g sucrose and final volume 50 ml.
c. 5% Sucrose: 2.5g sucrose and final volume 50 ml.
2. In Ultraclear Centrifuge tubes (14x89 mm Cat#344059, Beckman Coulter, Inc,
Brea, CA) , combine 2 fractions of lysate sample with 2 fractions of 90% sucrose
in the bottom of an ultracentrifuge tube. A fraction is 800μl. Be sure to cut the tip
larger for the thicker 90% sucrose solution. Vortex for 5 seconds on medium
speed. Volume should now be 3.2 ml.
3. Carefully layer on 5 fractions of 35% sucrose. The first two fractions should be
done drop by drop, down the inside side of the tube. Be sure to check for a layer
for the first 2 fractions, then addition can be faster, but still along the side to keep
mixing from occurring. Volume should be around 7.2 ml.
4. Carefully layer on 3 fractions of 5% sucrose in same manner.
5. Make sure to cool down ultra-centrifuge. Set to program of 39k m/s, 18 hours + 2
hours at 0 m/s, Max Accel, no brake, 4°C. Should be under “Hennig Sucrose
Gradient” program name.
6. Change gloves, wipe outside of tubes with DI water and chemwipes, and slide
tubes into the swinging buckets (should be cleaned before with DI water and
70% ethanol). This is to insure there are no sugar grains on the outside of the
tubes.
7. Place your first sample on the scale, then add a final fraction of 5% sucrose.
Rotate through the other tubes, adding the final fraction to all to the point that
they are within 0.01g of each other.
8. Place vacuum grease on the threads of all the bucket caps before screwing them
into place.
9. Carry out and load onto rotor & into ultracentrifuge. Initiate program. Make sure
to check back in 30 min or so to assure no problems have occurred.
Fraction collection
1. After removing the buckets, remove the first fraction while tube is still in the
bucket. Fractions are same as before, 800 μl.
2. Then, remove tube from bucket and place in holder.
3. Gently remove the remaining fractions. Make sure to keep the tip of the pipette
just below the surface. There will be a total of 13 fractions.
a. There is usually a floating mass near the bottom of the 4th fraction. Be
sure to collect it only in the 4th fraction until it actually seems to be lower,
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in the 5th fraction. Be careful, because as you collect, the mass may try to
shift downward.
4. Aliquot fractions a couple times (7μl sample buffer+ 42μl fraction sample).
5. Store samples in -80 until ready to use.
Western blotting for sucrose gradients
1. For TLR4 and other difficult antibodies, use 8% SDS gels. Run gels as normal.
Transfer using semi-dry.
2. During blocking, block the normal 4 hours in 5% milk, then 1 hour at room
temperature for the primary. Afterwards, place in cold room overnight.
3. Wash for one 8 minute and two 5 minute session. Then apply secondary and sit
for 2 hours.
4. When washing after secondary, wash for two 8 minute and two 5 minute
sessions before applying ECL. Let rock for at least 1 minute with ECL before
positioning in cassettes and developing.
Western Protocol
1) Make acrylamide gels:
a. Separating gel
Reagent
diH2O
1.5 M Tris-HCl
40% Acryl:Bis
10% SDS
10% APS
TEMED

(mL)
pH 8.8
(uL)

b. Stacking gel
Reagent
diH2O
(mL)
0.5 M Tris-HCl
40% Acryl:Bis
10% SDS
(uL)
10% APS
TEMED

pH 6.8

10 mL

20 mL

4.8
2.5
2.5
100
50
10

9.6
5.0
5.0
200
100
20

5 mL

10 mL

20 mL

3.05

6.1

12.2

1.35
0.65
50

2.5
1.3
100

5.0
2.6
200

25
5

50
10

100
20

2) Combine protein samples (30ug) with 6X loading dye as per BCA results.
3) Heat samples for 5min. at 100°C.
4) Set-up the Western apparatus and fill inner chamber with 1X Running Buffer until
it just overflows. Fill bottom of the chamber until it passes the wire.
5) Load samples into gel(s) with gel loading tips avoiding the flanking wells when
possible. Use 6uL of Rainbow Ladder for each gel.
6) Run for approx. 80min. at 130V.
7) Prepare the dry transfer blot system:
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a. Submerge the pads, nitrocellulose membrane, and the Western gel in
transfer buffer.
b. Pour a small amount of transfer buffer on the apparatus.
c. Using a forceps, place the “sandwich,” pad, membrane, gel, and pad on
the apparatus. After each layer use a plastic wedge, test tube, etc. to
gently remove bubbles.
d. Pour a little more transfer buffer over the sandwich and secure both lids.
e. Run the transfer at 350 mAmps for 1 hour.
8) Remove the nitrocellulose gel and rinse with TBST.
9) Cover with Ponceau stain, remove excess, wash 1-2x with TBST to view
banding, cut as needed. (May store ON at 4°C in TBST if unable to continue.)
10) Cover membrane with 5% milk (5g + 100mL TBST) and incubate with shaking
for 1-3hr at RT.
11) Remove milk and wash while shaking in TBST for 10 min.
12) Remove TBST and apply 4mL of 5% milk or appropriate volume and add
primary antibody. For most antibodies, add 1:1000 dilution (i.e. 4uL to 4mL, 8uL
to 8mL) except β-actin antibody add a minimum of 1:10,000 to a max of 1:4000
dilution.
13) Either store in primary antibody ON at 4°C with shaking or incubate at RT with
shaking for 3hrs.
14) Wash 3x with TBST for 5-10min. each (on shaker).
15) Add secondary antibody in 5% milk to a 1:4000 dilution. Incubate at RT for 12hrs on shaker.
16) Wash 4x with TBST for 5-10min. each (on shaker). (May store at 4°C in TBST.)
17) Combine equal amounts of “black” and “white” ECL reagents making enough to
apply 2-4mL to each membrane depending on size. Incubate with shaking for 1
min.
18) Cut appropriately sized plastic sheath for each membrane and tape into a
cassette.
19) Dab the edge of the membrane on some Kim wipes and place in the plastic
sheath.
20) In the dark room, bend the upper right corner of the film for orientation and place
on the membrane for an appropriate length of time.
21) Develop film and mark rainbow ladder bands.
22) Label appropriately.
23) Membranes may be stripped or stored in TBST.

137

Bibliography
1.
Carson R, Darling L, Darling L. Silent spring. Boston Cambridge, Mass.:
Houghton Mifflin ; Riverside Press; 1962.
2.
Friis RH. Essentials of environmental health. Sudbury, MA: Jones & Bartlett
Learning; 2012.
3.
Robertson LW, Hansen LG. Pcbs: Recent advances in environmental toxicology
and health effects. University Press of Kentucky; 2001.
4.
Fiedler H. Polychlorinated biphenyls (pcbs): Uses and environmental releases.
2004
5.
Safe S, Bandiera S, Sawyer T, Robertson L, Safe L, Parkinson A, Thomas PE,
Ryan DE, Reik LM, Levin W, et al. Pcbs: Structure-function relationships and
mechanism of action. Environ Health Perspect. 1985;60:47-56
6.
Tanabe S, Kannan N, Subramanian A, Watanabe S, Tatsukawa R. Highly toxic
coplanar pcbs: Occurrence, source, persistency and toxic implications to wildlife
and humans. Environ Pollut. 1987;47:147-163
7.
Kannan N, Tanabe S, Tatsukawa R. Potentially hazardous residues of non-ortho
chlorine substituted coplanar pcbs in human adipose tissue. Archives of
environmental health. 1988;43:11-14
8.
Leece B, Denomme MA, Towner R, Li SM, Safe S. Polychlorinated biphenyls:
Correlation between in vivo and in vitro quantitative structure-activity
relationships (qsars). Journal of toxicology and environmental health.
1985;16:379-388
9.
Gahrs M, Roos R, Andersson PL, Schrenk D. Role of the nuclear xenobiotic
receptors car and pxr in induction of cytochromes p450 by non-dioxinlike
polychlorinated biphenyls in cultured rat hepatocytes. Toxicol Appl Pharmacol.
2013
10.
Wong PW, Brackney WR, Pessah IN. Ortho-substituted polychlorinated
biphenyls alter microsomal calcium transport by direct interaction with ryanodine
receptors of mammalian brain. J Biol Chem. 1997;272:15145-15153
11.
Wahlang B, Falkner KC, Gregory B, Ansert D, Young D, Conklin DJ, Bhatnagar
A, McClain CJ, Cave M. Polychlorinated biphenyl 153 is a diet-dependent
obesogen that worsens nonalcoholic fatty liver disease in male c57bl6/j mice. J
Nutr Biochem. 2013
12.
Rignell-Hydbom A, Rylander L, Hagmar L. Exposure to persistent organochlorine
pollutants and type 2 diabetes mellitus. Human & experimental toxicology.
2007;26:447-452
13.
McFarland VA, Clarke JU. Environmental occurrence, abundance, and potential
toxicity of polychlorinated biphenyl congeners: Considerations for a congenerspecific analysis. Environ Health Perspect. 1989;81:225-239
14.
Toborek M, Barger SW, Mattson MP, Espandiari P, Robertson LW, Hennig B.
Exposure to polychlorinated biphenyls causes endothelial cell dysfunction.
Journal of biochemical toxicology. 1995;10:219-226
15.
Hennig B, Slim R, Toborek M, Robertson LW. Linoleic acid amplifies
polychlorinated biphenyl-mediated dysfunction of endothelial cells. Journal of
biochemical and molecular toxicology. 1999;13:83-91
16.
Wang L, Reiterer G, Toborek M, Hennig B. Changing ratios of omega-6 to
omega-3 fatty acids can differentially modulate polychlorinated biphenyl toxicity
in endothelial cells. Chem Biol Interact. 2008;172:27-38
17.
Van den Berg M, Birnbaum L, Bosveld AT, Brunstrom B, Cook P, Feeley M,
Giesy JP, Hanberg A, Hasegawa R, Kennedy SW, Kubiak T, Larsen JC, van
Leeuwen FX, Liem AK, Nolt C, Peterson RE, Poellinger L, Safe S, Schrenk D,
138

18.

19.
20.
21.
22.
23.
24.

25.
26.

27.
28.
29.

30.
31.

Tillitt D, Tysklind M, Younes M, Waern F, Zacharewski T. Toxic equivalency
factors (tefs) for pcbs, pcdds, pcdfs for humans and wildlife. Environ Health
Perspect. 1998;106:775-792
Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M,
Fiedler H, Hakansson H, Hanberg A, Haws L, Rose M, Safe S, Schrenk D,
Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walker N, Peterson RE. The
2005 world health organization reevaluation of human and mammalian toxic
equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci.
2006;93:223-241
Geyer H, Scheunert I, Korte F. Bioconcentration potential of organic
environmental chemicals in humans. Regulatory toxicology and pharmacology :
RTP. 1986;6:313-347
Yu GW, Laseter J, Mylander C. Persistent organic pollutants in serum and
several different fat compartments in humans. Journal of environmental and
public health. 2011;2011:417980
Jandacek RJ, Genuis SJ. An assessment of the intestinal lumen as a site for
intervention in reducing body burdens of organochlorine compounds.
TheScientificWorldJournal. 2013;2013:205621
Jandacek RJ, Rider T, Yang Q, Woollett LA, Tso P. Lymphatic and portal vein
absorption of organochlorine compounds in rats. Am J Physiol Gastrointest Liver
Physiol. 2009;296:G226-234
Mohammed A, Eklund A, Ostlund-Lindqvist AM, Slanina P. Distribution of
toxaphene, ddt, and pcb among lipoprotein fractions in rat and human plasma.
Arch Toxicol. 1990;64:567-571
Borlakoglu JT, Welch VA, Wilkins JPG, Dils RR. Transport and cellular uptake of
polychlorinated biphenyls (pcbs)—i: Association of individual pcb isomers and
congeners with plasma lipoproteins and proteins in the pigeon. Biochemical
Pharmacology. 1990;40:265-272
Mannetje A, Coakley J, Mueller JF, Harden F, Toms LM, Douwes J. Partitioning
of persistent organic pollutants (pops) between human serum and breast milk: A
literature review. Chemosphere. 2012;89:911-918
Kim D, Ryu HY, Lee JH, Lee JH, Lee YJ, Kim HK, Jang DD, Kim HS, Yoon HS.
Organochlorine pesticides and polychlorinated biphenyls in korean human milk:
Contamination levels and infant risk assessment. Journal of environmental
science and health. Part. B, Pesticides, food contaminants, and agricultural
wastes. 2013;48:243-250
Crinnion WJ. Polychlorinated biphenyls: Persistent pollutants with immunological,
neurological, and endocrinological consequences. Alternative medicine review : a
journal of clinical therapeutic. 2011;16:5-13
Birnbaum LS, Tuomisto J. Non-carcinogenic effects of tcdd in animals. Food
Addit Contam. 2000;17:275-288
White SS, Birnbaum LS. An overview of the effects of dioxins and dioxin-like
compounds on vertebrates, as documented in human and ecological
epidemiology. Journal of environmental science and health. Part C,
Environmental carcinogenesis & ecotoxicology reviews. 2009;27:197-211
Carlson DB, Perdew GH. A dynamic role for the ah receptor in cell signaling?
Insights from a diverse group of ah receptor interacting proteins. Journal of
biochemical and molecular toxicology. 2002;16:317-325
Wilson CL, Safe S. Mechanisms of ligand-induced aryl hydrocarbon receptormediated biochemical and toxic responses. Toxicol Pathol. 1998;26:657-671
139

32.
33.
34.
35.
36.

37.
38.
39.

40.
41.
42.
43.
44.

45.

46.
47.

Kobayashi A, Sogawa K, Fujii-Kuriyama Y. Cooperative interaction between
ahr.Arnt and sp1 for the drug-inducible expression of cyp1a1 gene. J Biol Chem.
1996;271:12310-12316
Nguyen LP, Bradfield CA. The search for endogenous activators of the aryl
hydrocarbon receptor. Chemical research in toxicology. 2008;21:102-116
Guyot E, Chevallier A, Barouki R, Coumoul X. The ahr twist: Ligand-dependent
ahr signaling and pharmaco-toxicological implications. Drug Discovery Today.
2013;18:479-486
Kohle C, Bock KW. Coordinate regulation of phase i and ii xenobiotic
metabolisms by the ah receptor and nrf2. Biochem Pharmacol. 2007;73:18531862
Stegeman JJ, Hahn ME, Weisbrod R, Woodin BR, Joy JS, Najibi S, Cohen RA.
Induction of cytochrome p4501a1 by aryl hydrocarbon receptor agonists in
porcine aorta endothelial cells in culture and cytochrome p4501a1 activity in
intact cells. Mol Pharmacol. 1995;47:296-306
Schlezinger JJ, Stegeman JJ. Induction and suppression of cytochrome p450 1a
by 3,3',4,4',5-pentachlorobiphenyl and its relationship to oxidative stress in the
marine fish scup (stenotomus chrysops). Aquat Toxicol. 2001;52:101-115
Schlezinger JJ, Struntz WD, Goldstone JV, Stegeman JJ. Uncoupling of
cytochrome p450 1a and stimulation of reactive oxygen species production by
co-planar polychlorinated biphenyl congeners. Aquat Toxicol. 2006;77:422-432
Shertzer HG, Clay CD, Genter MB, Chames MC, Schneider SN, Oakley GG,
Nebert DW, Dalton TP. Uncoupling-mediated generation of reactive oxygen by
halogenated aromatic hydrocarbons in mouse liver microsomes. Free Radic Biol
Med. 2004;36:618-631
Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP. Role of the
aromatic hydrocarbon receptor and [ah] gene battery in the oxidative stress
response, cell cycle control, and apoptosis. Biochem Pharmacol. 2000;59:65-85
Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. Redox regulation of nf-kappab
activation: Distinct redox regulation between the cytoplasm and the nucleus.
Antioxidants & redox signaling. 2005;7:395-403
Rollins BJ. Monocyte chemoattractant protein 1: A potential regulator of
monocyte recruitment in inflammatory disease. Molecular medicine today.
1996;2:198-204
Shin WS, Szuba A, Rockson SG. The role of chemokines in human
cardiovascular pathology: Enhanced biological insights. Atherosclerosis.
2002;160:91-102
Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, GutierrezRamos J-C, Connelly PW, Milstone DS. A major role for vcam-1, but not icam-1,
in early atherosclerosis. The Journal of Clinical Investigation. 2001;107:12551262
Dansky HM, Barlow CB, Lominska C, Sikes JL, Kao C, Weinsaft J, Cybulsky MI,
Smith JD. Adhesion of monocytes to arterial endothelium and initiation of
atherosclerosis are critically dependent on vascular cell adhesion molecule-1
gene dosage. Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:16621667
Sturgill MG, Lambert GH. Xenobiotic-induced hepatotoxicity: Mechanisms of liver
injury and methods of monitoring hepatic function. Clinical Chemistry.
1997;43:1512-1526
Klaassen CD. Casarett and doull's toxicology: The basic science of poisons.
McGraw-Hill; 2008.
140

48.
49.
50.
51.

52.
53.
54.

55.
56.
57.
58.
59.
60.

61.

62.
63.
64.

Aleksunes LM, Klaassen CD. Coordinated regulation of hepatic phase i and ii
drug-metabolizing genes and transporters using ahr-, car-, pxr-, pparα-, and nrf2null mice. Drug Metabolism and Disposition. 2012;40:1366-1379
Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340:115126
Ichihara S. The pathological roles of environmental and redox stresses in
cardiovascular diseases. Environmental health and preventive medicine.
2013;18:177-184
Hennig B, Ettinger AS, Jandacek RJ, Koo S, McClain C, Seifried H, Silverstone
A, Watkins B, Suk WA. Using nutrition for intervention and prevention against
environmental chemical toxicity and associated diseases. Environ Health
Perspect. 2007;115:493-495
Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease.
Arterioscler Thromb Vasc Biol. 2005;25:29-38
Liao JK. Linking endothelial dysfunction with endothelial cell activation. J Clin
Invest. 2013;123:540-541
Li H, Cybulsky MI, Gimbrone MA, Jr., Libby P. An atherogenic diet rapidly
induces vcam-1, a cytokine-regulatable mononuclear leukocyte adhesion
molecule, in rabbit aortic endothelium. Arteriosclerosis and thrombosis : a journal
of vascular biology / American Heart Association. 1993;13:197-204
Karimi S, Dadvar M, Modarress H, Dabir B. A new correlation for inclusion of
leaky junctions in macroscopic modeling of atherosclerotic lesion initiation.
Journal of theoretical biology. 2013;329:94-100
Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J. Chronic
inflammatory diseases and cardiovascular risk: A systematic review. The
Canadian journal of cardiology. 2011;27:174-182
Wilson PW. Evidence of systemic inflammation and estimation of coronary artery
disease risk: A population perspective. The American journal of medicine.
2008;121:S15-20
Libby P. Inflammatory mechanisms: The molecular basis of inflammation and
disease. Nutr Rev. 2007;65:S140-146
Codru N, Schymura MJ, Negoita S, Rej R, Carpenter DO. Diabetes in relation to
serum levels of polychlorinated biphenyls and chlorinated pesticides in adult
native americans. Environ Health Perspect. 2007;115:1442-1447
Silverstone AE, Rosenbaum PF, Weinstock RS, Bartell SM, Foushee HR,
Shelton C, Pavuk M. Polychlorinated biphenyl (pcb) exposure and diabetes:
Results from the anniston community health survey. Environ Health Perspect.
2012;120:727-732
Uemura H, Arisawa K, Hiyoshi M, Kitayama A, Takami H, Sawachika F,
Dakeshita S, Nii K, Satoh H, Sumiyoshi Y, Morinaga K, Kodama K, Suzuki T,
Nagai M, Suzuki T. Prevalence of metabolic syndrome associated with body
burden levels of dioxin and related compounds among japan's general
population. Environ Health Perspect. 2009;117:568-573
Cave M, Appana S, Patel M, Falkner KC, McClain CJ, Brock G. Polychlorinated
biphenyls, lead, and mercury are associated with liver disease in american
adults: Nhanes 2003-2004. Environ Health Perspect. 2010;118:1735-1742
Wahlang B, Beier JI, Clair HB, Bellis-Jones HJ, Falkner KC, McClain CJ, Cave
MC. Toxicant-associated steatohepatitis. Toxicologic Pathology. 2012
Lind PM, van Bavel B, Salihovic S, Lind L. Circulating levels of persistent organic
pollutants (pops) and carotid atherosclerosis in the elderly. Environ Health
Perspect. 2012;120:38-43
141

65.
66.
67.
68.

69.

70.

71.

72.

73.
74.
75.
76.
77.

78.
79.

Lind PM, Orberg J, Edlund UB, Sjoblom L, Lind L. The dioxin-like pollutant pcb
126 (3,3',4,4',5-pentachlorobiphenyl) affects risk factors for cardiovascular
disease in female rats. Toxicol Lett. 2004;150:293-299
Gustavsson P, Hogstedt C. A cohort study of swedish capacitor manufacturing
workers exposed to polychlorinated biphenyls (pcbs). Am J Ind Med.
1997;32:234-239
Choi JJ, Choi YJ, Chen L, Zhang B, Eum SY, Abreu MT, Toborek M.
Lipopolysaccharide potentiates polychlorinated biphenyl-induced disruption of the
blood–brain barrier via tlr4/irf-3 signaling. Toxicology. 2012
Fontes JD, Yamamoto JF, Larson MG, Wang N, Dallmeier D, Rienstra M,
Schnabel RB, Vasan RS, Keaney JF, Jr., Benjamin EJ. Clinical correlates of
change in inflammatory biomarkers: The framingham heart study.
Atherosclerosis. 2013;228:217-223
Kressel G, Trunz B, Bub A, Hulsmann O, Wolters M, Lichtinghagen R,
Stichtenoth DO, Hahn A. Systemic and vascular markers of inflammation in
relation to metabolic syndrome and insulin resistance in adults with elevated
atherosclerosis risk. Atherosclerosis. 2009;202:263-271
Baker NA, Karounos M, English V, Fang J, Wei Y, Stromberg A, Sunkara M,
Morris AJ, Swanson HI, Cassis LA. Coplanar polychlorinated biphenyls impair
glucose homeostasis in lean c57bl/6 mice and mitigate beneficial effects of
weight loss on glucose homeostasis in obese mice. Environ Health Perspect.
2013;121:105-110
Nakamoto M, Arisawa K, Uemura H, Katsuura S, Takami H, Sawachika F,
Yamaguchi M, Juta T, Sakai T, Toda E, Mori K, Hasegawa M, Tanto M, Shima
M, Sumiyoshi Y, Morinaga K, Kodama K, Suzuki T, Nagai M, Satoh H.
Association between blood levels of pcdds/pcdfs/dioxin-like pcbs and history of
allergic and other diseases in the japanese population. Int Arch Occup Environ
Health. 2012
Taylor KW, Novak RF, Anderson HA, Birnbaum LS, Blystone C, Devito M,
Jacobs D, Jr., Kohrle J, Lee DH, Rylander L, Rignell-Hydbom A, Tornero-Velez
R, Turyk ME, Boyles A, Thayer KA, Lind L. Evaluation of the association between
persistent organic pollutants (pops) and diabetes in epidemiological studies: A
national toxicology program workshop review. Environ Health Perspect. 2013
Hennig B, Meerarani P, Slim R, Toborek M, Daugherty A, Silverstone AE,
Robertson LW. Proinflammatory properties of coplanar pcbs: In vitro and in vivo
evidence. Toxicol Appl Pharmacol. 2002;181:174-183
Whitney EN, Rolfes SR. Understanding nutrition. Wadsworth Group; 2002.
Hall WL. Dietary saturated and unsaturated fats as determinants of blood
pressure and vascular function. Nutrition research reviews. 2009;22:18-38
Huang S, Rutkowsky JM, Snodgrass RG, Ono-Moore KD, Schneider DA,
Newman JW, Adams SH, Hwang DH. Saturated fatty acids activate tlr-mediated
pro-inflammatory signaling pathways. J Lipid Res. 2012
Enos RT, Davis JM, Velazquez KT, McClellan JL, Day SD, Carnevale KA,
Murphy EA. Influence of dietary saturated fat content on adiposity, macrophage
behavior, inflammation, and metabolism: Composition matters. J Lipid Res.
2013;54:152-163
Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors
in human atherosclerotic lesions: A possible pathway for plaque activation.
Circulation. 2002;105:1158-1161
Ding Y, Subramanian S, Montes VN, Goodspeed L, Wang S, Han C, Teresa AS,
3rd, Kim J, O'Brien KD, Chait A. Toll-like receptor 4 deficiency decreases
142

80.
81.
82.
83.
84.
85.
86.

87.
88.
89.
90.
91.

92.
93.
94.
95.

atherosclerosis but does not protect against inflammation in obese low-density
lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2012;32:15961604
Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens
CH, Willett WC. Dietary fat intake and the risk of coronary heart disease in
women. New England Journal of Medicine. 1997;337:1491-1499
Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of
increasing polyunsaturated fat in place of saturated fat: A systematic review and
meta-analysis of randomized controlled trials. PLoS medicine. 2010;7:e1000252
Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in
cardiovascular disease and other chronic diseases. Experimental Biology and
Medicine. 2008;233:674-688
Gorjão R, Azevedo-Martins AK, Rodrigues HG, Abdulkader F, Arcisio-Miranda M,
Procopio J, Curi R. Comparative effects of dha and epa on cell function.
Pharmacology & Therapeutics. 2009;122:56-64
Calder PC. Fatty acids and inflammation: The cutting edge between food and
pharma. European Journal of Pharmacology. 2011;668, Supplement 1:S50-S58
Massaro M, Scoditti E, Carluccio MA, De Caterina R. Basic mechanisms behind
the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot
Essent Fatty Acids. 2008;79:109-115
Massaro M, Habib A, Lubrano L, Turco SD, Lazzerini G, Bourcier T, Weksler BB,
De Caterina R. The omega-3 fatty acid docosahexaenoate attenuates endothelial
cyclooxygenase-2 induction through both nadp(h) oxidase and pkcε inhibition.
Proceedings of the National Academy of Sciences. 2006;103:15184-15189
Panigrahy D, Kaipainen A, Greene ER, Huang S. Cytochrome p450-derived
eicosanoids: The neglected pathway in cancer. Cancer metastasis reviews.
2010;29:723-735
Arnold C, Konkel A, Fischer R, Schunck WH. Cytochrome p450-dependent
metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.
Pharmacological reports : PR. 2010;62:536-547
James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and
inflammatory mediator production. Am J Clin Nutr. 2000;71:343S-348S
Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress
in vivo: An overview. Biomarkers : biochemical indicators of exposure, response,
and susceptibility to chemicals. 2005;10 Suppl 1:S10-23
Hennig B, Reiterer G, Toborek M, Matveev SV, Daugherty A, Smart E,
Robertson LW. Dietary fat interacts with pcbs to induce changes in lipid
metabolism in mice deficient in low-density lipoprotein receptor. Environ Health
Perspect. 2005;113:83-87
Majkova Z, Layne J, Sunkara M, Morris AJ, Toborek M, Hennig B. Omega-3 fatty
acid oxidation products prevent vascular endothelial cell activation by coplanar
polychlorinated biphenyls. Toxicol Appl Pharmacol. 2011;251:41-49
Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial G. N-3 fatty acids and
cardiovascular events after myocardial infarction. N Engl J Med. 2010;363:20152026
Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular
events: A systematic review. Clin Cardiol. 2009;32:365-372
Grenon SM, Aguado-Zuniga J, Hatton JP, Owens CD, Conte MS, HughesFulford M. Effects of fatty acids on endothelial cells: Inflammation and monocyte
adhesion. Journal of Surgical Research. 2012
143

96.
97.
98.
99.

100.
101.

102.
103.
104.

105.
106.
107.

108.
109.
110.

Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and
eicosapentaenoic acid: Emerging mediators of inflammation. Prostaglandins
Leukot Essent Fatty Acids. 2009;81:187-191
Ma DW, Seo J, Davidson LA, Callaway ES, Fan YY, Lupton JR, Chapkin RS. N-3
pufa alter caveolae lipid composition and resident protein localization in mouse
colon. FASEB J. 2004;18:1040-1042
Li Q, Zhang Q, Wang M, Liu F, Zhao S, Ma J, Luo N, Li N, Li Y, Xu G, Li J.
Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch
Biochem Biophys. 2007;466:250-259
Yin H, Liu W, Goleniewska K, Porter NA, Morrow JD, Peebles RS, Jr. Dietary
supplementation of omega-3 fatty acid-containing fish oil suppresses f2isoprostanes but enhances inflammatory cytokine response in a mouse model of
ovalbumin-induced allergic lung inflammation. Free Radic Biol Med.
2009;47:622-628
Kong W, Yen JH, Vassiliou E, Adhikary S, Toscano MG, Ganea D.
Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo
expression of the il-12 cytokine family. Lipids Health Dis. 2010;9:12
Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 fatty acidderived mediators 17(r)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin
d1 and resolvin d2 prevent experimental colitis in mice. The Journal of
Immunology. 2011;187:1957-1969
Zhang MJ, Spite M. Resolvins: Anti-inflammatory and proresolving mediators
derived from omega-3 polyunsaturated fatty acids. Annual review of nutrition.
2012;32:203-227
Itoh T, Yamamoto K. Peroxisome proliferator activated receptor gamma and
oxidized docosahexaenoic acids as new class of ligand. Naunyn-Schmiedeberg's
archives of pharmacology. 2008;377:541-547
Kusunoki C, Yang L, Yoshizaki T, Nakagawa F, Ishikado A, Kondo M, Morino K,
Sekine O, Ugi S, Nishio Y, Kashiwagi A, Maegawa H. Omega-3 polyunsaturated
fatty acid has an anti-oxidant effect via the nrf-2/ho-1 pathway in 3t3-l1
adipocytes. Biochemical and biophysical research communications.
2013;430:225-230
Layne J, Majkova Z, Smart EJ, Toborek M, Hennig B. Caveolae: A regulatory
platform for nutritional modulation of inflammatory diseases. J Nutr Biochem.
2011;22:807-811
Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH.
Differential modulation of toll-like receptors by fatty acids: Preferential inhibition
by n-3 polyunsaturated fatty acids. J Lipid Res. 2003;44:479-486
Wong SW, Kwon MJ, Choi AM, Kim HP, Nakahira K, Hwang DH. Fatty acids
modulate toll-like receptor 4 activation through regulation of receptor dimerization
and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J
Biol Chem. 2009;284:27384-27392
Pike LJ. Rafts defined: A report on the keystone symposium on lipid rafts and cell
function. J Lipid Res. 2006;47:1597-1598
Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins
in health and disease. Physiol Rev. 2004;84:1341-1379
Hnasko R, Lisanti MP. The biology of caveolae: Lessons from caveolin knockout
mice and implications for human disease. Molecular interventions. 2003;3:445464

144

111.
112.
113.
114.
115.
116.
117.
118.

119.

120.
121.

122.
123.
124.

125.
126.

Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP. Caveolaedeficient endothelial cells show defects in the uptake and transport of albumin in
vivo. J Biol Chem. 2001;276:48619-48622
Trigatti BL, Anderson RG, Gerber GE. Identification of caveolin-1 as a fatty acid
binding protein. Biochemical and biophysical research communications.
1999;255:34-39
Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP. Genetic
ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler
Thromb Vasc Biol. 2004;24:98-105
Mirza MK, Yuan J, Gao XP, Garrean S, Brovkovych V, Malik AB, Tiruppathi C,
Zhao YY. Caveolin-1 deficiency dampens toll-like receptor 4 signaling through
enos activation. Am J Pathol. 2010;176:2344-2351
Beutler B. Tlr4: Central component of the sole mammalian lps sensor. Current
opinion in immunology. 2000;12:20-26
Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. Mediators of innate
immune recognition of bacteria concentrate in lipid rafts and facilitate
lipopolysaccharide-induced cell activation. J Cell Sci. 2002;115:2603-2611
Triantafilou M, Morath S, Mackie A, Hartung T, Triantafilou K. Lateral diffusion of
toll-like receptors reveals that they are transiently confined within lipid rafts on the
plasma membrane. J Cell Sci. 2004;117:4007-4014
Zhu X, Owen JS, Wilson MD, Li H, Griffiths GL, Thomas MJ, Hiltbold EM, Fessler
MB, Parks JS. Macrophage abca1 reduces myd88-dependent toll-like receptor
trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res.
2010;51:3196-3206
Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, Feng L, Lee WH, Fitzgerald
KA, Hwang DH. Saturated fatty acid activates but polyunsaturated fatty acid
inhibits toll-like receptor 2 dimerized with toll-like receptor 6 or 1. J Biol Chem.
2004;279:16971-16979
HWANG D. Modulation of the expression of cyclooxygenase-2 by fatty acids
mediated through toll-like receptor 4-derived signaling pathways. The FASEB
Journal. 2001;15:2556-2564
Nakahira K, Kim HP, Geng XH, Nakao A, Wang X, Murase N, Drain PF, Wang X,
Sasidhar M, Nabel EG, Takahashi T, Lukacs NW, Ryter SW, Morita K, Choi AM.
Carbon monoxide differentially inhibits tlr signaling pathways by regulating rosinduced trafficking of tlrs to lipid rafts. J Exp Med. 2006;203:2377-2389
Ryter SW, Alam J, Choi AMK. Heme oxygenase-1/carbon monoxide: From basic
science to therapeutic applications. Physiological Reviews. 2006;86:583-650
Wang XM, Kim HP, Nakahira K, Ryter SW, Choi AM. The heme oxygenase1/carbon monoxide pathway suppresses tlr4 signaling by regulating the
interaction of tlr4 with caveolin-1. J Immunol. 2009;182:3809-3818
Lim EJ, Majkova Z, Xu S, Bachas L, Arzuaga X, Smart E, Tseng MT, Toborek M,
Hennig B. Coplanar polychlorinated biphenyl-induced cyp1a1 is regulated
through caveolae signaling in vascular endothelial cells. Chem Biol Interact.
2008;176:71-78
Majkova Z, Smart E, Toborek M, Hennig B. Up-regulation of endothelial
monocyte chemoattractant protein-1 by coplanar pcb77 is caveolin-1-dependent.
Toxicol Appl Pharmacol. 2009;237:1-7
Han SG, Eum SY, Toborek M, Smart E, Hennig B. Polychlorinated biphenylinduced vcam-1 expression is attenuated in aortic endothelial cells isolated from
caveolin-1 deficient mice. Toxicology and Applied Pharmacology. 2010;246:7482
145

127.
128.
129.
130.
131.
132.
133.
134.
135.

136.
137.
138.
139.
140.

141.
142.

Wang L, Lim E-J, Toborek M, Hennig B. The role of fatty acids and caveolin-1 in
tumor necrosis factorα - induced endothelial cell activation. Metabolism.
2008;57:1328-1339
Choi YJ, Arzuaga X, Kluemper CT, Caraballo A, Toborek M, Hennig B. Quercetin
blocks caveolae-dependent pro-inflammatory responses induced by co-planar
pcbs. Environment International. 2010;36:931-934
Zheng Y, Morris A, Sunkara M, Layne J, Toborek M, Hennig B. Epigallocatechingallate stimulates nf-e2-related factor and heme oxygenase-1 via caveolin-1
displacement. J Nutr Biochem. 2012;23:163-168
Han SG, Han SS, Toborek M, Hennig B. Egcg protects endothelial cells against
pcb 126-induced inflammation through inhibition of ahr and induction of nrf2regulated genes. Toxicol Appl Pharmacol. 2012
Zheng Y, Lim EJ, Wang L, Smart EJ, Toborek M, Hennig B. Role of caveolin-1 in
egcg-mediated protection against linoleic-acid-induced endothelial cell activation.
The Journal of Nutritional Biochemistry. 2009;20:202-209
Rodenburg LA, Guo J, Du S, Cavallo GJ. Evidence for unique and ubiquitous
environmental sources of 3,3'-dichlorobiphenyl (pcb 11). Environ Sci Technol.
2010;44:2816-2821
Hu D, Hornbuckle KC. Inadvertent polychlorinated biphenyls in commercial paint
pigments. Environ Sci Technol. 2010;44:2822-2827
Brown JF, Feng H, Bedard DL, Brennan MJ, Carnahan JC, May RJ.
Environmental dechlorination of pcbs. Environmental Toxicology and Chemistry.
1987;6:579-593
Rodenburg LA, Du S, Lui H, Guo J, Oseagulu N, Fennell DE. Evidence for
dechlorination of polychlorinated biphenyls and polychlorinated dibenzo-p-dioxins
and -furans in wastewater collection systems in the new york metropolitan area.
Environmental Science & Technology. 2012;46:6612-6620
Ruzo LO, Zabik MJ, Schuetz RD. Photochemistry of bioactive compounds.
Photoproducts and kinetics of polychorinated biphenyls. Journal of agricultural
and food chemistry. 1974;22:199-202
Hawari J, Demeter A, Samson R. Sensitized photolysis of polychlorobiphenyls in
alkaline 2-propanol: Dechlorination of aroclor 1254 in soil samples by solar
radiation. Environmental Science & Technology. 1992;26:2022-2027
Doskey PV, Andren AW. Concentrations of airborne pcbs over lake michigan.
Journal of Great Lakes Research. 1981;7:15-20
Zahran EM, Bhattacharyya D, Bachas LG. Development of reactive pd/fe
bimetallic nanotubes for dechlorination reactions. Journal of Materials Chemistry.
2011;21:10454-10462
Venkatachalam K, Arzuaga X, Chopra N, Gavalas VG, Xu J, Bhattacharyya D,
Hennig B, Bachas LG. Reductive dechlorination of 3,3',4,4'-tetrachlorobiphenyl
(pcb77) using palladium or palladium/iron nanoparticles and assessment of the
reduction in toxic potency in vascular endothelial cells. Journal of hazardous
materials. 2008;159:483-491
Beyer A, Biziuk M. Environmental fate and global distribution of polychlorinated
biphenyls. Reviews of environmental contamination and toxicology.
2009;201:137-158
Puga A, Sartor MA, Huang MY, Kerzee JK, Wei YD, Tomlinson CR, Baxter CS,
Medvedovic M. Gene expression profiles of mouse aorta and cultured vascular
smooth muscle cells differ widely, yet show common responses to dioxin
exposure. Cardiovasc Toxicol. 2004;4:385-404
146

143.
144.
145.
146.
147.
148.
149.
150.

151.

152.
153.
154.
155.
156.
157.
158.
159.

Hennig B, Oesterling E, Toborek M. Environmental toxicity, nutrition, and gene
interactions in the development of atherosclerosis. Nutr Metab Cardiovasc Dis.
2007;17:162-169
Ganey PE, Boyd SA. An approach to evaluation of the effect of bioremediation
on biological activity of environmental contaminants: Dechlorination of
polychlorinated biphenyls. Environ Health Perspect. 2005;113:180-185
Hennig B, Shasby DM, Fulton AB, Spector AA. Exposure to free fatty acid
increases the transfer of albumin across cultured endothelial monolayers.
Arteriosclerosis. 1984;4:489-497
Lim EJ, Kim CW. Functional characterization of the promoter region of the
chicken elongation factor-2 gene. Gene. 2007;386:183-190
Han SS, Yun H, Son DJ, Tompkins VS, Peng L, Chung ST, Kim JS, Park ES,
Janz S. Nf-kappab/stat3/pi3k signaling crosstalk in imyc e mu b lymphoma.
Molecular cancer. 2010;9:97
Environmental Protection Agency. Cleanup and disposal of polychlorinated
biphenyls (pcbs). 2011;2012
Sergeev AV, Carpenter DO. Exposure to persistent organic pollutants increases
hospitalization rates for myocardial infarction with comorbid hypertension.
Primary prevention insights. 2010;2:1-9
Sergeev AV, Carpenter DO. Residential proximity to environmental sources of
persistent organic pollutants and first-time hospitalizations for myocardial
infarction with comorbid diabetes mellitus: A 12-year population-based study.
International journal of occupational medicine and environmental health.
2010;23:5-13
Arsenescu V, Arsenescu R, Parulkar M, Karounos M, Zhang X, Baker N, Cassis
LA. Polychlorinated biphenyl 77 augments angiotensin ii-induced atherosclerosis
and abdominal aortic aneurysms in male apolipoprotein e deficient mice. Toxicol
Appl Pharmacol. 2011;257:148-154
Kopf PG, Scott JA, Agbor LN, Boberg JR, Elased KM, Huwe JK, Walker MK.
Cytochrome p4501a1 is required for vascular dysfunction and hypertension
induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci. 2010;117:537-546
Kopf PG, Walker MK. 2,3,7,8-tetrachlorodibenzo-p-dioxin increases reactive
oxygen species production in human endothelial cells via induction of
cytochrome p4501a1. Toxicol Appl Pharmacol. 2010;245:91-99
Han SG, Eum SY, Toborek M, Smart E, Hennig B. Polychlorinated biphenylinduced vcam-1 expression is attenuated in aortic endothelial cells isolated from
caveolin-1 deficient mice. Toxicol Appl Pharmacol. 2010;246:74-82
Espandiari P, Glauert HP, Lehmler HJ, Lee EY, Srinivasan C, Robertson LW.
Polychlorinated biphenyls as initiators in liver carcinogenesis: Resistant
hepatocyte model. Toxicol Appl Pharmacol. 2003;186:55-62
Oakley GG, Robertson LW, Gupta RC. Analysis of polychlorinated biphenyl-DNA
adducts by 32p-postlabeling. Carcinogenesis. 1996;17:109-114
Pereg D, Robertson LW, Gupta RC. DNA adduction by polychlorinated
biphenyls: Adducts derived from hepatic microsomal activation and from
synthetic metabolites. Chem Biol Interact. 2002;139:129-144
Hass JR, Jao LT, Wilson NK, Matthews HB. Metabolism of 4-chlorobiphenyl and
4,4'-dichlorobiphenyl in the rat: Qualitative and quantitative aspects. Journal of
agricultural and food chemistry. 1977;25:1330-1333
de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappab signaling
in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25:904-914
147

160.

161.
162.
163.
164.
165.

166.

167.
168.

169.

170.
171.
172.

173.

174.

Goncharov A, Haase RF, Santiago-Rivera A, Morse G, McCaffrey RJ, Rej R,
Carpenter DO. High serum pcbs are associated with elevation of serum lipids
and cardiovascular disease in a native american population. Environ Res.
2008;106:226-239
Faroon O, Jones D, de Rosa C. Effects of polychlorinated biphenyls on the
nervous system. Toxicology and industrial health. 2000;16:305-333
Newman J, Gallo MV, Schell LM, DeCaprio AP, Denham M, Deane GD,
Akwesasne Task Force on E. Analysis of pcb congeners related to cognitive
functioning in adolescents. Neurotoxicology. 2009;30:686-696
Mayura K, Spainhour CB, Howie L, Safe S, Phillips TD. Teratogenicity and
immunotoxicity of 3,3',4,4',5-pentachlorobiphenyl in c57bl/6 mice. Toxicology.
1993;77:123-131
Lim EJ, Smart EJ, Toborek M, Hennig B. The role of caveolin-1 in pcb77-induced
enos phosphorylation in human-derived endothelial cells. American Journal of
Physiology - Heart and Circulatory Physiology. 2007;293:H3340-H3347
Ramadass P, Meerarani P, Toborek M, Robertson LW, Hennig B. Dietary
flavonoids modulate pcb-induced oxidative stress, cyp1a1 induction, and ahrDNA binding activity in vascular endothelial cells. Toxicological Sciences.
2003;76:212-219
White RD, Shea D, Schlezinger JJ, Hahn ME, Stegeman JJ. In vitro metabolism
of polychlorinated biphenyl congeners by beluga whale (delphinapterus leucas)
and pilot whale (globicephala melas) and relationship to cytochrome p450
expression. Comparative biochemistry and physiology. Toxicology &
pharmacology : CBP. 2000;126:267-284
Alcock RE, Behnisch PA, Jones KC, Hagenmaier H. Dioxin-like pcbs in the
environment - human exposure and the significance of sources. Chemosphere.
1998;37:1457-1472
Jokinen MP, Walker NJ, Brix AE, Sells DM, Haseman JK, Nyska A. Increase in
cardiovascular pathology in female sprague-dawley rats following chronic
treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,3',4,4',5pentachlorobiphenyl. Cardiovasc Toxicol. 2003;3:299-310
Lai I, Chai Y, Simmons D, Luthe G, Coleman MC, Spitz D, Haschek WM,
Ludewig G, Robertson LW. Acute toxicity of 3,3',4,4',5-pentachlorobiphenyl (pcb
126) in male sprague-dawley rats: Effects on hepatic oxidative stress, glutathione
and metals status. Environ Int. 2010;36:918-923
Alkhouri N, Gornicka A, Berk MP, Thapaliya S, Dixon LJ, Kashyap S, Schauer
PR, Feldstein AE. Adipocyte apoptosis, a link between obesity, insulin
resistance, and hepatic steatosis. J Biol Chem. 2010;285:3428-3438
Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury.
Gastroenterology. 2008;134:1641-1654
Forgacs AL, Kent MN, Makley MK, Mets B, DelRaso N, Jahns GL, Burgoon LD,
Zacharewski TR, Reo NV. Comparative metabolomic and genomic analyses of
tcdd-elicited metabolic disruption in mouse and rat liver. Toxicol Sci.
2012;125:41-55
National Toxicology P. Ntp toxicology and carcinogenesis studies of 3,3',4,4',5pentachlorobiphenyl (pcb 126) (cas no. 57465-28-8) in female harlan spraguedawley rats (gavage studies). National Toxicology Program technical report
series. 2006:4-246
Fisher JW, Campbell J, Muralidhara S, Bruckner JV, Ferguson D, Mumtaz M,
Harmon B, Hedge JM, Crofton KM, Kim H, Almekinder TL. Effect of pcb 126 on
148

175.

176.
177.
178.
179.
180.
181.
182.
183.

184.

185.
186.

187.

188.

189.
190.

hepatic metabolism of thyroxine and perturbations in the hypothalamic-pituitarythyroid axis in the rat. Toxicol Sci. 2006;90:87-95
Kopec AK, Boverhof DR, Burgoon LD, Ibrahim-Aibo D, Harkema JR, Tashiro C,
Chittim B, Zacharewski TR. Comparative toxicogenomic examination of the
hepatic effects of pcb126 and tcdd in immature, ovariectomized c57bl/6 mice.
Toxicological Sciences. 2008;102:61-75
Koga N, Beppu M, Yoshimura H. Metabolism in vivo of 3,4,5,3',4'pentachlorobiphenyl and toxicological assessment of the metabolite in rats.
Journal of pharmacobio-dynamics. 1990;13:497-506
Philip W. Harvey KCR, Andrew Cockburn. Endocrine and hormonal toxicology.
1999;3:596
Schecter A. Dioxins and health. Springer; 1994.
Baraona E, Leo M, Borowsky S, Lieber C. Alcoholic hepatomegaly: Accumulation
of protein in the liver. Science. 1975;190:794-795
Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC.
Acute-phase response of human hepatocytes: Regulation of acute-phase protein
synthesis by interleukin-6. Hepatology. 1990;12:1179-1186
Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response.
The Biochemical journal. 1990;265:621-636
Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T,
Zinkernagel R, Bluethmann H, Kohler G. Impaired immune and acute-phase
responses in interleukin-6-deficient mice. Nature. 1994;368:339-342
Ichihara S, Yamada Y, Gonzalez FJ, Nakajima T, Murohara T, Ichihara G.
Inhibition of ischemia-induced angiogenesis by benzo[a]pyrene in a manner
dependent on the aryl hydrocarbon receptor. Biochemical and biophysical
research communications. 2009;381:44-49
Jensen BA, Leeman RJ, Schlezinger JJ, Sherr DH. Aryl hydrocarbon receptor
(ahr) agonists suppress interleukin-6 expression by bone marrow stromal cells:
An immunotoxicology study. Environmental health : a global access science
source. 2003;2:16
Puz P, Lasek-Bal A, Ziaja D, Kazibutowska Z, Ziaja K. Inflammatory markers in
patients with internal carotid artery stenosis. Archives of medical science : AMS.
2013;9:254-260
McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated
with chronic inflammation, smoking, diabetes, and visceral obesity: Downregulation with essential fatty acids, ethanol and pentoxifylline. Medical
hypotheses. 1999;52:465-477
Siow RC, Sato H, Leake DS, Ishii T, Bannai S, Mann GE. Induction of antioxidant
stress proteins in vascular endothelial and smooth muscle cells: Protective action
of vitamin c against atherogenic lipoproteins. Free radical research. 1999;31:309318
He M, Siow RC, Sugden D, Gao L, Cheng X, Mann GE. Induction of ho-1 and
redox signaling in endothelial cells by advanced glycation end products: A role
for nrf2 in vascular protection in diabetes. Nutr Metab Cardiovasc Dis.
2011;21:277-285
Speciale A, Chirafisi J, Saija A, Cimino F. Nutritional antioxidants and adaptive
cell responses: An update. Current molecular medicine. 2011;11:770-789
Yang YC, Lii CK, Wei YL, Li CC, Lu CY, Liu KL, Chen HW. Docosahexaenoic
acid inhibition of inflammation is partially via cross-talk between nrf2/heme
oxygenase 1 and ikk/nf-kappab pathways. J Nutr Biochem. 2013;24:204-212
149

191.

192.

193.
194.

195.

196.

197.
198.
199.

200.

201.

202.
203.

204.

Kopec AK, Burgoon LD, Ibrahim-Aibo D, Burg AR, Lee AW, Tashiro C, Potter D,
Sharratt B, Harkema JR, Rowlands JC, Budinsky RA, Zacharewski TR.
Automated dose-response analysis and comparative toxicogenomic evaluation of
the hepatic effects elicited by tcdd, tcdf, and pcb126 in c57bl/6 mice.
Toxicological Sciences. 2010;118:286-297
Zheng JL, Parfett C, Williams A, Yagminas A, Zhou G, Douglas GR, Yauk CL.
Assessment of subclinical, toxicant-induced hepatic gene expression profiles
after low-dose, short-term exposures in mice. Regulatory Toxicology and
Pharmacology. 2011;60:54-72
Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood
PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and
myocardial reinfarction: Diet and reinfarction trial (dart). Lancet. 1989;2:757-761
Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan
HS, Lau J. N-3 fatty acids from fish or fish-oil supplements, but not alphalinolenic acid, benefit cardiovascular disease outcomes in primary- and
secondary-prevention studies: A systematic review. Am J Clin Nutr. 2006;84:5-17
Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A,
Hoogeveen R, Folsom AR, Heiss G. Low-grade systemic inflammation and the
development of type 2 diabetes: The atherosclerosis risk in communities study.
Diabetes. 2003;52:1799-1805
Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy
subjects: Associations with obesity, insulin resistance, and endothelial
dysfunction: A potential role for cytokines originating from adipose tissue?
Arterioscler Thromb Vasc Biol. 1999;19:972-978
Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in
diabetes. Diabetes & vascular disease research : official journal of the
International Society of Diabetes and Vascular Disease. 2007;4:84-88
Wong ET, Tergaonkar V. Roles of nf-kappab in health and disease: Mechanisms
and therapeutic potential. Clin Sci (Lond). 2009;116:451-465
Hennig B, Lei W, Arzuaga X, Ghosh DD, Saraswathi V, Toborek M. Linoleic acid
induces proinflammatory events in vascular endothelial cells via activation of
pi3k/akt and erk1/2 signaling. The Journal of Nutritional Biochemistry.
2006;17:766-772
Toborek M, Blanc EM, Kaiser S, Mattson MP, Hennig B. Linoleic acid potentiates
tnf-mediated oxidative stress, disruption of calcium homeostasis, and apoptosis
of cultured vascular endothelial cells. Journal of Lipid Research. 1997;38:21552167
Ye S, Tan L, Ma J, Shi Q, Li J. Polyunsaturated docosahexaenoic acid
suppresses oxidative stress induced endothelial cell calcium influx by altering
lipid composition in membrane caveolar rafts. Prostaglandins Leukot Essent
Fatty Acids. 2010;83:37-43
Iso H. Changes in coronary heart disease risk among japanese. Circulation.
2008;118:2725-2729
Turunen AW, Jula A, Suominen AL, Mannisto S, Marniemi J, Kiviranta H,
Tiittanen P, Karanko H, Moilanen L, Nieminen MS, Kesaniemi YA, Kahonen M,
Verkasalo PK. Fish consumption, omega-3 fatty acids, and environmental
contaminants in relation to low-grade inflammation and early atherosclerosis.
Environ Res. 2013;120:43-54
Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, Zanoni G, Vidari G, Blackwell
TS, Montine TJ, Milne GL, McLaughlin B, Morrow JD. Electrophilic
cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the
150

205.

206.

207.
208.
209.
210.

211.
212.
213.
214.
215.
216.
217.

218.
219.

peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J
Biol Chem. 2008;283:19927-19935
Gao L, Wang J, Sekhar KR, Yin H, Yared NF, Schneider SN, Sasi S, Dalton TP,
Anderson ME, Chan JY, Morrow JD, Freeman ML. Novel n-3 fatty acid oxidation
products activate nrf2 by destabilizing the association between keap1 and
cullin3. J Biol Chem. 2007;282:2529-2537
Roberts LJ, 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S,
Dettbarn WD, Morrow JD. Formation of isoprostane-like compounds
(neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem.
1998;273:13605-13612
Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin e1 and protectin d1
activate inflammation-resolution programmes. Nature. 2007;447:869-874
Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L. Atherosclerosis: Evidence
for impairment of resolution of vascular inflammation governed by specific lipid
mediators. FASEB J. 2008;22:3595-3606
Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, Serhan CN, Colgan
SP. Resolvin e1 promotes mucosal surface clearance of neutrophils: A new
paradigm for inflammatory resolution. FASEB J. 2007;21:3162-3170
Rogers LK, Valentine CJ, Pennell M, Velten M, Britt RD, Dingess K, Zhao X,
Welty SE, Tipple TE. Maternal docosahexaenoic acid supplementation
decreases lung inflammation in hyperoxia-exposed newborn mice. The Journal of
Nutrition. 2011;141:214-222
Watkins BA, Li Y, Seifert MF. Dietary ratio of n-6/n-3 pufas and docosahexaenoic
acid: Actions on bone mineral and serum biomarkers in ovariectomized rats. J
Nutr Biochem. 2006;17:282-289
Chen YJ, Chen CC, Li TK, Wang PH, Liu LR, Chang FY, Wang YC, Yu YH, Lin
SP, Mersmann HJ, Ding ST. Docosahexaenoic acid suppresses the expression
of foxo and its target genes. J Nutr Biochem. 2012;23:1609-1616
Daugherty A, Manning MW, Cassis LA. Angiotensin ii promotes atherosclerotic
lesions and aneurysms in apolipoprotein e–deficient mice. The Journal of Clinical
Investigation. 2000;105:1605-1612
Jiao S, Cole TG, Kitchens RT, Pfleger B, Schonfeld G. Genetic heterogeneity of
plasma lipoproteins in the mouse: Control of low density lipoprotein particle sizes
by genetic factors. J Lipid Res. 1990;31:467-477
Yang WC, Adamec J, Regnier FE. Enhancement of the lc/ms analysis of fatty
acids through derivatization and stable isotope coding. Analytical chemistry.
2007;79:5150-5157
Deems R, Buczynski MW, Bowers-Gentry R, Harkewicz R, Dennis EA. Detection
and quantitation of eicosanoids via high performance liquid chromatographyelectrospray ionization-mass spectrometry. Methods Enzymol. 2007;432:59-82
Gomolka B, Siegert E, Blossey K, Schunck WH, Rothe M, Weylandt KH. Analysis
of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human
and mouse blood samples. Prostaglandins & other lipid mediators. 2011;94:8187
Masoodi M, Nicolaou A. Lipidomic analysis of twenty-seven prostanoids and
isoprostanes by liquid chromatography/electrospray tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM. 2006;20:3023-3029
Delanty N, Reilly M, Pratico D, FitzGerald DJ, Lawson JA, FitzGerald GA. 8-epi
pgf2 alpha: Specific analysis of an isoeicosanoid as an index of oxidant stress in
vivo. British journal of clinical pharmacology. 1996;42:15-19
151

220.
221.
222.
223.

224.

225.

226.
227.
228.

229.
230.

231.
232.
233.

Basu S. Oxidative injury induced cyclooxygenase activation in experimental
hepatotoxicity. Biochemical and biophysical research communications.
1999;254:764-767
Yoshida Y, Hayakawa M, Habuchi Y, Itoh N, Niki E. Evaluation of lipophilic
antioxidant efficacy in vivo by the biomarkers hydroxyoctadecadienoic acid and
isoprostane. Lipids. 2007;42:463-472
Claria J, Nguyen BT, Madenci AL, Ozaki CK, Serhan CN. Diversity of lipid
mediators in human adipose tissue depots. American journal of physiology. Cell
physiology. 2013;304:C1141-1149
Sapieha P, Stahl A, Chen J, Seaward MR, Willett KL, Krah NM, Dennison RJ,
Connor KM, Aderman CM, Liclican E, Carughi A, Perelman D, Kanaoka Y,
Sangiovanni JP, Gronert K, Smith LE. 5-lipoxygenase metabolite 4-hdha is a
mediator of the antiangiogenic effect of omega-3 polyunsaturated fatty acids.
Science translational medicine. 2011;3:69ra12
Stephensen CB, Armstrong P, Newman JW, Pedersen TL, Legault J, Schuster
GU, Kelley D, Vikman S, Hartiala J, Nassir R, Seldin MF, Allayee H. Alox5 gene
variants affect eicosanoid production and response to fish oil supplementation. J
Lipid Res. 2011;52:991-1003
McDaniel JC, Massey K, Nicolaou A. Fish oil supplementation alters levels of
lipid mediators of inflammation in microenvironment of acute human wounds.
Wound repair and regeneration : official publication of the Wound Healing
Society [and] the European Tissue Repair Society. 2011;19:189-200
Duttaroy AK, Spener F, Wiley J. Cellular proteins and their fatty acids in health
and disease. Wiley Online Library; 2003.
Kansanen E, Kivela AM, Levonen AL. Regulation of nrf2-dependent gene
expression by 15-deoxy-delta12,14-prostaglandin j2. Free Radic Biol Med.
2009;47:1310-1317
Rollins MD, Sudarshan S, Firpo MA, Etherington BH, Hart BJ, Jackson HH,
Jackson JD, Emerson LL, Yang DT, Mulvihill SJ, Glasgow RE. Anti-inflammatory
effects of ppar-gamma agonists directly correlate with ppar-gamma expression
during acute pancreatitis. Journal of gastrointestinal surgery : official journal of
the Society for Surgery of the Alimentary Tract. 2006;10:1120-1130
Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of
large gene lists using david bioinformatics resources. Nature protocols.
2009;4:44-57
Sierra S, Lara-Villoslada F, Comalada Mn, Olivares Mn, Xaus J. Dietary
eicosapentaenoic acid and docosahexaenoic acid equally incorporate as
decosahexaenoic acid but differ in inflammatory effects. Nutrition. 2008;24:245254
Arterburn LM, Boswell KD, Lawlor T, Cifone MA, Murli H, Kyle DJ. In vitro
genotoxicity testing of arasco® and dhasco® oils. Food and Chemical
Toxicology. 2000;38:971-976
Abuzaytoun R, Shahidi F. Oxidative stability of algal oils as affected by their
minor components. Journal of agricultural and food chemistry. 2006;54:82538260
Beyer A, Biziuk M. Environmental fate and global distribution of polychlorinated
biphenyls

reviews of environmental contamination and toxicology vol 201. In: Whitacre DM, ed.:
Springer US; 2009:137-158.

152

234.

235.
236.

237.
238.

239.

240.
241.

242.

243.

244.

245.

246.
247.

Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A.
Incorporation of epa and dha into plasma phospholipids in response to different
omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs.
Krill oil. Lipids Health Dis. 2011;10:145
Plourde M, Chouinard-Watkins R, Vandal M, Zhang Y, Lawrence P, Brenna JT,
Cunnane S. Plasma incorporation, apparent retroconversion and beta-oxidation
of 13c-docosahexaenoic acid in the elderly. Nutrition & Metabolism. 2011;8:5
Gronn M, Christensen E, Hagve TA, Christophersen BO. Peroxisomal
retroconversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid
(20:5(n-3)) studied in isolated rat liver cells. Biochimica et biophysica acta.
1991;1081:85-91
Conquer JA, Holub BJ. Dietary docosahexaenoic acid as a source of
eicosapentaenoic acid in vegetarians and omnivores. Lipids. 1997;32:341-345
Stark KD, Holub BJ. Differential eicosapentaenoic acid elevations and altered
cardiovascular disease risk factor responses after supplementation with
docosahexaenoic acid in postmenopausal women receiving and not receiving
hormone replacement therapy. The American Journal of Clinical Nutrition.
2004;79:765-773
Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E,
Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V, Claria J. Obesityinduced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty
acids: A role for resolvins and protectins. FASEB J. 2009;23:1946-1957
Lehrke M, Lazar MA. Inflamed about obesity. Nature medicine. 2004;10:126-127
Berger J, Bailey P, Biswas C, Cullinan CA, Doebber TW, Hayes NS, Saperstein
R, Smith RG, Leibowitz MD. Thiazolidinediones produce a conformational
change in peroxisomal proliferator-activated receptor-gamma: Binding and
activation correlate with antidiabetic actions in db/db mice. Endocrinology.
1996;137:4189-4195
Yu YH, Lin EC, Wu SC, Cheng WT, Mersmann HJ, Wang PH, Ding ST.
Docosahexaenoic acid regulates adipogenic genes in myoblasts via porcine
peroxisome proliferator-activated receptor gamma. Journal of animal science.
2008;86:3385-3392
Awazawa M, Ueki K, Inabe K, Yamauchi T, Kubota N, Kaneko K, Kobayashi M,
Iwane A, Sasako T, Okazaki Y, Ohsugi M, Takamoto I, Yamashita S, Asahara H,
Akira S, Kasuga M, Kadowaki T. Adiponectin enhances insulin sensitivity by
increasing hepatic irs-2 expression via a macrophage-derived il-6-dependent
pathway. Cell metabolism. 2011;13:401-412
CHU I, VILLENEUVE DC, YAGMINAS A, LECAVALIER P, POON R, FEELEY M,
KENNEDY SW, SEEGAL RF, HÄKANSSON H, AHLBORG UG, VALLI VE.
Subchronic toxicity of 3,3′,4,4′,5-pentachlorobiphenyl in the rat: I. Clinical,
biochemical, hematological, and histopathological changes. Toxicological
Sciences. 1994;22:457-468
Arzuaga X, Ren N, Stromberg A, Black EP, Arsenescu V, Cassis LA, Majkova Z,
Toborek M, Hennig B. Induction of gene pattern changes associated with
dysfunctional lipid metabolism induced by dietary fat and exposure to a persistent
organic pollutant. Toxicol Lett. 2009;189:96-101
Masi LN, Rodrigues AC, Curi R. Fatty acids regulation of inflammatory and
metabolic genes. Current opinion in clinical nutrition and metabolic care.
2013;16:418-424
Wang S, Matthan NR, Wu D, Reed DB, Bapat P, Yin X, Grammas P, Shen C-L,
Lichtenstein AH. Lipid content in hepatic and gonadal adipose tissue parallel
153

248.

249.
250.
251.
252.

253.
254.
255.
256.

257.

258.
259.
260.
261.
262.

aortic cholesterol accumulation in mice fed diets with different omega-6 pufa to
epa plus dha ratios. Clinical Nutrition. 2013
Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF,
Varghese Z. Epa and dha reduce lps-induced inflammation responses in hk-2
cells: Evidence for a ppar-[gamma]-dependent mechanism. Kidney Int.
2005;67:867-874
Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit nf-kappab
activation via a pparalpha-dependent pathway. Arterioscler Thromb Vasc Biol.
2004;24:1621-1627
Trinchieri G. Interleukin-12: A proinflammatory cytokine with immunoregulatory
functions that bridge innate resistance and antigen-specific adaptive immunity.
Annual Review of Immunology. 1995;13:251-276
Matsumoto K, Morita I, Hibino H, Murota S. Inhibitory effect of docosahexaenoic
acid-containing phospholipids on 5-lipoxygenase in rat basophilic leukemia cells.
Prostaglandins Leukot Essent Fatty Acids. 1993;49:861-866
German JB, Lokesh B, Kinsella JE. The effect of dietary fish oils on eicosanoid
biosynthesis in peritoneal macrophages is influenced by both dietary n-6
polyunsaturated fats and total dietary fat. Prostaglandins, Leukotrienes and
Essential Fatty Acids. 1988;34:37-45
Touyz RM, Schiffrin EL. Peroxisome proliferator-activated receptors in vascular
biology-molecular mechanisms and clinical implications. Vascular pharmacology.
2006;45:19-28
Arzuaga X, Reiterer G, Majkova Z, Toborek M, B H. Ppar-alpha agonists protect
against pcb-induced vascular endothelial cell activation. 9th Annual Gill Heart
Institute Cardiovascular Research Day. 2006
Arzuaga X, Reiterer G, Majkova Z, Kilgore M, Toborek M, Hennig B. Pparî±
ligands reduce pcb-induced endothelial activation: Possible interactions in
inflammation and atherosclerosis. Cardiovascular Toxicology. 2007;7:264-272
Cho H-Y, Gladwell W, Wang X, Chorley B, Bell D, Reddy SP, Kleeberger SR.
Nrf2-regulated pparγ expression is critical to protection against acute lung injury
in mice. American Journal of Respiratory and Critical Care Medicine.
2010;182:170-182
Jover R, Hoffmann F, Scheffler-Koch V, Lindberg RLP. Limited heme synthesis
in porphobilinogen deaminase-deficient mice impairs transcriptional activation of
specific cytochrome p450 genes by phenobarbital. European Journal of
Biochemistry. 2000;267:7128-7137
Gurusamy N, Goswami S, Malik G, Das DK. Oxidative injury induces selective
rather than global inhibition of proteasomal activity. Journal of Molecular and
Cellular Cardiology. 2008;44:419-428
Donohue TM, Zetterman RK, Zhang-Gouillon Z-Q, French SW. Peptidase
activities of the multicatalytic protease in rat liver after voluntary and intragastric
ethanol administration. Hepatology. 1998;28:486-491
French S. Mechanisms of alcoholic liver injury. Canadian Journal of
Gastroenterology. 2000;14:327 - 332
Oliva J, French SW, Li J, Bardag-Gorce F. Proteasome inhibitor treatment
reduced fatty acid, triacylglycerol and cholesterol synthesis. Experimental and
Molecular Pathology. 2012;93:26-34
Welch CL, Xia YR, Shechter I, Farese R, Mehrabian M, Mehdizadeh S, Warden
CH, Lusis AJ. Genetic regulation of cholesterol homeostasis: Chromosomal
organization of candidate genes. Journal of Lipid Research. 1996;37:1406-1421
154

263.
264.
265.
266.
267.
268.
269.

270.
271.

272.
273.
274.
275.
276.
277.
278.
279.
280.

Lobo S, Wiczer BM, Bernlohr DA. Functional analysis of long-chain acyl-coa
synthetase 1 in 3t3-l1 adipocytes. J Biol Chem. 2009;284:18347-18356
Monsalve FA, Pyarasani RD, Delgado-Lopez F, Moore-Carrasco R. Peroxisome
proliferator-activated receptor targets for the treatment of metabolic diseases.
Mediators of inflammation. 2013;2013:549627
Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, Stoilov I. Comparative
expression profiling of 40 mouse cytochrome p450 genes in embryonic and adult
tissues. Archives of Biochemistry and Biophysics. 2003;414:91-100
Feng S, Cao Z, Wang X. Role of aryl hydrocarbon receptor in cancer. Biochimica
et biophysica acta. 2013;1836:197-210
Rockett BD, Franklin A, Harris M, Teague H, Rockett A, Shaikh SR. Membrane
raft organization is more sensitive to disruption by (n-3) pufa than nonraft
organization in el4 and b cells. J Nutr. 2011;141:1041-1048
Fessler MB, Parks JS. Intracellular lipid flux and membrane microdomains as
organizing principles in inflammatory cell signaling. J Immunol. 2011;187:15291535
Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, Jacobs DR, Jr. A
strong dose-response relation between serum concentrations of persistent
organic pollutants and diabetes: Results from the national health and
examination survey 1999-2002. Diabetes Care. 2006;29:1638-1644
Majkova Z, Toborek M, Hennig B. The role of caveolae in endothelial cell
dysfunction with a focus on nutrition and environmental toxicants. J Cell Mol
Med. 2010;14:2359-2370
Yorita Christensen KL, White P. A methodological approach to assessing the
health impact of environmental chemical mixtures: Pcbs and hypertension in the
national health and nutrition examination survey. International journal of
environmental research and public health. 2011;8:4220-4237
Xu Y, Buikema H, van Gilst WH, Henning RH. Caveolae and endothelial
dysfunction: Filling the caves in cardiovascular disease. Eur J Pharmacol.
2008;585:256-260
Parton RG, Joggerst B, Simons K. Regulated internalization of caveolae. The
Journal of cell biology. 1994;127:1199-1215
Parton RG, Howes MT. Revisiting caveolin trafficking: The end of the
caveosome. The Journal of cell biology. 2010;191:439-441
Hayer A, Stoeber M, Ritz D, Engel S, Meyer HH, Helenius A. Caveolin-1 is
ubiquitinated and targeted to intralumenal vesicles in endolysosomes for
degradation. The Journal of cell biology. 2010;191:615-629
Parton RG, del Pozo MA. Caveolae as plasma membrane sensors, protectors
and organizers. Nature reviews. Molecular cell biology. 2013;14:98-112
Pelkmans L, Bürli T, Zerial M, Helenius A. Caveolin-stabilized membrane
domains as multifunctional transport and sorting devices in endocytic membrane
traffic. Cell. 2004;118:767-780
Blanco AM, Perez-Arago A, Fernandez-Lizarbe S, Guerri C. Ethanol mimics
ligand-mediated activation and endocytosis of il-1ri/tlr4 receptors via lipid rafts
caveolae in astroglial cells. Journal of Neurochemistry. 2008;106:625-639
Martin MU, Wesche H. Summary and comparison of the signaling mechanisms
of the toll/interleukin-1 receptor family. Biochimica et biophysica acta.
2002;1592:265-280
Takeda K, Akira S. Tlr signaling pathways. Seminars in immunology. 2004;16:3-9

155

281.
282.
283.
284.

285.
286.
287.

288.
289.
290.
291.
292.
293.
294.
295.

296.

297.

Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O,
Sugiyama M, Okabe M, Takeda K, Akira S. Role of adaptor trif in the myd88independent toll-like receptor signaling pathway. Science. 2003;301:640-643
Hyun J, Kanagavelu S, Fukata M. A unique host defense pathway: Trif mediates
both antiviral and antibacterial immune responses. Microbes and infection /
Institut Pasteur. 2013;15:1-10
Pestka J, Zhou HR. Toll-like receptor priming sensitizes macrophages to
proinflammatory cytokine gene induction by deoxynivalenol and other toxicants.
Toxicol Sci. 2006;92:445-455
Doz E, Noulin N, Boichot E, Guenon I, Fick L, Le Bert M, Lagente V, Ryffel B,
Schnyder B, Quesniaux VF, Couillin I. Cigarette smoke-induced pulmonary
inflammation is tlr4/myd88 and il-1r1/myd88 signaling dependent. J Immunol.
2008;180:1169-1178
Curtiss LK, Tobias PS. Emerging role of toll-like receptors in atherosclerosis. J
Lipid Res. 2009;50 Suppl:S340-345
Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E,
Willeit J, Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N
Engl J Med. 2002;347:185-192
Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S,
Rajavashisth TB, Arditi M. Lack of toll-like receptor 4 or myeloid differentiation
factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient
in apolipoprotein e. Proc Natl Acad Sci U S A. 2004;101:10679-10684
Li H, Sun B. Toll-like receptor 4 in atherosclerosis. J Cell Mol Med. 2007;11:8895
den Dekker WK, Cheng C, Pasterkamp G, Duckers HJ. Toll like receptor 4 in
atherosclerosis and plaque destabilization. Atherosclerosis. 2010;209:314-320
Singh RD, Marks DL, Pagano RE. Using fluorescent sphingolipid analogs to
study intracellular lipid trafficking. Current protocols in cell biology. John Wiley &
Sons, Inc.; 2001.
Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane
cholesterol content: Evidence, misconceptions and control strategies. Biochimica
et Biophysica Acta (BBA) - Biomembranes. 2007;1768:1311-1324
Levitan I, Christian AE, Tulenko TN, Rothblat GH. Membrane cholesterol content
modulates activation of volume-regulated anion current in bovine endothelial
cells. The Journal of General Physiology. 2000;115:405-416
Mueller M, Brandenburg K, Dedrick R, Schromm AB, Seydel U. Phospholipids
inhibit lipopolysaccharide (lps)-induced cell activation: A role for lps-binding
protein. The Journal of Immunology. 2005;174:1091-1096
Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H. Tak-242 selectively
suppresses toll-like receptor 4-signaling mediated by the intracellular domain.
Eur J Pharmacol. 2008;584:40-48
Yoshimura H, Yonemoto Y, Yamada H, Koga N, Oguri K, Saeki S. Metabolism in
vivo of 3,4,3',4'-tetrachlorobiphenyl and toxicological assessment of the
metabolites in rats. Xenobiotica; the fate of foreign compounds in biological
systems. 1987;17:897-910
Wehler EK, Bergman A, Brandt I, Darnerud PO, Wachtmeister CA. 3,3',4,4'tetrachlorobiphenyl. Excretion and tissue retention of hydroxylated metabolites in
the mouse. Drug metabolism and disposition: the biological fate of chemicals.
1989;17:441-448
Maitra U, Deng H, Glaros T, Baker B, Capelluto DG, Li Z, Li L. Molecular
mechanisms responsible for the selective and low-grade induction of
156

298.
299.

300.
301.
302.
303.
304.
305.
306.
307.
308.
309.
310.
311.
312.

313.

proinflammatory mediators in murine macrophages by lipopolysaccharide. J
Immunol. 2012;189:1014-1023
Murphey ED, Fang G, Varma TK, Sherwood ER. Improved bacterial clearance
and decreased mortality can be induced by lps tolerance and is not dependent
upon ifn-gamma. Shock. 2007;27:289-295
Fu C, He J, Li C, Shyy JYJ, Zhu Y. Cholesterol increases adhesion of monocytes
to endothelium by moving adhesion molecules out of caveolae. Biochimica et
Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2010;1801:702710
Patel HH, Murray F, Insel PA. Caveolae as organizers of pharmacologically
relevant signal transduction molecules. Annual review of pharmacology and
toxicology. 2008;48:359-391
Huot PSP, Sarkar B, Ma DWL. Conjugated linoleic acid alters caveolae
phospholipid fatty acid composition and decreases caveolin-1 expression in mcf7 breast cancer cells. Nutrition Research. 2010;30:179-185
Dunzendorfer S, Lee H-K, Soldau K, Tobias PS. Toll-like receptor 4 functions
intracellularly in human coronary artery endothelial cells: Roles of lbp and scd14
in mediating lps-responses. The FASEB Journal. 2004;18:1117-1119
Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F,
Kagan JC. Cd14 controls the lps-induced endocytosis of toll-like receptor 4. Cell.
2011;147:868-880
Lloyd KL, Kubes P. Gpi-linked endothelial cd14 contributes to the detection of
lps. American journal of physiology. Heart and circulatory physiology.
2006;291:H473-481
Lloyd-Jones KL, Kelly MM, Kubes P. Varying importance of soluble and
membrane cd14 in endothelial detection of lipopolysaccharide. J Immunol.
2008;181:1446-1453
Hennig B, Hammock BD, Slim R, Toborek M, Saraswathi V, Robertson LW. Pcbinduced oxidative stress in endothelial cells: Modulation by nutrients. Int J Hyg
Environ Health. 2002;205:95-102
Eske K, Newsome B, Han SG, Murphy M, Bhattacharyya D, Hennig B. Pcb 77
dechlorination products modulate pro-inflammatory events in vascular endothelial
cells. Environmental science and pollution research international. 2013
Collins FS, Gray GM, Bucher JR. Toxicology. Transforming environmental health
protection. Science. 2008;319:906-907
Ambrose AM, Booth AN, Deeds F, Cox AJ. A toxicological study of biphenyl, a
citrus fungistat. Journal of Food Science. 1960;25:328-336
EPA US. Health and environmental effects profile for 1,1'-biphenyl. 1984
Gui M, Ormsbee LE, Bhattacharyya D. Reactive functionalized membranes for
polychlorinated biphenyl degradation. Industrial & Engineering Chemistry
Research. 2013;52:10430-10440
Pieterse B, Felzel E, Winter RE, Van Der Burg B, Brouwer A. Pah-calux, an
optimized bioassay for ahr-mediated hazard identification of polycyclic aromatic
hydrocarbons (pahs) as individual compounds and in complex mixtures. Environ
Sci Technol. 2013
Hadrup N, Taxvig C, Pedersen M, Nellemann C, Hass U, Vinggaard AM.
Concentration addition, independent action and generalized concentration
addition models for mixture effect prediction of sex hormone synthesis in vitro.
PloS one. 2013;8:e70490

157

314.
315.

316.
317.

318.
319.
320.
321.

322.
323.
324.

325.
326.

327.

Daughton CG. The matthew effect and widely prescribed pharmaceuticals
lacking environmental monitoring: Case study of an exposure-assessment
vulnerability. The Science of the total environment. 2013;466-467C:315-325
Hennig B, Ormsbee L, Bachas L, Silverstone A, Milner J, Carpenter D,
Thompson C, Suk WA. Introductory comments: Nutrition, environmental toxins
and implications in prevention and intervention of human diseases. J Nutr
Biochem. 2007;18:161-162
Consonni D, Sindaco R, Bertazzi PA. Blood levels of dioxins, furans, dioxin-like
pcbs, and teqs in general populations: A review, 1989–2010. Environment
International. 2012;44:151-162
Yamazaki K, Suzuki M, Itoh T, Yamamoto K, Kanemitsu M, Matsumura C,
Nakano T, Sakaki T, Fukami Y, Imaishi H, Inui H. Structural basis of species
differences between human and experimental animal cyp1a1s in metabolism of
3,3′,4,4′,5-pentachlorobiphenyl. Journal of Biochemistry. 2011;149:487-494
Fromme H, Albrecht M, Boehmer S, Büchner K, Mayer R, Liebl B, Wittsiepe J,
Bolte G. Intake and body burden of dioxin-like compounds in germany: The ines
study. Chemosphere. 2009;76:1457-1463
Deckelbaum RJ, Worgall TS, Seo T. N-3 fatty acids and gene expression. Am J
Clin Nutr. 2006;83:1520S-1525S
Hennig B, Reiterer G, Majkova Z, Oesterling E, Meerarani P, Toborek M.
Modification of environmental toxicity by nutrients: Implications in atherosclerosis.
Cardiovasc Toxicol. 2005;5:153-160
Tiesset H, Pierre M, Desseyn JL, Guery B, Beermann C, Galabert C, Gottrand F,
Husson MO. Dietary (n-3) polyunsaturated fatty acids affect the kinetics of proand antiinflammatory responses in mice with pseudomonas aeruginosa lung
infection. J Nutr. 2009;139:82-89
Baker NA. Polychlorinated biphenyl ligands of the aryl hydrocarbon receptor
promote adipocyte-mediated diabetes. Nutritional Sciences. 2013;Ph.D. of
Nutritional Science
Lichtenstein AH, Kennedy E, Barrier P, Danford D, Ernst ND, Grundy SM,
Leveille GA, Van Horn L, Williams CL, Booth SL. Dietary fat consumption and
health. Nutrition Reviews. 1998;56:3-19
Reeves PG, Nielsen FH, Fahey GC, Jr. Ain-93 purified diets for laboratory
rodents: Final report of the american institute of nutrition ad hoc writing
committee on the reformulation of the ain-76a rodent diet. J Nutr. 1993;123:19391951
Sethi S, Ziouzenkova O, Ni H, Wagner DD, Plutzky J, Mayadas TN. Oxidized
omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through
activation of ppar alpha. Blood. 2002;100:1340-1346
Pelham CJ, Keen HL, Lentz SR, Sigmund CD. Dominant negative pparγ
promotes atherosclerosis, vascular dysfunction, and hypertension through
distinct effects in endothelium and vascular muscle. American Journal of
Physiology - Regulatory, Integrative and Comparative Physiology.
2013;304:R690-R701
Schopfer FJ, Cole MP, Groeger AL, Chen CS, Khoo NK, Woodcock SR, GolinBisello F, Motanya UN, Li Y, Zhang J, Garcia-Barrio MT, Rudolph TK, Rudolph V,
Bonacci G, Baker PR, Xu HE, Batthyany CI, Chen YE, Hallis TM, Freeman BA.
Covalent peroxisome proliferator-activated receptor gamma adduction by nitrofatty acids: Selective ligand activity and anti-diabetic signaling actions. J Biol
Chem. 2010;285:12321-12333
158

328.
329.

330.
331.

332.
333.
334.
335.
336.

337.
338.

339.

340.
341.
342.
343.

Trostchansky A, Bonilla L, Gonzalez-Perilli L, Rubbo H. Nitro-fatty acids:
Formation, redox signaling, and therapeutic potential. Antioxidants & redox
signaling. 2012
Kansanen E, Bonacci G, Schopfer FJ, Kuosmanen SM, Tong KI, Leinonen H,
Woodcock SR, Yamamoto M, Carlberg C, Yla-Herttuala S, Freeman BA,
Levonen AL. Electrophilic nitro-fatty acids activate nrf2 by a keap1 cysteine 151independent mechanism. J Biol Chem. 2011;286:14019-14027
Freeman BA, Baker PR, Schopfer FJ, Woodcock SR, Napolitano A, d'Ischia M.
Nitro-fatty acid formation and signaling. J Biol Chem. 2008;283:15515-15519
Lefils-Lacourtablaise J, Socorro M, Geloen A, Daira P, Debard C, Loizon E,
Guichardant M, Dominguez Z, Vidal H, Lagarde M, Bernoud-Hubac N. The
eicosapentaenoic acid metabolite 15-deoxy-delta(12,14)-prostaglandin j3
increases adiponectin secretion by adipocytes partly via a ppargammadependent mechanism. PloS one. 2013;8:e63997
Leonarduzzi G, Gamba P, Gargiulo S, Biasi F, Poli G. Inflammation-related gene
expression by lipid oxidation-derived products in the progression of
atherosclerosis. Free Radic Biol Med. 2012;52:19-34
Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In vivo.
1999;13:295-309
Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontology
2000. 2013;63:149-164
Yaqoob P, Shaikh SR. The nutritional and clinical significance of lipid rafts.
Current opinion in clinical nutrition and metabolic care. 2010;13:156-166
Walton KA, Cole AL, Yeh M, Subbanagounder G, Krutzik SR, Modlin RL, Lucas
RM, Nakai J, Smart EJ, Vora DK, Berliner JA. Specific phospholipid oxidation
products inhibit ligand activation of toll-like receptors 4 and 2. Arteriosclerosis,
Thrombosis, and Vascular Biology. 2003;23:1197-1203
Lidington EA, Moyes DL, McCormack AM, Rose ML. A comparison of primary
endothelial cells and endothelial cell lines for studies of immune interactions.
Transplant immunology. 1999;7:239-246
Bauerfeld CP, Rastogi R, Pirockinaite G, Lee I, Huttemann M, Monks B,
Birnbaum MJ, Franchi L, Nunez G, Samavati L. Tlr4-mediated akt activation is
myd88/trif dependent and critical for induction of oxidative phosphorylation and
mitochondrial transcription factor a in murine macrophages. J Immunol.
2012;188:2847-2857
Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N, Hwang DH.
Reciprocal modulation of toll-like receptor-4 signaling pathways involving myd88
and phosphatidylinositol 3-kinase/akt by saturated and polyunsaturated fatty
acids. Journal of Biological Chemistry. 2003;278:37041-37051
Laird MH, Rhee SH, Perkins DJ, Medvedev AE, Piao W, Fenton MJ, Vogel SN.
Tlr4/myd88/pi3k interactions regulate tlr4 signaling. Journal of leukocyte biology.
2009;85:966-977
Arcaro A, Aubert M, Espinosa del Hierro ME, Khanzada UK, Angelidou S, Tetley
TD, Bittermann AG, Frame MC, Seckl MJ. Critical role for lipid raft-associated src
kinases in activation of pi3k-akt signalling. Cellular signalling. 2007;19:1081-1092
Deng H, Maitra U, Morris M, Li L. Molecular mechanism responsible for the
priming of macrophage activation. J Biol Chem. 2013;288:3897-3906
Hutchinson TH, Lyons BP, Thain JE, Law RJ. Evaluating legacy contaminants
and emerging chemicals in marine environments using adverse outcome
pathways and biological effects-directed analysis. Marine pollution bulletin. 2013
159

344.
345.

346.
347.
348.
349.
350.

Kim MJ, Pelloux V, Guyot E, Tordjman J, Bui L-C, Chevallier A, Forest C, Benelli
C, Clément K, Barouki R. Inflammatory pathway genes belong to major targets of
persistent organic pollutants in adipose cells. Environ Health Perspect. 2012;120
Rossmeislová L, Mališová L, Kračmerová J, Tencerová M, Kováčová Z, Koc M,
Šiklová-Vítková M, Viquerie N, Langin D, Štich V. Weight loss improves the
adipogenic capacity of human preadipocytes and modulates their secretory
profile. Diabetes. 2013;62:1990-1995
Herder C, Baumert J, Thorand B, Koenig W, Jager W, Meisinger C, Illig T, Martin
S, Kolb H. Chemokines as risk factors for type 2 diabetes: Results from the
monica/kora augsburg study, 1984–2002. Diabetologia. 2006;49:921-929
Everett CJ, Mainous Iii AG, Frithsen IL, Player MS, Matheson EM. Association of
polychlorinated biphenyls with hypertension in the 1999–2002 national health
and nutrition examination survey. Environmental Research. 2008;108:94-97
Lind L, Lind PM. Can persistent organic pollutants and plastic-associated
chemicals cause cardiovascular disease? Journal of internal medicine.
2012;271:537-553
Zheng Y, Toborek M, Hennig B. Epigallocatechin gallate-mediated protection
against tumor necrosis factor-α - induced monocyte chemoattractant protein-1
expression is heme oxygenase-1 dependent. Metabolism. 2010;59:1528-1535
Zhao L, Lee JY, Hwang DH. Inhibition of pattern recognition receptor-mediated
inflammation by bioactive phytochemicals. Nutrition Reviews. 2011;69:310-320

160

Vita
Katryn Elizabeth Eske

A. Education
Messiah College
Grantham, PA

Graduate Research Assistant, Doctoral Candidate

2002-2006

University of Kentucky 2009-Present
Lexington, KY

B.S. in Biochemistry

05/06

Ph.D. in Nutritional Science Candidate

B. Personal Statement
Nutrition as a modulator of environmentally induced disease is my key research
interest. I have a broad background in basic science including nutritional science,
environmental toxicology, and genomics. My research experience has included gene
sequencing, genotyping, in vitro work with primary cell cultures, basic animal
handling, animal diet formulation, Western blotting, real time-PCR, and ELISA. I am
familiar with basic toxicological testing techniques and have tested remediation
mixtures. My research has given me the opportunity to experience cross-disciplinary
collaborations. I was mentored within the University of Kentucky Superfund
Research Program (UK-SRP), which trained me to communicate scientific research
to both scientific and lay audiences. Following this training, I have had opportunities
to communicate our research to government officials and staff, members of the
Kentucky Department of Environmental Protection and to teachers involved in
secondary education. In addition, I have had the opportunity to mentor several
undergraduate students and have found the mentorship process to be very
rewarding. In the future, I intend to incorporate a cross-disciplinary focus in my
research and plan to develop my ability to successfully mentor students. I have
interests in expanding my research to the public health and international arenas. My
background with the UK-SRP has provided me with a broad understanding of the
environmental and physiological consequences of pollution, which will support future
collaborative work.
C. Positions and Honors
Positions and Employment
Summer 2003
Laboratory Assistant, TestAmerica, Inc., Watertown, WI
Nov. 2002 – May 2005 Natural Sciences Team Leader, Water for the World
(student group), Grantham, PA
Summer 2005

Laboratory Assistant, SMART Program of Baylor College
of Medicine, Houston, TX

Aug. 2004 – May 2006 Supplemental Instruction Leader, Messiah College,
Grantham, PA
Spring 2005 & 2006

Senior Research, Messiah College, Grantham, PA

161

Aug. 2006 – June 2009 Research Technologist I, Medical College of Wisconsin,
Milwaukee, WI
July 2009 – Present

Graduate Research Assistant, University of Kentucky,
Lexington, KY
Other Experiences and Professional Memberships
Spring 2010 – Present Student/Postdoc/Alumni Network (SPAN) Committee,
Superfund Research Program, Research Triangle Park,
NC
Dec. 2011 – Present Society of Toxicology Student Member, Society of
toxicology, Reston, VA
May 2012 – Present Nutritional Sciences Student Association Secretary,
Graduate Center for Nutritional Sciences, Lexington, KY
Dec. 2012 – Present American Society for Nutrition Student Member, American
Society for Nutrition, Bethesda, MD
Honors
Spring 2013
Pfizer Predoctoral Fellowship from the American

Society for Nutrition
D. Peer Reviewed Publications
Eske K, Newsome B, Han SG, Murphy M, Bhattacharyya D, Hennig B (2013)
PCB 77 dechlorination products modulate pro-inflammatory events in vascular
endothelial cells. Environmental science and pollution research international.
doi:10.1007/s11356-013-1591-3
E. Oral Presentations
Eske K: PCBs and Cardiovascular Disease – The Role of Fatty Acids. Fighting
with Foods Teacher’s Training Workshop; Middletown, OH, June 26, 2013.
Eske K: The Role of PCBs in inflammatory diseases. Nutritional Sciences
Seminar Series; Lexington, KY, October 10, 2012.
Eske K: PCBs and Cardiovascular Disease – The Role of Fatty Acids. Fighting
with Foods Teacher’s Training Workshop; Middletown, OH, June 20, 2012.
Eske K: PCBs and Cardiovascular Disease: The Role of Fatty Acids. Fighting
with Foods Teacher’s Training Workshop; Cold Spring, KY, June 27, 2012.
Eske K: Therapeutic properties of omega-3 fatty acids against inflammatory
stressors. Nutritional Sciences Seminar Series; Lexington, KY, March 23, 2011.
Eske K and Murphy M: PCBs and Cardiovascular Disease – Understanding the
Risk and Implementing Interventions. Kentucky Department of Environmental
Protection Seminar Series; Frankfort, KY, August 18, 2010.
F. Abstracts
Eske K, Murphy M, Petriello P, Newsome B, Han SG, Hennig B: Dietary DHA
promotes an anti-oxidant response in mice exposed to environmental pollutants.
Experimental Biology 2013; April 20-24, 2013; Boston, MA
162

Eske K, Murphy M, Petriello P, Newsome B, Han SG, Hennig B: Dietary DHA
promotes an anti-oxidant response in mice exposed to environmental pollutants.
8th Annual Center for Clinical and Translational Science Spring Conference; April
8, 2013; Lexington, KY
Eske K, Newsome B, Murphy M, Han SG, Bhattacharyya D, Hennig B: PCB77
dechlorination mixtures alter proinflammatory events in vascular endothelial cells.
25th Annual Superfund Basic Research Program Meeting; October 21-24, 2012;
Raleigh, NC
Eske K, Brock R, Layne J, Petriello M, Hennig B: TLR4 signaling and
subsequent inflammation is modulated by 3,3’,4,4’,5-pentachlorobiphenyl (PCB
126) and LPS. 21st Annual South East Lipid Research Conference; September
27-29, 2012; Pine Mountain, GA
Eske K and Murphy M: University of Kentucky Superfund Research Program.
Connecting Research and Practice: A Dialogue between ATSDR and the NIEHS
Superfund Research Program Workshop; August 7-8, 2012; Atlanta, GA
Eske K, Murphy M, Layne J, Han SG, Hennig B: Toxicity and inflammatory
endpoints in C57BL/6 mice exposed to different doses of 3,3’,4,4’,5pentachlorobiphenyl (PCB 126). 2012 Barnstable Brown Obesity & Diabetes
Research Day; May 14, 2012; Lexington, KY
Eske K, Murphy M, Layne J, Han SG, Hennig B: Toxicity and inflammatory
endpoints in C57BL/6 mice exposed to different doses of 3,3’,4,4’,5pentachlorobiphenyl (PCB 126). 51st Annual Meeting of the Society of
Toxicology; March 11-15, 2012; San Francisco, CA
Eske K, Murphy M, Layne J, Newsome B, Han SG, Hennig B: Dose response of
3,3’,4,4’,5-pentachlorobiphenyl (PCB 126) exposure on toxicity and inflammatory
endpoints in C57BL/6 mice. Superfund Research Program Annual Meeting 2011;
October 24-25, 2011; Lexington, KY
Eske K, Murphy M, Layne J, Han SG, Hennig B: Toxicity and inflammatory
endpoints in C57BL/6 mice exposed to different doses of 3,3’,4,4’,5pentachlorobiphenyl (PCB 126). Gill Heart Institute Cardiovascular Research Day
2011; October 21, 2011; Lexington, KY
Eske K, Murphy M, Layne J, Han SG, Barton, Hennig B: Dose response of
3,3’,4,4’,5-pentachlorobiphenyl (PCB 126) exposure on toxicity and inflammatory
endpoints in C57BL/6 mice. OVSOT 2011 Annual Fall Meeting; September 23,
2011; Dayton, OH

163

Eske K, Han SG, Barton CR, Palumbo AN, Majkova Z, Zahran EM, Bachas DB,
Toborek M, Hennig B: PCB77 dechlorination mixtures modulate pro-inflammatory
events in vascular endothelial cells. 50th Annual Society of Toxicology Meeting;
March 6-10, 2011; Washington, D.C.
Eske K, Han SG, Barton CR, Palumbo AN, Majkova Z, Zahran EM, Bachas DB,
Toborek M, Hennig B: PCB77 dechlorination mixtures modulate pro-inflammatory
events in vascular endothelial cells. 2010 John P. Wyatt Symposium on
Environmental Health and Disease; November 19, 2010; Lexington, KY
Eske K, Han SG, Barton CR, Palumbo AN, Majkova Z, Zahran EM, Bachas DB,
Toborek M, Hennig B: PCB77 dechlorination mixtures modulate pro-inflammatory
events in vascular endothelial cells. 23rd Annual Superfund Basic Research
Program Meeting; November 10-12, 2010; Portland, OR
G. Support
Pfizer Predoctoral Fellowship from the American Society for Nutrition
Spring 2013
The University of Kentucky Superfund Basic Research Program Interdisciplinary
Training Grant
Spring 2011 – spring 2012

164

